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Julia Margaret Allen 
 
 
 The first synthesis and full characterization of a new functionality, called the 
diaziridinium ion, is reported.  The original synthetic intent behind its design was to 
explore its potential use as a non-metal based N-transfer reagent.  During this study, we 
have uncovered a practical rearrangement to access 2,3-benzodiazepines reliably and 
efficiently.  Efforts to achieve N-transfer from these species are described and are 
ongoing. 
 We have identified the tropylium ion as a highly efficient organic-based amine 
oxidant and have demonstrated its practical use in a one-pot protocol for α-aminonitrile 
synthesis.  We also report an application of this new oxidant towards an aza-Cope 
rearrangement. 
 Finally, we report a multicatalytic method that uses bismuth(III) triflate to 
catalyze a nucleophilic addition to an aldehyde followed by hydroalkoxylation to 
generate highly functionalized tetrahydrofuran rings, a motif that is often encountered in 
natural product architectures. 
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Studies Toward the Use of Diaziridinium Ions as 
Non-Metal Based N-Transfer Reagents1 
 
 
I.  Introduction 
 
The ubiquity of nitrogen-containing products, ranging from material to medicinal, 
and the limited number of methods currently available to directly introduce nitrogen into 
hydrocarbons have provided our group with an impetus to create a new functional group, 
termed the diaziridinium ion, that could perhaps serve as a new nitrogen-transfer reagent.  
Towards this goal, we have successfully synthesized and isolated the first diaziridinium 
ion and have uncovered a unique benzodiazepine rearrangement pathway.  Although we 
have not yet observed N-transfer, we have demonstrated use of this novel functionality in 
the practical synthesis of 2,3-benzodiazepines from a wide variety of easily prepared 
isoquinoline-based diaziridines.  
We hypothesized that one of the most synthetically useful N-transfer applications 
to be accomplished by these diaziridinium ions is olefin aziridination.  Aziridines not 
only provide versatile, chiral building blocks for organic synthesis, but are also a vital 
functionality for the biological activity of many natural products, such as the mitomycin, 
porifiromycin, mitiromycin, azinomycin, and PBI families.2  The most prevalent 
aziridination methods today utilize metals such as Mn, Cu, Rh, Ru, and Ag to facilitate 
nitrene transfer to olefins and carbene transfer to imines.3  Despite the obvious 
advantages of metal-free conditions, such as reduced toxicity and the use of 
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environmentally friendly reagents, the field of organocatalysis is highly underdeveloped 
with regard to aziridination methods. 
 Given their structural similarity, we hypothesized that the nitrogen-transfer 
behavior of the diaziridinium ion should be analogous to the olefin epoxidation and C-H 
oxidation chemistry of dioxiranes, oxaziridines, and oxaziridinium ions that has been so 
widely established in the synthetic community (Figure 1). 
 
Figure 1.  Established O-transfer reagents and their proposed N-analog. 
 
 
Dioxiranes, oxaziridines, and oxaziridinium ions comprise the large majority of 
known organocatalytic heteroatom-transfer reagents that are in use today.  While 
dioxiranes and oxazirinium ions are used solely as O-transfer reagents, oxaziridines have 
a dual role in both O- and N- transfer reactions.   
 Dioxiranes are a powerful class of oxidants well known for their ability to 
efficiently carry out olefin epoxidations and C-H bond hydroxylations.4  These reagents 
have dominated the field of organocatalytic O-transfer for years because of their powerful 
reactivity, mild reaction conditions, and most of all their ability to induce asymmetry.  
Edwards and Curci first demonstrated the oxidizing power of dioxiranes by generating 




Figure 2.  First in situ generation of dioxiranes for alkene epoxidation. 
 
 
The mechanism for this electrophilic oxygen-transfer is syn stereospecific and 
occurs in a cis-spiro transition state that is analogous to the butterfly mechanism of olefin 
epoxidations by peroxyacids (Figure 3).6  Oxygen-transfer from dioxiranes, however, is 
typically much more rapid than from peroxides because it is accompanied by relief of 
ring strain and an enthalpic gain associated with strong C=O π-bond formation.  For 
example, epoxidation of cyclohexene occurs with a rate constant of 1.4 M-1s-1 with 
DMDO but the rate constant decreases to 1.9 x 10-2 M-1s-1 when peroxybenzoic acid is 
used as the oxidant. 
 
Figure 3.  Mechanism for electrophilic oxygen-atom transfer from dioxiranes. 
 
 
 One significant advantage to being able to generate these dioxiranes in situ is the 
possibility for catalysis because the ketone catalyst is regenerated after the epoxidation 
step.  In 1984, Curci reported the first catalytic procedure by which chiral ketones were 




Figure 4.  First attempts at asymmetric epoxidations with dioxiranes. 
 
 
 This discovery inspired many groups to begin working to design chiral ketones as 
asymmetric epoxidaton catalysts.  Among the multitude of ketone catalysts that have 















Figure 5.  Representative chiral ketone epoxidation catalysts. 
 
 
 Perhaps the most well known O-transfer reagent used today is Shi’s D-fructose 
derived chiral dioxirane.13  Shi has demonstrated use of his catalytic system in the 
asymmetric epoxidation of a variety of substrates, including trans- and tri-substituted 















 Although not as widely exploited in synthesis as dioxiranes, oxaziridines have 
also been extensively used as both eletrophilic O- and N-transfer reagents and are 
operationally similar to dioxiranes.14  Oxaziridines are typically prepared by oxidation of 
the imine precursor, either by mCPBA or oxone.  In contrast to the high reactivity of 
dioxiranes, however, oxaziridines are very stable and require strong nucleophiles such as 
enolates to facilitate oxygen transfer. 
 Similarly to their dioxirane counterpart, the synthetic utility of these reagents 
depends greatly on their ability to induce asymmetry during oxidation.  In 1983, Davis et 
al. made the first chiral oxaziridines that effectively carried out alkene epoxidation in a 








Figure 7.  Asymmetric epoxidations with Davis’ chiral 2-sulfonyloxaziridines. 
 
 
 Davis,16 Uchinda,17 and Evans18 have all demonstrated use of oxaziridines in 
Rubottom-type reactions during which a preformed enolate reacts with the oxaziridines to 
install  α-hydroxy carbonyl functionality with substrate-controlled enantioselectivity.  A 
few years later, Davis developed a chiral, camphor-derived sulfonyloxaziridine that is 
highly effective in carrying out reagent-controlled, asymmetric hydroxylations (Figure 
8).19   
 
Figure 8.  Hydroxylations with Davis’ chiral camphorsulfonyl oxaziridine. 
 
 
 DuBois et al. designed the first oxaziridine catalyst capable of hydroxylating 
unactivated tertiary C-H bonds.  They demonstrated the oxidation power of these species 
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by carrying out H2O2-catalyzed C-H and alkene oxidation, co-catalyzed by Ar2Se2 and a 
novel benzoxathiazine oxaziridine.  During the catalytic cycle, the diselenide reacts with 
H2O2 to produce perseleninic acid, which then serves as the oxidant for the formation of 
the oxaziridine from the corresponding imine.  This catalytic cycle provides a highly 
economical way to carry out both alkene and C-H bond oxidations (Figure 9). 
 




 One very unique property of oxaziridines in comparison to dioxiranes and 
oxaziridinium ion is that, in addition to serving as an electrophilic source of oxygen, 
oxaziridines have also seen use as nitrogen-transfer reagents.  Oxaziridines with bulky 
groups on the nitrogen favor oxygen transfer, whereas those with small groups on 
nitrogen act as aminating agents.   
 Hata et al.20 and Schmitz21 have shown that secondary amines react with 
oxaziridines to form hydrazines, and primary amines react to form azo compounds that 
result from subsequent oxidation of the hydrazine intermediate (Figure 10). Thiols, 
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sulfonates, and thiocyanates all react with oxaziridines to provide their S-substituted 
counterpart in good yield.     
 
Figure 10.  Reaction of amines with oxaziridines. 
 
 
In addition, oxaziridines have been used as reagents in the O-amination of alkoxides 
(Figure 11).22 
 
Figure 11. O-amination of alkoxides by oxaziridines. 
 
 
 Although aromatic alkene aziridinations using certain oxaziridines have been 
reported, they generally require relatively forcing conditions to achieve moderate product 
yields and cannot be applied to aliphatic alkenes (Figure 12).23 
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Figure 12. Alkene aziridinations with oxaziridines. 
 
 
 While oxaziridines react with mild nucleophiles such as alkenes, their N-alkylated 
partner, the oxaziridinium ion, is extremely reactive towards nucleophilic substrates such 
as alkenes.  These species are readily prepared by either N-alkylation of an oxaziridine 
with trimethyloxonium tetrafluoroborate or by oxidation of iminium salts with either 
oxone or a peracid.  Oxaziridinium ions were first reported in the literature by Lusinchi, 
where his preliminary work indicated that this functional group could indeed serve as a 
catalytic epoxidation reagent (Figure 13).24  In the catalytic cycle, the iminium catalyst is 
oxidized with mCPBA.  Comparison studies have shown this method, using 10 mol% of 
the iminium ion catalyst, to be significantly more rapid than the traditional epoxidation 







Figure 13.  First report of an oxiridinium ion serving as an epoxidation catalyst. 
 
 
 Lusinchi then went on to synthesize the first chiral oxaziridinium ion, which was 
easily prepared in five steps from norephedrin.25  This catalyst induces some asymmetry 
during epoxidation, with ee values up to 42%.  Epoxidation is believed to occur by a 
single step process, as in the butterfly mechanism, because complete retention of 
stereochemistry is observed (Figure 14).   
 
Figure 14.  Epoxidations with the first chiral oxaziridinium salt. 
 
 
 Aggerwal et al. has prepared a binapthalene-derived iminium salt that catalyzes 
asymmetric epoxidations under similar conditions, using oxone as the co-oxidant, with 
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moderate ee values as well.  Here, they are able to epoxidize 1-phenylcyclohexene with a 
71% ee and an 80% yield.26   
 In addition to oxaziridines, diaziridines represent another class of aza-analogs to 
well-known epoxidation reagents.  These reagents have been shown to carry out 
aziridinations as a nucleophilic source of nitrogen.  Upon deprotonation, these reagents 
have been shown to undergo a conjugate addition with α,β-unsaturated carbonyl 
compounds to form the corresponding aziridines in good yield (Figure 15).27 
 
Figure 15.  Diaziridines as N-transfer reagents. 
 
 
 Similarily, a bis-hydrazinium has demonstrated similar conjugate addition 
aziridination reactivity in the presence of a base with excellent yield (Figure 16).28  This 
reaction proceeds by deprotonation of the hydrazinium ion to provide an ylide that 
undergoes Michael addition/ring closure to form the aziridine product.  Again, the 








Figure 16.  Bis-hydrazinium dication as a N-transfer reagent. 
 
 
 In addition to these stoichemetric aziridination methods, oganocatalytic 
aziridination have been demonstrated in several other contexts.   Armstrong et al. has 
extended this idea of using N-N ylides for aziridinations to develop a novel procedure for 
organocatalytic aziridination of chalcone derivatives using 50 mol% N-methylmorpholine 
(NMM), O-(diphenylphosphinyl)hydroxylamine, and NaOH (Figure 17).29  Notably, 
when quinine is used as the base, enantioselectivity up to 56% was observed. 
 
Figure 17.  Armstrong’s organocatalytic azirdination method. 
 
 
 There have been a number of conditions that have been developed to synthesize 
Tosyl- and Cbz-protected aziridines.  One report by Ando et al. showed that a 
chloramine-T/iodine system is highly effective at carrying out catalytic alkene 
aziridinations to yield the N-tosyl aziridine product (Figure 18).30 
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 Sharpless deomstrated a similar bromine-catalyzed system using chloramines-T as 
the nitrogen source.  In this system, PTAB (phenyltrimethyammonium tribromide) serves 
as a source of Br+ to initiate the catalytic cycle with alkene activation followed by 
nucleophilic attack on the bromonium ion by chloramine-T (Figure 19).31  
 
Figure 19.  Catalytic Br/chloramines-T aziridination method. 
 
 
 Vesely et al. were the first to develop a highly enantioselective, organocatalytic 
method for the aziridination of α,β-unsaturated aldehydes.32  In this method, a chiral 
amine catalyst is used to direct the addition of the acetyl hydroxycarbamate nitrogen 
atom source (Figure 20).  Here, excellent ee values of up to 99% are achieved.  However, 






Figure 20.  Organocatalytic, enantioselective enal aziridination. 
 
 
 Due to the underdevelopment of organic reagents able to facilitate olefin 
aziridinations and the limited substrate scope that accompanies these reactions, we sought 
to explore a new functional group, the diaziridinium ion, as a potential aziridination 
reagent (Figure 21).  
 
Figure 21.  Proposed diaziridinium ion mediated alkene aziridination. 
 
 
Although the synthesis and isolation of a diaziridinium ion has yet to be reported, 
the reaction intermediacy of this functional group has been implied in select cases of 
diaziridine alkylation and acylation reactions.  The first experimental study of N-
alkylation of diaziridines was carried out by Makhova et al.33  Here, during an attempted 
diaziridine alkylation to synthesize 1,2-dialkylaziridines, they proposed an unstable, 
transient diaziridinium ion intermediate that decomposed to the corresponding ketone, 
secondary amine, and ammonia precursors upon treatment with water (Figure 22).  No 
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1,2-dialkylated aziridine product was isolated.  Makhova subsequently noted that an 
effective way to alkylate the unsubstituted nitrogen atom of a N-monoalkyldiaziridine is 
to first deprotonate it with sodium amide followed by electrophilic addition. 
 
Figure 22.  Proposed alkylated diaziridinium intermediate by Makhova et al. 
 
 
In a related work by Shustov et al., the treatment of a diaziridine with an acid 
chloride provided an 85% product yield as mixture of N-acetyldiaziridine and N-acyl 
hydrazone that presumably arose by a diaziridinium ion intermediate (Figure 23).34  
When this reaction was carried out on a bicyclic diaziridine, acylation selectively 
occurred at the tertiary nitrogen and provided only the hydrazone product in a 79% yield. 
 




Interestingly, Schmitz reported in 1958 that, while many diaziridines are stable as 
a protonated salt, other diaziridines breakdown to the ketone or aldehyde precursor and a 
hydrazine when heated with aqueous mineral acids.35  He proposed that hydrolysis takes 
place by one of two possible mechanisms: (i) by ionization of the protonated 
diaziridinium ion to the carbocation in an SN1 pathway if a polar solvent is used or (ii) by 
cleavage of the N-N bond by hydride migration from an adjacent carbon atom if a non-
polar, organic solvent is used (Figure 24). 
 
Figure 24.  Two diaziridinium ion hydrolysis pathways proposed by Schmitz. 
 
 
Because N-N bond cleavage is a very stereoelectronically demanding process, 
many diaziridines that do not contain C-H bonds properly oriented to assist in this 
cleavage are stable to HCl/CCl4.  Examples of such diaziridines include unsubstituted 
diaziridines, N-monoalkylated diaziridines, and some sterically rigid N,N-








A theoretical study of diaziridinium ions by Houk and coworkers has indicated 
that such species should in fact be stable and theoretical calculations predict N-transfer 
from diazidinium ions to be significantly more facile than from their oxaziridine 
counterpart.  These diaziridinium ions generally have a lower activation energy for olefin 
aziridination than that of oxaziridines on the basis that a protonated amine is a better 
leaving group than an alkoxide (Figure 26).36   
 
Figure 26.  Comparison of activation energies for aziridination of ethylene with 
oxaziridinium and diaziridinium ions. 
 
 
Houk’s studies have also shown that diaziridinium ions should prefer to react with 
electron-rich olefins as indicated by an activation energy of 2.1 kcal/mol for 
methoxyethene versus that of 18.6 kcal/mol for acrylonitrile.  This observation begs the 
question as to whether over amination via N-transfer to aziridine products could occur.  
In this case, it may be necessary to use N-protected diaziridinium salts.  Houk has shown 
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that N-trifluoroacetyl diaziridinium ions (12.4 kcal/mol) have a slightly higher 
aziridination activation energy than the N-unsubstituted derivative (11.2 kcal/mol), so 
installation of this substituent should indeed be feasible. 
It is believed that aziridination by diaziridinium ions should operate similarily to 
the butterfly-like peracid epoxidation mechanism.  The preferred spiro geometry is 
predicted to allow for maximum orbital overlap between the lone pair of the nitrogen to 
be transferred with the alkene LUMO as well as the π-bond of the alkene with the 
diaziridinium N-N σ* bond (Figure 27). 
 




 While we have not been able to demonstrate use of these diaziridinium salts as N-
transfer reagents to date, we did, however, uncover in the study of this new functionality 
a new facile rearrangement for the synthesis of 2,3-benzodiazepines (Figure 28).  We 
have found that isoquinoline-based diaziridines react with electrophiles such as 
trimethyloxonium tetrafluoroborate and acid chlorides to form transient diaziridinium 
ions that undergo ring expansion to form 2,3-benzodiazepines.  We believe this 
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rearrangement to be general and to serve as a practical method to generate 2,3-
benzodiazepines. 
 
Figure 28.  Electrophilic addition to diaziridines to form 2,3-benzodiazepines. 
 
 
Benzodiazepines have seen wide use in the area of drug discovery because of 
their anticonvulsant, sedative, anxiolytic (anti-anxiety), and muscle relaxant properties.  
The 1,4-benzodiazepine isomer comprises the majority of the benzodiazepine-derived 
drugs that are currently on the market (Figure 29).   
 
Figure 29.  A few widely used 1,4-benzodiazepine-derived drugs. 
 
 
Perhaps the most well known example is Valium, also known as diazepam, which 
has been marketed by Hoffman-La Roche since 1963 to treat anxiety, insomnia, seizures, 
alcohol withdrawal, and other disorders.  Others, such as temazepam (to treat insomnia), 
clonazepam (to prevent seizures), midazolam (for sedation), and alprazolam (to treat 
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anxiety) are widely used as well.  These 1,4-benzodiazepines enhance the binding of the 
neutrotransmitter GABA (γ-aminobutyric acid) to the GABA receptor complex.  This 
binding causes an increase in chloride flux into the cell, and the subsequent 
hyperpolarization results in decreased neuronal firing.   
Similarly, 2,3-benzodiazepines have been shown to exhibit anticonvulsant 
properties37 as well as behavior as a neuroprotective agent in ischemia.38  In contrast with 
their 1,4-isomer, these 2,3-benzodiazepines typically do not possess sedative properties.  
The activity in these compounds arises because they act as a non-competitive antagonist 
at AMPA receptors, which mediate synaptic transmission in the CNS.  For example, 
benzodiazepine GYKI 52466 has been shown to possess strong anitconvulsant properties 
(Figure 30). 
 
Figure 30.  2,3-benzodiazepine GYKI 52466, which acts as an anticonvulsant. 
 
 
 The current, principle method for 2,3-benzodiazepine synthesis involves 
intramolecular condensation of a hydrazone with an ester or carboxylic acid (Figure 
31).39  Chaplan et al. have used a sequence that begins with the nucleophilic coupling of 
an aryl alcohol with an aryl ketone followed by Friedel-Crafts ring closure to form a 
bicyclic ether.  Subsequent Jones oxidation opens the ring and allows for hydrazone 
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formation followed by ring closure to form the desired benzodiazepine.  While this 
procedure provides a simple, three-step approach to benzodiazepine synthesis, the use of 
strong acid throughout the synthesis limits the functional group tolerance of the method.  
The Friedel-Crafts step greatly constrains the synthesis in two key regards:  (i) it restricts 
the electronic variance of the aryl ring by requiring very electron-rich substituents, such 
as a methoxy group, and (ii) it necessitates the presence of a second aryl ring at the C1 
position of the benzodiazepine ring, greatly limiting functional group variance at that 
position.  Other very similar syntheses have been reported, but similar structural 
requirements limit the variance of this core 2,3-benzodiazepine motif.40  
 
Figure 31.  Hydrazone condensation approach to 2,3-benzodiazepine synthesis. 
 
 
Because of the promising development of 2,3-benzodiazepines in the medicinal 
chemistry community as potential therapeutic agents for the treatment of epilepsy and 
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cerebral ischemia and the limited methods currently available to build this motif, we 
believe that a new route for 2,3-benzodiazepine synthesis stands as a worthwhile goal. 
 
II.  Experimental Results 
 
Our studies of the diaziridinium functionality began with attempts to synthesize 
diaziridinium ion 1.  The isoquinoline framework was chosen based on the precedent 
established by Lusinchi et al, in which oxaziridinium ion 2 was shown to efficiently carry 
out olefin epoxidations (Figure 32).41  
 




 In hopes of employing similar heteroatom transfer reactivity, we set out to 
synthesize diaziridinium ion 1.  We found that imine 3 is easily accessible from 
commercially available 1,2,3,4-tetrahydroisoqinoline via NBS oxidation in 77% yield.42  
Our initial approach to diaziridinium ion synthesis involved treatment methyl iminium 






Figure 33.  Initial diaziridinium ion preparation attempt. 
 
 
 With failure of this approach, we decided to first form the diaziridine ring and 
then attempt to selectively alkylate the tertiary nitrogen.  To synthesize isoquinoline 
diaziridine 5, we initially followed an established procedure by Eckenhoff et al. that 
involved treating the imine with hydroxylaminesulfonic acid and triethylamine in ethanol 
at 0 °C.43  Later, we found that a similar method by Ortega and coworkers, which uses 
ammonium hydroxide in methanol instead of TEA in ethanol, is much higher yielding 
and more reliable (Figure 34).44 
 
Figure 34.  Preparation of isoquinoline-based diaziridine 5. 
 
 
 Following a similar methylation procedure for the synthesis of oxaziridinium 
ions,45 we found that regiospecific N-alkylation of the tertiary nitrogen of diaziridine 5 
could be achieved using trimethyloxonium tetrafluoroborate (Meerwein’s salt).  
Subsequent recrystallization by dissolving the crude yellow oil in a hot 1:1 DCM/ethyl 
acetate solvent mixture followed by the addition of hexanes yielded the desired 




Figure 35.  Successful preparation of diaziridinium ion 1. 
 
 
 Happily, we were able to successfully synthesize this new functionality in just 
three steps from the inexpensive, commercially availability tetrahydroisoquinoline 
starting material.  The stability of this diaziridinium ion was quite surprising to us.  Under 
argon, diaziridinium ion 1 can be stored indefinitely at 5 °C as no decomposition has 
been observed at this temperature.  At room temperature, however, the diaziridinium ion 
slowly decomposes over time into an oil of unidentified structure.  Diaziridinium salt 1 
stands as the first diaziridinium salt to be isolated and characterized, with its structure 
confirmed by X-ray crystallography (Figure 36).46  
 
Figure 36.  X-ray crystal structure of diaziridinium salt 1.  
 
                          
 
 
 With a viable synthetic protocol for diaziridinium ion 1 in hand, we set out to 
investigate our principle goal of N-transfer with various olefin substrates.  We carried out 
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many aziridination attempts using olefin substrates such as 4-phenyl-1-butene, cis- and 
trans- stilbene, α-pinene, 3-carene, styrene, cyclododecene, methyl acrylate, as well as 
strained alkene substrates such as norbornylene.  Tertiary C-H amination attempts of 
decalin and adamantane substrates using diaziridinium ion 1 were also unsuccessful.  
Unfortunately, we have observed no N-transfer to date.   
 Instead of undergoing the desired N-transfer with olefin substrates, diaziridinium 
ion 1 rearranges to the corresponding 2,3-benzodiazepine 6 at elevated temperatures in 
acetonitrile (Figure 37). 
 
Figure 37.  Benzodiazepine rearrangement of diaziridinium 1 at elevated temperatures. 
 
 
 Although this rearrangement was initially unexpected, we believed it to be 
mechanistically interesting and synthetically practical from the standpoint of 
benzodiazepine synthesis.  This sequence essentially represents insertion of a nitrogen 
atom into the dihydroisoquinoline starting material.  
 We then began to explore the impact of placing an alkyl substituent in the C1 
benzylic position of the diaziridine.  These substituted diaziridines were readily 
synthesized from commercially available phenethylamine derivatives in just three steps.  
For example, methyl-substituted diaziridine 7 was prepared by initial acetylation of 2-
phenethylamine.  Subsequent Bischler-Naplieralski cyclization of N-
phenethylethanamide provided 1-methyl-3,4-dihydroisoquinoline with an 81% yield.  
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Finally, treatment of this imine with hydroxylamine-O-sulfonic acid under basic 
conditions provided 1-methyl substituted diaziridine 7 in 63% yield (Figure 38). 
 
Figure 38.  Synthesis of C1-substituted isoquinoline-based diaziridines. 
 
 
 We noticed that placement of an alkyl substituent at the benzylic position 
destabilized the diaziridinium ion and made it impossible to isolate.  Upon methylation 
with Meerwein’s salt, we isolated the corresponding 2,3-benzodiazepine in an 82% yield 
after just 30 min at –40 °C (Figure 39).  
 
Figure 39.  Benzodiazepine rearrangement pathway for C1-substituted diaziridines. 
 
 
 The isolation of this benzodiazepine product suggests in situ formation of a 
transient diaziridinium ion intermediate that subsequently rearranges to cleanly provide 
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benzodiazepine 8 as the sole product.  When the reaction itself is conducted in an NMR 
tube in d3-MeCN, the only product that was observed is the protonated benzodiazepine 
product, which is neutralized upon work-up with NaHCO3.  
 We attribute the diaziridinium ion instability and the subsequent facile nature of 
this benzodiazepine rearrangement pathway to the presence of the benzylic methyl 
substituent.  We believe this alkyl group helps to stabilize the charge deficiency at the 
benzylic position during the course of this rearrangement, effectively weakening the 
benzylic C-NMe bond of the transient diaziridinium intermediate when compared to its 
unsubstituted counterpart (Figure 40).  This consequently weaker C-N bond destabilizes 
the diaziridinium ion and contributes to the facile nature of this benzodiazepine 
rearrangement even at low temperatures (–40 °C). 
 
Figure 40.  Substituent effects on diaziridinium stability. 
 
 
 Although the production of benzodiazepines was not our original intention when 
studying the diaziridinium functionality, we saw in this unexpected rearrangement an 
opportunity to create a viable method for the synthesis of 2,3-benzodiazepines from very 
simple and easily accessible isoquinoline-derived diaziridine precursors. 
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 To test the broad applications of this rearrangement, we have altered many 
substituents on the diaziridine framework as well as the type of electrophile used to 
initiate the rearrangement.  Although this study at the moment is incomplete, we have 
illustrated in Table 41 a number of diaziridines that efficiently rearrange upon alkylation 
with trimethyloxonium tetrafluoroborate in acetonitrile at –40 °C to form the 
corresponding benzodiazepine products.  Notably, we have efficiently synthesized seven 
benzodiazepines using this methylation technique.  Entry 3 shows that the electron-
deficient aryl ring of diaziridine 9 is well tolerated, providing a 93% yield of 
benzodiazepine 10.  A C4 methyl or phenyl substituent on diaziridines 11 and 13 has no 
impact on reaction efficiency, and the corresponding benzodiazepines 12 and 14 are 
provided in excellent yield (Entry 4 and 5).  As might be anticipated, our rearrangement 
proceeds smoothly with the presence of a phenyl ring as the C1 substituent to provide 
benzodiazepine 16 (Entry 6).  It should be noted, however, that formation of phenyl-
substituted diaziridine 15 using the method of Ortega et al. is a very low-yielding process 
due to steric constraints.  Interestingly, a trifluoromethyl group at the C1 position of 
diaziridine 17 caused a significant reduction in the reaction efficiency as indicated by the 
25% yield of benzodiazepine 18, presumably by inductive destabilization of a charge 








Table 41.  Substrate scope for the benzodiazepine rearrangement pathway. 
 
 
 We also found that treatment of diaziridines with electrophiles other than 
trimethyloxonium tetrafluoroborate could also facilitate a similar benzodiazepine 
rearrangement with a variety of functionality at the tertiary nitrogen atom (Table 42).  
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Treatment of diaziridines with acid chlorides results in ring expansion to the 
corresponding N-acylbenzodiazepine in excellent yield.  We again believe this 
rearrangement to proceed through a transient diaziridinium ion intermediate (Figure 43).   
 
Table 42.  Benzodiazepine rearrangement with acid chlorides. 
 
 
Figure 43.  Preparation of N-acylbenzodiazepines via N-acylation of diaziridines. 
 
 


































 The stability of these N-acyldiaziridinium ions has no apparent dependence on the 
presence of an alkyl substituent at the C1 benzylic position (Entry 1 and 2).  In stark 
contrast to the stability of the isolable N-methyldiaziridinium ion 1, the N-acyl 
diaziridinium ion counterpart only exists transiently and cannot be isolated.  This 
rearrangement is a practical extension of the aforementioned N-acylation of diaziridines 
to yield N-acyl hydrazones by Shustov et al.  In a similar rearrangement pathway, we 
have found that treatment of diaziridine 7 with benzyl chloroformate yields the 
corresponding Cbz-protected benzodiazepine 21 in good yield (Entry 3).  Formation of 
benzodiazepine 22  (Entry 4) demonstrates the extension of this acylation method 
towards aryl acid chlorides in the presence of various heteroatoms.  
 Ring expansion attempts to form benzodiazepines using other electrophiles have 
failed (Figure 44).  When diaziridine 5 was treated with 1.05 eq. of HCl in ether at 0 °C 
under our standard conditions, only decomposition was observed.  Alkylation attempts 
with diaziridine 5 using methyl iodide and allyl bromide at room temperature have failed 
due to no reactivity.  Surprisingly, both diaziridines 5 and 7 did not react with 
triethyloxonium tetrafluoroborate in a productive manner. Diaziridine 5 did not cleanly 
undergo ethylation to form a stable diaziridinium salt.  Similarly, diaziridine 7 did not 
undergo rearrangement to form a 2,3-benzodiazepine in acetonitrile at –40 °C as might be 
expected. Instead, in both cases starting material and decomposition to unidentified 










 Despite the efficiency of this 2,3-benzodiazepine rearrangement, we still hoped 
that the transient diaziridinium ion generated during this process might be able to 
undergo nitrogen-transfer in the presence of an olefin.  Aziridination attempts carried out 
by generating the diaziridinium ion in situ in the presence of olefins have failed, 
presumably due to the facile nature of this benzodiazepine rearrangement even at low 
temperatures.  For example, when diaziridine 7 was added to a solution of 
trimethyloxonium tetrafluoroborate and styrene in acetonitrile at –40 °C, only the 





Figure 45.  N-transfer attempts when generating a diaziridinium ion in situ. 
 
 
 Among the C1-substituted diaziridines, the CF3 functionalized one had the least 
tendency to undergo benzodiazepine rearrangement presumably due to inductive 
destabilization of a carbocation at the C1 benzylic position.  Therefore, we thought that it 
would be worthwhile to explore any potential N-transfer capabilities of its in situ 
generated diaziridinium ion counterpart (Figure 46).  Unfortunately, these aziridination 
attempts have failed and, once again, the only isolated product was the rearranged 2,3-
benzodiazepine and unidentified byproducts. 
 




 In an attempt to circumvent this rearrangement, we thought it worthwhile to 
explore other diaziridinium ions motifs outside the confines of isoquinoline-based 
architectures.  We believe that perhaps the benzylic carbon atom of the diaziridinium ion 
ring is polarizing the C-N bond to sufficiently aid the benzodiazepine rearrangement.  We 
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then set out to explore the effect of aliphatic substitution on the reactivity of the 
diaziridinium ring.  We attempted to prepare the following diaziridinium ions, but, 
regrettably, we have been unable to explore their reactivity due to purification difficulties 
arising from their instability (Figure 47). 
 
Figure 47.  Diaziridinium ions that were not sufficiently stable for isolation. 
 
 
Our study of the diaziridinium ion functionality is currently incomplete.  
Although we were never able to achieve N-transfer with these new diaziridinium ion 
reagents, we do believe that further studies of this new functionality may be more fruitful.  
Due to the unique stability of diaziridinium ions containing an isoquinoline scaffold, 
future directions may involve synthesis of diaziridinium ions with strongly electron-
deficient aryl substituents, such as a nitro group.  This might prove challenging due to 
electronic limitations associated with Bischler-Naplieralski cyclization.  Also, exploration 
of other diaziridinium ion scaffolds is worthwhile because it may lead to the discovery of 







III.  Final Remarks 
 
We have established a viable synthetic route to access the new diaziridinium ion 
functionality and were able to isolate and fully characterize the first stable diaziridinium 
ion.  We have also elucidated a likely rearrangement pathway for diaziridinium ions 
composed of an isoquinoline framework.  From a practical standpoint, this rearrangement 
pathway provides a very simple and efficient way to access a wide variety of substituted 
2,3-benzodiazepines, which are potential therapeutic targets.  Future endeavors towards 
achieving N-transfer with this functionality should be devoted to coupling its stability 
with the desired electrophilic reactivity.  Our hope is that exploration of other core motifs 
with subtle electronic modifications could perhaps stabilize the diaziridinium ion so that 














Tropylium Ion Mediated α-Cyanation of Amines47 
 
 
I.  Introduction 
 
With our group’s current interests in investigating the unique reactivity of 
aromatic ions for reaction development in mind, we have recently identified the 
tropylium ion as a new, organic-based amine oxidant, and we used this discovery to 
formulate a new method for α-aminonitrile synthesis.   
Iminium ions are among the most versatile synthetic intermediates in forging 
carbon-carbon bonds and stereocenters in amine substrates.  By far, the Strecker reaction 
is the most well known means of accessing α-aminonitriles via the traditional 
condensation approach to imine synthesis.48  In this process, an aldehyde or ketone is 
condensed with ammonium chloride (or a primary or secondary amine) in the presence of 
KCN to provide an α-aminonitrile, which can subsequently be hydrolyzed to access the 
corresponding amino acid (Figure 1).   
 




Although the classic Strecker reaction is composed of a one-pot, three-component 
condensation reaction under aqueous conditions, most modern modified Strecker 
reactions occur via hydrocyanation of a preformed imine in organic solvent.  Recently, 
interest in this reaction has been devoted to developing an asymmetric process to prepare 
optically active α-amino acids.   
There have been many examples over the years that have used organocatalysts, 
such as a chiral diketopiperazine, a bicyclic guandidine, or imine-containing urea 
derivatives to carry out asymmetric hydrocyanations.  A key, uniting feature of these 
catalysts is an imino bond that, once protonated by HCN, helps to organize the 
hydrocyanation process by controlling its nucleophilic cyanide counterion.  
The first catalyst successfully developed for the asymmetric Strecker reaction was 
Lipton’s chiral diketopiperazine organocatalyst.49  With a catalyst loading of only 2 
mol%, Lipton and coworkers were able to carry out the hydrocyanation of N-benzhydryl 
imine to form the corresponding aminonitrile product in 97% yield and > 99% ee (Figure 
2).  This chiral aminonitrile can subsequently be hydrolyzed to yield the amino acid (S)-
phenylgylcine with an impressive >99% ee in an overall yield of 92% from 
benzaldehyde. However, low enantioselectivity was observed for heteroaromatic and 








Figure 2.  Lipton’s asymmetric Strecker reaction. 
 
 
 Another group to harness the catalytic power of the guanidine moiety was the 
Corey group in their development of a chiral bicyclic guanidine Strecker catalyst.50  
Although with a slightly higher catalyst loading, efficient asymmetric hydrocyanations of 
comparable yield and ee values are observed with Corey’s bicyclic guanidine catalyst 
(Figure 3).  Noteworthy is the ability of this catalyst to induce asymmetry in into 
aliphatic imines, which was not achieved by Lipton’s catalyst. 
 
Figure 3.  Corey’s asymmetric Strecker catalyst. 
 
 
One drawback of both the Lipton and Corey catalysts is the need for the aldimine 
substrate to bear a N-benzhydryl substituent.  Asymmetric induction for both catalysts is 





























observation, however, becomes trivial if the α-aminonitrile is hydrolyzed to the amino 
acid. 
 Another type of highly efficient organocatalyst that has been developed by the 
Jacobsen group is the chiral urea/thiourea-derived catalyst (Figure 4).51  These catalysts 
have provided very high enantioselectivities with imines containing an N-allyl group 
regardless of whether they are derived from aryl or aliphatic aldehydes.  
 
Figure 4.  Jacobsen’s asymmetric catalysts. 
 
 
Also noteworthy, Jacobsen’s imine-based organocatalyst represents the first 
highly effective means of achieving hydrocyanation of ketimines, ultimately providing an 
efficient route to access α-quaternary α-amino acids.  Also interesting is that fact that 
asymmetric induction is not strongly affected on the presence of an N-allyl group, which 
is supported by the high ees (88-95%) observed with N-benzylated aromatic ketimines.  
Because this catalyst provides a highly effective means of asymmetric induction into a 
broad array or aromatic and aliphatic aldimines and ketimines, the Jacobsen catalyst is 
currently being used industrially to generate optically active α-amino acids. 
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 In addition to the elegant organocatalysts that have been developed over the years 
for the asymmetric Strecker reaction, a number of other highly effective metal-based 
options have proven highly successful.  The most well-known of the metal-based Lewis-
acidic catalysts include chiral aluminium(III) catalysts, chiral titanium(IV) catalysts, and 
chiral zirconium(IV) catalysts. In these Strecker catalysts, the metal center is believed to 
act as a Lewis acid and activate the imine towards a highly controlled, enantioselective 
attack by the cyanide counterpart. 
 Both the Jacobsen and Shibasaki groups have developed different aluminum-
based catalysts for the asymmetric Strecker reaction.  Jacobsen’s salen-based aluminum 
catalyst has proven highly effective towards hydrocyanation of aromatic aldimines, with 
yields ranging from 91-99% and excellent enantioselectivity (81-95% ee).52  The 
Shibasaki group, on the other hand, has created a chiral binaphthol-based catalyst that has 
provided a unique and highly efficient application of the asymmetric Strecker to 
traditionally difficult heteroaromatic imines, α,β-unsaturated imines, and aliphatic imines 
with good to excellent enantioselectivity using a N-fluorenyl substituent (Figure 5).53   
 





The Hoveyda group has developed a titanium(IV) peptide-based catalytic system 
that significantly broadens the scope of asymmetric Strecker reactions by utilizing 
aromatic imines, aromatic α,β-unsaturated imines, aliphatic α,β-unsaturated imines, 
aliphatic imines, and even doubly unsaturated imines as viable substrates with good yield 
and enantioselectivity (85-99%).54  Also, the Vallée group has investigated a different 
type of titanium(IV) complex that utilizes a BINOL ligand to induce asymmetry, albeit 
with moderate enantioselectivity (Figure 6).55 
 
Figure 6.  Titanium(IV)-based asymmetric Strecker catalysts. 
 
 
 The use of a zirconium(IV)-BINOL complex was first reported by the Kobayashi 
group, in which they carried out asymmetric Strecker reactions with both aromatic as 
well as aliphatic imines with good enantioselectivity (Figure 7).56   
 





 Although the Strecker reaction is an invaluable resource for α-aminonitrile 
synthesis, sometimes circumstances exist in which it may be more convenient to generate 
the α-aminonitrile directly from a tertiary amine starting material as opposed to amine 
condensation on an aldehyde or ketone.  This method is particularly attractive when one 
considers alkaloid derivatization.  If one wishes to α-functionalize an amine in this 
manner, the amine must be first oxidized to an imine or iminium ion then subjected to 
nucleophilic attack by cyanide.   
 Many metals have been shown to catalyze the functionalization of tertiary amines.  
There are two broad mechanisms by which this derivatization may occur: (i) C-H 
activation by treating the amine with an oxometal (M=O)57 or (ii) C-H activation at the α-
position with a low-valent metal catalyst58 (Figure 8). 
 
Figure 8.  Two modes of metal-catalyzed amine α-functionalization. 
 
  
 While ruthenium59 is known to be operative by both mechanisms, many other 
transition metals such as iridinium,60 rhodium,61 and copper62 have been shown to interact 
with the amine by metal orbital overlap with the α C-H bond.  Once this activated η2-
iminimium hydride complex forms, amine derivatization proceeds.   Regardless of the 
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oxidation strategy, generation of these iminium ions is followed by nucleophilic attack to 
form α-substituted products.  
If this reaction is to be performed in a one-pot sequence, the cyanide ion or the 
cyanide ion equivalent must be compatible with the oxidation conditions.  Few examples 
of metals efficiently carrying out a one-pot oxidative cyanation protocol have been 
reported.  Murahashi and coworkers have demonstrated ruthenium-catalyzed oxidative 
cyanation of tertiary amines with sodium cyanide.63  Excellent aminonitrile yields on a 
number of N,N-dimethylanilines with electron-donating and electron-withdrawing groups 
are obtained with this simple and mild method (Figure 9).  Application of this method to 
tertiary amines beyond the scope of dimethylaniline derivatives or N-phenyl 
tetrahydroisoquine, however, was not demonstrated. 
 
Figure 9.  Ruthenium-catalyzed aerobic oxidative cyanation of tertiary amines. 
 
 
The substrate scope for this reaction has been increased to aryl-substituted piperidine and 











The difference in reactivity between choice of oxygen or hydrogen peroxide as 
the oxidant is due to the formation of either an oxoruthenium species derived from 
hydrogen peroxide or the low-valent ruthenium complex fromed under aerobic 
conditions.  The oxoruthenium complex has been proven to have greater reactivity as 
illustrated by the decrease in reaction temperature.  
The use of metal reagents is sometimes undesirable for reasons of cost or toxicity, 
necessitating the development of mild and selective non-metal based approaches to amine 
oxidation.  There are surprisingly few of these non-metal based methods for amine α-
functionalization is use today.  
Singlet oxygen has been shown to effectively carry out tertiary amine oxidations 
in the presence of cyanide to provide α-aminonitriles in good yield.64  The utility and 
selectivity of this single electron transfer method has been demonstrated for a number of 
alkaloids, including sparteine, dextromethorphan, indoloquinolizidine, and 
vincadifformine (Figure 11). This specific method reports the use of 1,4-





Figure 11.  Singlet oxygen oxidation of (–)-sparteine. 
 
 
 DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone) is another known organic-
based reagent that has been shown to be effective towards amine oxidations.65  Beyond a 
limited number of successful oxidizations of a few biologically important alkaloids such 
as leurosine66 and vindoline,67  DDQ has not enjoyed popular use as an amine oxidant.  
One particularily interesting report illustrates the use of DDQ in the oxidative 
fragmentation pathways of the alkaloid catharanthine (Figure 12).68  Here, one example 
of the compatibility of cyanide with the organic oxidant is shown in a one-pot oxidative 
amine cyanation method, albeit in low yield. 
 
Figure 12.  Oxidative cyanation of catharanthine. 
 
 
Hypervalent iodine(III) reagents have also been shown to carry out the α-
functionalization of tertiary amines.69  These reagents are particularly attractive because 
of their low toxicity, high reactivity, and ease of use.  Recently, Shu et al. has 
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demonstrated the oxidative coupling of tertiary amines with cyanide in the presence of 
diacetoxyiodobenzene and malononitrile.  In this reaction, diacetoxyiodobenzene 
oxidizes the amine to the iminium ion, and malononitrile serves as a less toxic source of 
cyanide.  The success of this reaction has been shown with several isoquinoline 
derivatives with good yield (Figure 13). 
 
Figure 13.  Hypervalent iodide-mediated oxidative coupling of tertiary amines with 
cyanide.   
 
  
Due to the underdevelopment of organic reagents for amine oxidative coupling 
reactions, we believed that the exploration of new oxidants is a worthwhile goal.  We set 
out exploring the tropylium ion as a potential amine oxidant that would hopefully 
broaden the substrate scope and functional group tolerance beyond that of current 
methods.  Choice of the tropylium ion as a new oxidant was spurred by our group’s 
broader interest in the development of aromatic ions in synthesis. 
Our group has initiated a platform of methods development based on the unique 
and versatile properties of aromatic ions.70  We have utilized the complementary 
properties of aromatic stability and ionic charge to establish a facile equilibrium between 
cyclopropenium ions and reversible association with an anion or the lone pairs of a 
heteroatom.  The establishment of such an equilibrium relies on the unique ability of the 
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aromatic ion to shuttle between charged and neutral states via this nucleophilic 
association (Figure 14). 
 
Figure 14.  Equilibrium established between cyclopropenium and counterion, X–. 
 
 
Our group has captured this equilibrium process in the development of a number 
of dehydrative processes that use cyclopropenium ions to activate alcohols toward 
nucleophilic displacement.  The cyclopropenium ion activation of alcohols towards 
chlorination71 and diols towards cyclodehydration has been achieved (Figure 15).72   
 





This concept of alcohol activation was subsequently extended to the derivatization 
of carboxylic acids to the corresponding acid chloride by the activation of these acids 
towards nucleophilic acyl substitution (Figure 16). 
 




In a similar vein, our group has also shown that oximes can also be activated in a 
cyclopropenium-activated Beckmann rearrangement (Figure 17).73    
 
Figure 17.  Cyclopropenium activation of oximes in a Beckmann rearrangement. 
 
 
Along a different avenue of using aromatic ions to develop new reaction methods 
is the use of a substituted cyclopentadienyl anion as a carbon-based leaving group in a 
Tsuji-Trost type reaction.  Here, the oxidative leaving group potential of a 
cyclopentadienyl anion towards oxidation addition is established (Figure 18).74 
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All of these previous works have mustered a continued interest over the last few 
years for our group to develop new methods based on this interesting reactivity of 
aromatic ions.  Along these lines, we set out to investigate the possibility of using the 
tropylium ion as a oxidant to α-functionalize tertiary amines. 
Tropylium ion, a 6π-electron homolog of benzene, was initially prepared by 
Doering and Knox in 1954.75  When tropilidene (cycloheptatriene) was treated with one 
equivalent of bromine, a liquid dibromide was observed.  An attempted distillation 
provided a mass of hygroscopic, water-soluble crystals that were later proven to be 
tropylium bromide salt crystals (Figure 19).  Tropylium salts are currently commercially 
available as the tetrafluoroborate or hexafluorophosphate salt. 
 





The tropylium ion is an aromatic cation that behaves as a Lewis acid in water, and 
an equilibrium is established with the covalently bonded carbinol and the hydronium ion 
(Figure 20).  With a pKR+ value of 4.75,76 the tropylium ion is among the most stable 
carbenium ions and is about as acidic as acetic acid with water as the reference base. 
 
Figure 20.  Lewis acidity of tropylium ion. 
 
 
 Tropylium ion is also a very effective π-acceptor, as exemplified by the 
numerous reports of charge-transfer complexes77 and by the complexation of tropylium 
ion with crown ethers.78  Another important consideration that becomes critical for the 
development of our α-cyanation protocol is the tendency for tropylium to form electron 
donor-acceptor complexes with aryl rings.79  These EDA complexes arise from the 
donor-acceptor interactions of a filled π-HOMO of the aromatic donor with that of the 
unfilled π-LUMO of the electron-deficient tropylium cation (Figure 21).   
 





Aryl-tropylium EDA complexes derived from the benzenes, naphthalene, and 
anthracenes are typically weak as indicated by the low value for their formation constants 
(K < 1 M-1), however, they are sometimes stable enough to be isolated and characterized 
by X-ray crystallography, as was the case with napthlene and tropylium 
hexafluoroantimonate(V).  We believe the formation of such EDA complexes affects the 
efficiency by which aryl amines are oxidized by tropyium.  This will be discussed in 
more detail in the experimental section of this chapter. 
 In a practical sense, we were specifically interested in coupling the hydride 
abstraction capability of the tropylium ion with a nucleophilic cyanide addition, 
providing a simple method that would allow access to α-aminonitriles (Figure 22).  One 
key feature in developing such a scheme involves choosing an appropriate nucleophile 
such that nucleophilic attack selectively occurs on the iminium electrophile and not with 
the tropylium ring generating undesirable, substituted cycloheptatriene products.  We 
have successfully observed this selectivity with cyanide. 
 





 The capability of carbocations to oxidize amines via hydride abstration has been 
demonstrated in limited contexts.  Meerwein and coworkers have shown that when 
tribenzylamine is treated with trityl (triphenylcarbonium) tetrafluoroborate, the resulting 
iminium salt is formed in a 94% yield.80  This preliminary work successfully 
demonstrates the ability of the trityl ion to cleanly accept α-methylene hydrides from 
tertiary amine substrates.  Damico and Broaddus then attempted to extend this oxidation 
method to amines containing β-hydrogen atoms.81  They have observed that the trityl ion 
can readily oxidize these aliphatic tertiary amines to form triphenylmethane and the 
corresponding iminium ions, which further react to form non-isolable enamines.  In many 
of the reported oxidations, reaction efficiency was measured based not on an amine 
product but instead on the isolated yield of triphenylmethane.  Although mechanistically 
interesting, this amine oxidation protocol has not been developed into a practical 
synthetic method.   
 Alternatively, there have been preliminary studies suggesting the oxidizing power 
of the tropylium ion.  McGeachin made an intriguing observation in 1965 when he his 
treatment of triethylamine with tropylium tetrafluoroborate resulted in the production of a 
ditropyl iminium ion, which presumably arose via hydride abstraction.82  This discovery 
arose as the unexpected result of McGeachin’s attempted deprotonation of the tropylium 
cation with triethylamine to form the cycloheptatrienyl carbene.  Instead of this expected 
deprotonation, he observed uncontrollable hydride-abstration/β-tropylation sequences 
that finally provided ditropylacetaldehyde after hydrolysis. Isolation of 
ditropylacetaldehyde in 66% yield strongly suggested the role of tropylium ion as an 
oxidant (Figure 23). 
  
54 
Figure 23.  McGeachin’s finding suggesting that tropylium is capable of abstracting a 
hydride from a tertiary amine. 
 
 
We were attracted developing the tropylium ion as an amine oxidant for a variety 
of reasons.  By implementing the tropylium ion as an organic oxidant, there is a great 
deal of potential to finely tune the electronic and steric environment of the aromatic 
system, hopefully providing a very versatile hydrocarbon-based oxidizing agent.  We also 
believe there is a practical advantage of using the tropylium ion instead of the trityl ion as 
an oxidant because the only byproduct of the oxidation is cycloheptatriene, a volatile 
hydrocarbon.  In contrast, the byproduct use of the trityl ion as an oxidant is 
triphenylmethane, a nonvolatile compound. 
Lastly, we set out to expand the scope of our oxidation method outside the 
confines of aminonitrile synthesis by developing an oxidative aza-Cope rearrangement 







Figure 24.  The aza-Cope rearrangement and our oxidative aza-Cope rearrangement. 
 
 
The well-known aza-Cope rearrangement is the [3,3]-sigmatropic isomerization 
of N-substituted 1,5-dienes upon heating.83  The aza-Cope rearrangement is a concerted 
process that occurs via a chair-like transition state, typically with substituents in a quasi-
equatorial position.  We set out to develop an oxidative variant of this reaction in which 
tropylium first oxidizes the amine, then subsequently undergoes the aza-Cope 
rearrangement. 
 
II.  Experimental Results 
 
Our initial oxidation studies were carried out on triisobutylamine, an amine 
substrate that we believed would not be prone to enamine formation / β-alkylation due to 
steric hindrance.  After stirring triisobutylamine and tropylium tetrafluoroborate in 
acetonitrile for 30 min. at room temperature, we observed quantitative formation of 
iminium ion 1.  On a practical note, the only work-up for this reaction was the removal of 
solvent and the cycloheptatriene byproduct by simply concentrating the reaction.  
Happily, no additional purification steps were necessary, and we did not encounter any 
issues with enamine production whatsoever.  In an attempt to create a viable α-
functionalization method, we performed the same oxidation procedure in the presence of 
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potassium cyanide.  In this case we observed the α-cyanated product 2 in 81% yield after 
just stirring for 3 hr at room temperature (Figure 25). 
 
Figure 25.  Preliminary oxidation studies with triisobutylamine. 
 
 
 The compatibility of tropylium and cyanide ions was somewhat surprising 
because Doering had previously reported the preparation of cycloheptatrienylnitrile by 
this combination in water.84  The fact that tropylium did not undergo quenching by 
cyanide under these conditions offered a mild yet powerful means of achieving amine α-
cyanation.  Also, it is worth noting that the only byproducts of this transformation were 
cycloheptatriene, a volatile hydrocarbon (b.p. 116 °C), and the water-soluble salt 
potassium tetrafluoroborate. 
 Our rationale for the success of the cyanation reaction shown is centered on the 
fact that potassium cyanide is insoluble in acetonitrile, preventing formation of 
cycloheptatrienylnitrile and allowing tropylium ion to abstract a hydride from the amine 






































solid KCN to produce KBF4 and an iminium cyanide intermediate, which then collapses 
to provide the α-aminonitrile product (Figure 26).   
 
Figure 26.  Tropylium-mediated cyanation mechanism. 
 
 
 It is not currently understood why an iminium ion is capable of solubilizing 
cyanide ion whereas tropylium ion is not.  If tropylium ion did solubilize cyanide, no 
amine oxidation would be observed, as tropylium would be quenched by cyanide to 
produce cyanocycloheptatriene.  When this cyanation protocol is attempted using soluble 
cyanide sources (TMSCN or KCN with 18-crown-6) under similar conditions, no amine 
oxidation is observed and cyanocycloheptatriene 3 is the only product (Figure 27).  
 











 Further supporting our hypothesis is that α-functionalization attempts using 
soluble nucleophiles, such as silyl ketene acetals, have yielded only the functionalized 
cycloheptatriene system, completely shutting down oxidation.  An example of this is 
illustrated in Figure 28, where the silyl ketene acetal of ethyl acetate reacts exclusively 
with tropylium ion to form cycloheptatrienyl ester 4. 
 
Figure 28.  Quenching tropylium with a silyl ketene acetal. 
 
 
 For these reasons, we believe the insolubility of KCN in acetonitrile prevents 
functionalization of tropylium to form cyanocycloheptatriene and is a key parameter in 
our oxidative cyanation procedure.   
 Our studies to probe the substrate scope of our cyanation method are shown in 
Table 29.  In addition to iBu3N, tribenzylamine also underwent α-cyanation with a 38% 
isolated yield (64% yield BRSM).  This substrate required elevated temperature because 
of N-alkylation and did not proceed to complete conversion (entry 1).  The benzylic 
position of N-methyltetrahydroisoquinoline was also subject to selective derivatization 
with a 62% yield at elevated temperature (80 °C) after just 2 hrs (entry 2).  Interestingly, 
benzyldiisobutylamine was found to undergo efficient cyanation with preference for an 
aliphatic rather than the benzylic methylene (5.9:1.0, entry 3). This inherent 3:1 
selectivity for aliphatic versus benzylic positions contradicts that would be expected 
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based on C–H bond dissociation energies.  Instead, it seems that the most electron-rich 
methylene is oxidized.  In support of this hypothesis, the influence of an electron-
deficient benzyl substituent led to the exclusive aliphatic oxidation of nitrobenzylamine 
(entry 4).  Conversely, the influence of an electron-rich, methoxybenzyl substituent still 
favors aliphatic oxidation, but less so than benzylamine (entry 5). 
 Notably, benzyldimethylamine was found to undergo preferential cyanation at a 
methyl group instead of the expected benzylic site, albeit with poor efficiency (3.7:1.0, 
entry 6).  Improved selectivity and yield (71%) were observed with the more sterically 
hindered 2,4,6-trimethylbenzylamine (entry 7).  Similar methyl selectivity was observed 
with neopentyl entry 8, which is also attributed to steric blocking of the more electron-
rich aliphatic position.  Bicyclic entry 9, however, showed contradictory selectivity for 
cyanation at one of the more sterically encumbered α-methylene positions rather than the 
N-methyl group.  
 In exploring some of the functional group compatibility of this method, we found 
that an N-allyl group is well tolerated, and that cyanation at an aliphatic position was 
preferred over the allylic site exclusively with a 73% yield in just 15 min (entry 10).  In 
addition, aminoester entry 11, was found to undergo cyanation exclusively at the more 
electron-rich isobutyl group with good efficiency (75% yield).  Lastly, to test the 
preparative utility of this cyanation method, we conducted the cyanation of the alkaloid 
(–)-sparteine, providing access to cyanosparteine (entry 12) in high yield on a 1-g scale 









 Although our tropylium-mediated α-cyanation protocol is quite efficient with 
many substrates, we have encountered several fundamental constraints to substrate scope 
and compatibility.  Namely, these include N-alkylation by tropylium, steric hindrance 
preventing oxidation, enamine formation, and Friedel-Crafts interference.  These 
complications are addressed below. 
 
Limitations of Our Tropylium Oxidation Method 
 
1.  N-alkylation by tropylium:  Many substrates required elevated temperatures for 
hydride-abstration to occur.  This temperature dependence is explained by the tendency 
for N-alkylation by tropylium ion to form N-tropyl ammonium salts at ambient 
temperature.  We believe that an equilibrium is established between the free amine and 
the N-tropylated salt.  At room temperature, we have observed that in some cases the 
quaternary ammonium salt is favored and that heat is required to regenerate the free 
amine.  This trend was observed with many unhindered amines.  For example, when 
dimethylbenzylamine is treated with one equivalent of tropylium tetrafluoroborate in 
acetonitrile at room temperature, full conversion to ammonium salt 17 is observed by 1H 
NMR (Figure 30).  
 




 The amount of heat required to break the ammonium salt greatly depends on the 
degree of steric hindrance provided by the amine substituents.  In the case of 
dimethylbenzylamine, heating at 80 °C allowed reversion to the free amine and tropylium 
so that a productive oxidative pathway is operative.  Heating dimethylbenzylamine and 
tropylium tetrafluoroborate in the presence of potassium cyanide provided the desired α-
aminonitrile product. 
 There are cases, however, when the amine is not sufficiently hindered so that no 
amount of heat will free the amine substrate from the ammonium salt, preventing hydride 
abstraction and subsequent oxidation.  McGeachin first noticed this concept in 1969 
when he treated trimethylamine with tropylium tetrafluoroborate to irreversibly form an 
ammonium salt, which decomposed upon heating (Figure 31).86 
 
Figure 31:  Irreversible alkylation of unhindered amines with tropylium. 
 
 
Examples of substrates that we have encountered that also did not oxidize in the presence 
of the tropylium ion can be seen in Figure 32.  Notably, many N-methyl aniline, 
allylamine, and dimethylbenzylamine derivatives have all resisted hydride abstration by 
the tropylium ion.  We believe this is caused by the absence of β-branches in the amine’s 
alkyl substituents.  In these cases, the N-alkylated ammonium salt was observed by 1H 
NMR.  To recover starting material, the reaction is simply concentrated and purified by 
alumina plug to break up the ammonium salt and regenerate starting material. 
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Figure 32.  Tertiary amines that are irreversibly N-alkylated by tropylium. 
 
 
2.  Steric hindrance preventing approach by tropylium:  While too little steric hindrance 
can cause irreversible N-alkylation, sufficiently bulky substituents such as the tert-butyl 
group have been observed to shut down both hydride abstraction and N-alkylation 
altogether, presumably due to steric blocking.  Examples that we have noticed are shown 
in Figure 33 below.  We have only observed this trend in a limited number of instances 
in which we attempted to oxidize an amine with a tert-butyl substituent (Figure 33).  In 
both cases, only starting material was recovered. 
 





3. Enamine Formation:  As McGeachin first reported with his reported tropylium-
medited oxidation of triethylamine, there is a strong tendency for amines containing 
linear alkyl substituents to form enamines.  When this enamine formation occurs in the 
presence of the tropylium ion, a strong electrophile, the result is typically β-tropylation of 
the amine.  Table 34 shows several substrates that we were unable to oxidize because of 
this tendency for enamine formation to occur.  Often these reactions were quite messy, 
but β-tropylation was observed as a major product. 
 
Figure 34.  Amine substrates that underwent β-tropylation upon oxidation by tropylium. 
 
 
 We have noticed that β-brached alkyl substituents on amine substrates not only 
provide sufficient steric bulk to disfavor N-alkylation but also prevents problematic 
enamine formation via steric blocking of the β-hydrogen.  The impact of these β-brached 
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alkyl substituents becomes particularly clear when one compares the results of oxidation 
attempts of tributylamine with that of triisobutylamine (Figure 35).   
 
Figure 35.  Impact of β-brached alkyl substituents on the amine oxidation efficiency. 
 
 
In just 30 min, triisobutylamine is oxidized quantitatively to the corresponding iminium 
tetrafluoroborate.  While tributylamine undergoes a similar oxidation pathway, β-
tropylation is observed in the major product (18). 
 
4.  Friedel-Crafts Interference:  In addition to the aforementioned tropylium-mediated 
oxidation limitations, we have also observed several cases in which aniline derivatives 
undergo immediate Friedel-Crafts alkylation in the presence of tropylium 







Figure 36.  Aniline derivatives that are prone to Friedel-Crafts alkylation with tropylium. 
 
 
 With these electron-rich aniline-derived substrates, we have been unable to 
observe the standard tropylium-mediated hydride-abstraction pathway.  The Friedel-
Crafts adduct forms instantaneously at room temperature as indicated by a dramatic color 
change in the reaction solution.  In the case of the neopentyl methylaniline entry, the 
reaction changed color to an intense purple color as soon as the amine substrate was 
added to a room temperature solution of tropylium and KCN in acetonitrile, yielding 
para-tropylated adduct 19 as the sole product.  When julolidine was subjected to the 
same conditions, the reaction color changed from colorless to bright blue instantly as the 
amine was added to a room temperature solution of tropylium and KCN in acetonitrile.  
The resulting product was quantitative formation of para-tropylated julolidine 20.  No 







 With regard to the mechanism of the tropylium-mediation amine oxidation, we 
believe there are two distinct possibilities (Figure 37).  The first involves direct hydride 
transfer from the amine to tropylium ion.  The second involves an initial single electron 
transfer from the amine to tropylium ion, yielding an amine radical cation and a tropyl 
radical.  Abstraction of a hydride radical by the tropyl radical then would provide 
cycloheptatriene and the iminium salt.  
 
Figure 37.  Mechanistic alternatives for tropylium-mediated amine oxidation. 
 
 
 While we cannot definitively state which pathway is operative, experimental 
evidence suggests that the direct hydride abstraction mechanism is dominant.  We believe 
this because of the regioselectivity difference in oxidation product ratios for p-
methoxybezyldiisobutylamine using our conditions and that of DDQ, a known single-




Figure 38.  Regioselectivity comparison between tropylium-mediated amine oxidation 




 When p-methoxybenzyldiisobutylamine is subjected to our standard reaction 
conditions, a mixture of aminonitrile products is obtained with a 3.7:1.0 product ratio in 
favor of aliphatic oxidation over that of benzylic oxidation.  Conversely, when this 
substrate was subjected to DDQ oxidation, the outcome was a mixture of products with a 
1.7:1.0 product ratio in favor of benzylic oxidation over that of aliphatic oxidation.  This 
difference in regioselectivity suggests that two different pathways are operative.  Because 
DDQ is known as a single-electron oxidant, that leaves the direct hydride pathway as a 
viable alternative. 
 Another important mechanistic factor that must be taken into account is the 








 These complexes are known,88 and their formation is believed to contribute to the 
regioselectivity and overall reactivity of amines containing aryl substituents.  For 
example, the effect of such a complex may decrease oxidation efficiency if it is especially 
stable.  Amine substrates containing very electron-rich aryl substituents, such as the p-
methoxybenzyl group, would be expected to form quite stable donor-acceptor complexes, 
presumably leading to a reduction in hydride abstraction efficiency.  Conversely, one 
would expect electron-withdrawing substituents, such as a nitro group, on the aryl ring to 
destabilize this complex, minimizing its effect on oxidation efficiency.  These trends are 
supported in the oxidation efficiency of neutral, electron-deficient, and electron-rich 









Figure 40.  The effect of the proposed EDA complex on oxidation efficiency. 
 
 
 The p-nitrobenzylamine substrate has essentially the same oxidation efficiency 
(77% yield) as the unsubstituted benzyldiisobutylamine (78% yield).  On the other hand, 
p-methoxybenzyl diisobutylamine suffered a dramatic decrease in efficiency (43% yield) 
relative to its neutral counterpart, supporting the notion that an electron donor-acceptor 
complex can negatively impact the efficiency of hydride abstraction.  
 To expand the synthetic application of this oxidation method beyond α-
aminonitrile synthesis, we began to explore tropylium’s unique hydride abstraction 
ability in alternative contexts of carbon-carbon bond formation.  We first attempted to 
develop a one-pot tropylium-mediated oxidative Pictet-Spengler reaction.  We began our 
initial Pictet-Spengler studies with amine 21, containing an N-allyl group and aryl 
framework that we hoped would be sufficiently hindered to prevent irreversible N-




Figure 41.  Attempted oxidative Pictet-Spengler reaction. 
 
 
 Unfortunately, this allyl methylamine substrate was irreversibly N-tropylated 
under these conditions, and only starting material was recovered after heating the reaction 
overnight at 120 °C.  Because of our successful oxidation at the benzylic position of the 
isoquinoline framework (see entry 2 of Table 29), we then redesigned our Pictet-
Spengler substrate to incorporate this structural motif and hopefully the corresponding 
selectivity (Figure 42).   
 
Figure 42.  Pictet-Spengler attempt with isoquinoline-based amine 22.  
 
 
 Happily, we did observe complete conversion to iminium ion 23 selectively at the 
benzylic position of the isoquinoline unit, but unfortunately we observed no Pictet-
Spengler cyclization.  This was surprising because this very cyclized product has been 
reported by a similar Pictet-Spengler combination.89  Our initial hypothesis for the failure 











sufficiently electron-rich to attack the iminium ion.  Our solution to this problem was to 
synthesize the 3,4-dimethoxy analog with the hope that the aryl ring would be sufficiently 
nucleophilic (Figure 43).   
 
Figure 43.  Pictet-Spengler attempt with a modified isoquinoline-based amine substrate. 
 
 
 To our surprise, installation of this second methoxy substituent did not facilitate 
cyclization.  Tropylium ion oxidization cleanly provided the corresponding iminium ion 
after just one hour, but again, no Pictet-Spengler cyclization was observed.   With little 
luck for the isoquinoline substrates, we decided to apply this dimethoxy aryl ring idea to 
our original framework.  We believed that by using a diisobutylamine derivative we 
might be able to alleviate the N-tropylation preventing oxidation.  Also, we thought that 
the dimethoxy substituents might facilitate cyclization (Figure 44). 
 





Regrettably, only starting material was recovered – no iminium ion or cyclized product 
was observed.  We are uncertain why this was the case, since we have not observed any 
cases of tertiary diisobutylamines resisting oxidation due to N-tropylation. 
 Because of our difficulty in finding an appropriate Pictet-Spengler substrate to 
illustrate our broad goal of increasing the synthetic utility of tropylium’s oxidation 
power, we began to explore the aza-Cope rearrangement as a viable alternative (Figure 
45).   
 
Figure 45.  Proposed tropylium-mediated oxidative aza-Cope rearrangement. 
 
 
 We prepared homoallylic amine 26 as our initial aza-Cope substrate in part 
because we felt that the two isobutyl groups typically yield fortuitous oxidation results by 
preventing N-tropylation and enamine formation.  Another key factor in substrate design 
for the aza-Cope reaction was to install substituents that provide a thermodynamic 
driving force to drive the reaction to completion.  For this reason, we installed a phenyl 
group as the R1 substituent.  Assuming we observe the same preference for aliphatic 
selectivity, the isobutyl group should be oxidized to form the less stable aliphatic 
iminium.  The resulting aza-Cope product should form a stable benzylic iminium ion.   
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 When we attempted an oxidative aza-Cope rearrangement with amine 26 by 
heating in acetonitrile with tropylium tetrafluoroborate, a mixture of iminium products 
corresponding to initial oxidation and the rearranged product in a 2.8:1.0 ratio were 
obtained (Figure 46). 
 
Figure 46.  Oxidative aza-Cope rearrangement with diisobutyl benzylamine 26. 
 
 
 Because a single unsubstituted phenyl group at the R1 position was not providing 
sufficient driving force to drive the rearrangement to completion, a similar substrate was 
synthesized with a p-methoxy group in place of the phenyl group.  When this homoallylic 
amine 28 was subjected to similar conditions, only the product benzylic iminium was 
observed, indicating that the equilibrium favored product formation, but the reaction was 
very messy and contained undetermined byproducts (Figure 47).  The allyl group was 
used in place of one of the isobutyl substituents for ease of synthesis.  It is not known 
why this reaction is significantly messier than amine 26, but it is thought that the allyl 







Figure 47.  Oxidative aza-Cope rearrangement with allyl isobutylamine 28.  
 
 
 As an alternative to using a more electron-rich aryl group to help drive the 
conversion of this aza-Cope rearrangement, we began to investigate the use of gem-
diphenyl substituents next to the amine to drive the thermodynamic equilibrium to favor 
product formation (Figure 48).  When we heated amine 30 with tropylium 
tetrafluoroborate in acetonitrile at 80 °C overnight, an iminium ion was noted by MS 
(m/z 278.0).  We confirmed by 1H NMR that this product was in fact the rearranged 
iminium product.  Initial isolation attempts involved hydrolysis of the iminium ion to 
yield benzophenone and the volatile homoallylic amine counterpart.    
 




 A temperature screen of oxidation temperature indicated that the yield of isolated 
benzophenone was highest at 50 °C, corresponding to a 42% isolated yield.  At 
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temperatures below 50 °C oxidation does not go to completion, and the yield is 
significantly stifled due to low conversion (Table 49).   
 
Table 49.  Temperature screen of our oxidative aza-Cope rearrangement. 
 
 
 In light of these promising results and with the hope of being able to isolate the 
amine product after hydrolysis, the decision was made to move from an isobutyl to a 
methylene cyclohexyl substituent to decrease volatility in the homoallylic amine product.  
Shortly after switching substrates, we found out that a simple NaHCO3 work-up cleanly 
provided the imine product that is easily purified by silica gel chromatography.  Similar 
results were obtained for both substrates.  Here we report optimization studies for the 
methylene cyclohexyl amine 31 (Table 50).  The optimal temperature and solvent for the 
oxidation/aza-Cope rearrangement protocol is 120 °C in acetonitrile.  The influence in the 
equivalency of tropylium tetrafluoroborate is unclear, as it did not have a consistent 
impact on the reaction efficiency.  Also, a decrease in concentration notably increased the 






Table 50.  Optimization studies for oxidative aza-Cope rearrangement. 
 
 
In the presence of tropylium tetrafluoroborate (1.5 eq) at 120 °C in acetonitrile 
(0.04 M), homoallylic amine 31 underwent an oxidative aza-Cope rearrangement to 




Figure 51.  Oxidative aza-Cope Rearrangement. 
 
 
 Notably, this result expands our oxidation scope to encompass sterically hindered 
secondary amines.  Previously, we have only been able to oxidize tertiary amines that are 
sufficiently hindered to avoid irreversible N-tropylation.  In our oxidative aza-Cope 
rearrangement, for the first time we were able to oxidize a secondary amine presumably 
due to steric blocking from the adjacent gem-diphenyl group.   
 The observations that tropylium ion efficiently oxidizes a wide variety of tertiary 
amines and even very hindered secondary amines may lead one to wonder if using a 
substituted tropylium ring might substantially expand the substrate scope and efficiency 
of our oxidation method.  Substituents could be tuned such that they are sufficiently 
hindered so as to block amine N-tropylation, but not so much that they block interaction 
with the amine altogether.  Substituents on tropylium could also open up the door to 
electronically tuning the tropylium ring, which could raise interesting possibilities.  We 







III.  Final Remarks 
  
 We have successfully developed a new one-pot protocol that α-functionalizes 
tertiary amines.  The tropylium ion abstracts a hydride from the tertiary amine to form an 
iminum ion, and in the presence of KCN, efficiently produces aminonitriles in high yield.  
The only byproducts of this reaction are cycloheptatriene, a volatile innocuous 
hydrocarbon, and KBF4, a water-soluble salt.  We have observed that this method is 
viable on a preparative, 1-g scale as well as on a 20-mg scale.  This hydride abstraction 
method is also applied to the development of an aza-Cope rearrangement, demonstrating 

















Multicatalytic Synthesis of Complex Tetrahydrofurans Involving Bismuth(III) 
Triflate Catalyzed Intramolecular Hydroalkoxylation of Unactivated Olefins.90 
 
I.  Introduction 
 
 The development of a process that incorporates several distinct catalytic cycles in 
a single reaction vessel provides a highly economical way to build molecular complexity.  
This concept, which we call multicatalysis, was developed in an attempt to streamline 
synthesis by reducing the time-intensive isolation and purification procedures that so 
often make traditional iterative synthesis tedious.  The multicatalytic process may employ 
one or more catalysts, which must be compatible with all substrates, intermediates, and 
other catalysts in the reaction flask (Figure 1).  One key feature of this multicatalytic 
paradigm that is particularly attractive to our group is the need to create new methods that 
is often spurred by multicatalytic design. 
 




 The concept of cascade catalysis has been elegantly demonstrated in the synthetic 
community.91  The following examples are few in the wealth of published cascade 
catalysis literature.  Mikami was among the first to demonstrate enantioselective cascade 
catalysis where he used a binaphthol titanium(IV) complex as a catalyst to carry out a 
double Mukaiyama aldol sequence with excellent yield and selectivity (Figure 2).92 
 
Figure 2.  Mikami’s asymmetric multicatalytic double Mukaiyama aldol sequence. 
 
 
 In 2001, MacMillan used a chiral imidazolidinone catalyst to carry out two 
tandem enantioselective Friedal-Crafts alkylations in the bis-alkylation of N-
methylpyrrole.  Notably, this was the first example of an organocatalytic Friedel-Crafts 
alkylation (Figure 3). 
 






 Our group has also demonstrated the broad synthetic utility and efficiency of this 
multicatalytic concept.  Tim Cernak from our group has developed an 
aminochlorocarbonylation/Friedel-Crafts sequence that uses a dual catalyst system to 
efficiently produce highly-functionalized α-pyrrolidinyl ketones.  Palladium(II) catalyzes 
the initial aminochlorocarbonylation, and the indium(III) catalyst then couples this newly 
generated acid chloride with a Friedel-Crafts acylation (Figure 4).93  This sequence was 
later applied to the total syntheses of three natural products: (–)-13aα-secoantofine, (–)-
antofine, and (–)-tylophorine.94 
 
Figure 4.  Multicatalytic aminochlorocarbonylation/Friedel-Crafts acylation. 
 
 
 Our group has also been interested in directing this multicatalytic concept towards 
carrying out several distinct transformations with the aid of a single catalyst.  Towards 
this goal, we set out to develop a multicatalytic method for the synthesis of 
tetrahydrofuran and tetrahydropyran rings.  These motifs are especially attractive because 
of their prevalence in many biologically-active natural products, such as zincophorin, 
nonactin, pamamycin 607, and ambruticin.  We believe that the synthesis of these 
structurally complex oxacycles could be greatly simplified with the aid of a Bi(OTf)3 – 
catalyzed multicatalytic reaction that consists of an initial nucleophilic addition into an 
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unsaturated aldehyde followed by intramolecular hydroalkoxylation (Figure 5).  This 
chapter describes our efforts towards this goal. 
 
Figure 5.  Proposed multicatalytic synthesis of tetrahydrofurans. 
 
 
II.  Experimental Work 
 
Given our multicatalytic reaction design, our group believed that the proposed 
sequence would be well attended with a Lewis acid that is amenable to both nucleophilc 
addition and hydroalkoxylation steps.  Towards this goal, Brendan Kelly and Rachel 
Tundel subsequently identified Bi(OTf)3 as a highly effective, inexpensive catalyst for 
the hydroalkoxylation of unactivated olefins (Figure 6).   
 
Figure 6.  Bismuth(III) triflate as a new hydroalkoxylation catalyst. 
 
 
Because bismuth triflate has been shown to be an effective Lewis acid catalyst for 
the Mukaiyama aldol reaction, we then sought to develop a multicatalytic Bi(OTf)3 – 
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catalyzed Mukaiyama aldol/hydroalkoxylation reaction as an efficient route to access 
these substituted tetrahydrofuran and perhaps tetrahydropyran systems.   Le Roux has 
demonstrated the coupling of aldehydes with silyl enol ethers using only 1 mol% 




Based on the promising precedent for the Bi(OTf)3-catalyzed synthesis of β-
hydroxyketones via the Mukiayama aldol reaction, initial attempts at using this structural 
motif for the second step of our multicatalytic procedure were attempted.  Unfortunately, 
we only observed elimination of water to form the unsaturated ketone product (Figure 7).   
 
Figure 7.  Attempted Bi(OTf)3-catalyzed hydroalkoxylation of a β-hydroxyketone.   
 
 
Despite the potential for elimination of water, we have found that β-hydroxyesters 
are suitable hydroalkoxylation substrates for our multicatalytic Mukaiyama aldol / 
hydroalkoxylation reaction.  β-Hydroxy ester 1 efficiently underwent 5-exo cyclization in 





Figure 8.  Bi(OTf)3-catalyzed hydroalkoxylation of a β-hydroxyester. 
 
 
 To get an idea for the versatility of this reaction, an analogous intramolecular 
hydroalkoxylation of methyl 3-hydroxyl-7-octenoate to generate a tetrahydropyran ring 
was performed.  As anticipated, a 6-exo cyclization occurs to create the desired 
tetrahydropyran product, but this reaction is accompanied by acid-catalyzed alkene 
isomerization to generate an undesirable tetrahydrofuran product (Figure 9).  We were 
unable to find reaction conditions that preclude olefin isomerization, eliminating 
formation of the unwanted tetrahydrofuran byproduct. 
 




 Attempts aimed to extend this hydroalkoxylation towards thioesters were 
unsuccessful and only resulted in starting material decomposition when subjected to our 




Figure 10.  Attempted Bi(OTf)3-catalyzed hydroalkoxylation of a β-hydroxythioesters. 
 
  
Because  β-hydroxylesters were the most promising structural motif for our 
multicatalytic mukiayama aldol/hydroalkoxylation studies, our preliminary studies began 
with attempts to develop a Bi(OTf)3-catalyzed Mukiayama aldol reaction that coupled 
silyl ketene acetals and unsaturated aldehydes.  A preliminary attempt at this 
multicatalytic sequence indicated that the idea was indeed feasible.  Treatment of 4-
pentenal with the silyl ketene acetal of methyl isobutyrate in the presence of 10 mol% 
Bi(OTf)3 provided the anti-tetrahydrofuran product 6 in 49% yield (Figure 11). 
 
Figure 11.  Preliminary multicatalytic tetrahydrofuran synthesis. 
 
 
To optimize this sequence, we first analyzed each step individually.  The 
Mukaiyama aldol component of our multicatalytic design gave a mixture of the 
trimethylsilyl-protected and deprotected β-hydroxy ester aldol products in a 1.3:1.0 ratio 
with a combined yield of 55% by adding a solution containing 4-pentenal and the silyl 
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ketene acetal to a solution of Bi(OTf)3 that had been cooled to 0 °C (Figure 12).  By 
sequentially adding a solution of the aldehyde and then a solution of the silyl ketene 
acetal to the solution of Bi(OTf)3 at 0 °C, the yield consequently increased to 68%.  A 
solvent and temperature screen demonstrated the optimal reaction efficiency occurred in 
DCE at 0 °C (Figure 13). 
 
Figure 12.  Bi(OTf)3-catalyzed Mukaiyama aldol reaction. 
 
 
Figure 13.  Solvent screen for Mulkaiyama aldol reaction. 
 
aSequential, drowise addition of aldehyde and silyl ketene. 
 
 To test the efficiency of the hydroalkoxylation component of our multicatalytic 
sequence, the β-hydroxyester aldol product was heated in DCE for 12hr at 80 °C to 




Figure 14.  Hydroalkoxylation of β-hydroxyester aldol product. 
 
 
Because the Mukaiyama aldol reaction yields a mixture of TMS-protected and 
deprotected products, one major obstacle we faced in trying to put these two reactions 
together in a one-pot sequence was the reduced efficiency in the hydroalkoxylation step 
caused by the inability of the silyl ether intermediate to undergo hydroalkoxylation.  We 
then sought an additive that would remove the TMS group from the protected aldol 
product.  Addition of 1.5 equivalents of methanol after the hydroalkoxylation step 
efficiently removed the silyl group from the protected aldol product and resulted in a 
significant increase in tetrahydrofuran yield for our multicatalytic sequence (Figure 15).  
GC analysis of the product indicated a dr of 5.9:1.0 in favor of the anti diastereomer. 
 






 The chair-like transition state of the hydroalkoxylation step is most stable when 
the nucleophilic substituent is in the equatorial position, resulting in a selectivity 
preference for the anti diastereomer (Figure 16). 
 
Figure 16.   Rationale for anti selectivity during hydroalkoxylation. 
 
 
Now that we have established a viable multicatalytic protocol, our next step was 
to probe the substrate scope of the sequence (Table 17).  We have found that a variety of 
silyl ketene acetals react with unsaturated aldehydes to yield 2-acetyltetrahydrofurans in 
excellent yield.  Also, we have shown that the silylated nucleophilic partner is not limited 
to silyl ketene acetals.  Trimethylsilyl cyanide is a viable nucleophile for the first step as 
well.  Entry 3 shows one example in which Bi(OTf)3 catalyzes both the nucleophilic 
addition of cyanide to an unsaturated aldehyde and the subsequent cyanohydrin 
hydroalkoxylation reaction in a 68% yield.  A coworker, Brendan Kelly, later extended 









Table 17.  Multicatalytic substrate scope. 
 
 
There were a number of cases, however, in which addition of the silylated 
nucleophilic partner to the unsaturated aldehyde was quite problematic for a variety of 
reasons.  In hopes of creating bicyclic architectures, silyl ketene acetal 10 was 
synthesized.  Upon exposure to paraformaldehyde at 0 °C or room temperature, no 
reaction occurred and only the hydrolyzed ester was isolated.  When the reaction was 
heated at 40 °C decomposition occurs to some extent, and the major product could not be 
identified.  Similarly, when either propionaldehyde or furfural was used as the aldehyde 
source, there was also no reactivity in DCE at 0 °C or room temperature.  When the 
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desired β-hydroxyester was isolated.  An attempted hydroalkoxylation of this substrate by 
heating in DCE at 80 °C in the presence of 10 mol% Bi(OTf)3 was unsuccessful and 
resulted in decomposition of starting material.  Similarly, a Mukaiyama aldol reaction 
occurs with ethyl glyoxalate at 0 °C in DCE with a 63% isolated yield, but only starting 
material was recovered from the hydroalkoxylation step (Figure 18).  
 





Attempts at developing a Bi(OTf)3-catalyzed Mukaiyama aldol reaction with silyl 
ketene acetal 13 was unsuccessful as well, presumably because of steric blocking by the 
two gem-dimethyl groups on the silyl nucleophile hindering approach of the aldehyde 
(Figure 19).  Both ethyl gyloxalate and cyclohexane carboxaldehyde resist nucleophilic 
addition under these conditions and only starting material is recovered. 
 
Figure 19.  Attempted use of silyl ketene acetal 13 in multicatalytic developement. 
 
 
Because of this presumed steric hindrance, the unsubstituted counterpart of this 
silyl ketene acetal was synthesized.  As might be expected, its reactivity was substantially 
increased by this alteration, and we were able to carry out a one-pot multicatalytic 
Mukaiyama aldol/hydroalkoxylation sequence with a 51% isolated yield of the 
tetrahydrofuran product.  The dr, however, remained poor so further optimizations studies 






Figure 20.  Use of silyl ketene acetal 14 in a multicatalytic sequence. 
 
 
Similar results were obtained when furanone-derived silyl ketene acetal 16 was 
used as our nucleophilic partner.  When 4-pentenal was treated with silyl ketene acetal 
16, desired alcohol 17 was obtained in 87% yield when the reaction was conducted in 
DCM at –78 °C.  Although we were never able to achieve complete conversion during 
hydroalkoxylation, we were able to isolate our expected tetrahydrofuran product 18 with 
a 40% yield with a dr of 1.3:1.0 (Figure 21).  The combined impressions of a low 
conversion and low diastereoselectivity led us to pursue other silyl ketene acetals for 
multicatalytic development.  
 
Figure 21.  Use of silyl ketene acetal 16 in multicatalytic development. 
 
 
A similar disappointing product diastereoselectivity was observed when silyl 
ketene acetal 19 was reacted with ethyl glyoxalate in a stepwise Mukaiyama 
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aldol/hydroalkoxylation procedure to create a spiro-substituted tetrahudrofuran (Figure 
22). 
 
Figure 22. Attempted use of silyl ketene acetal 19 in multicatalytic development. 
 
 
In terms of finding appropriate cyanohydrins for this multicatalytic procedure, the 
most formidable challenge was to find appropriate substrates that would undergo 
hydroalkoxylation with a practical level of diastereoselectivity.  Treatment of 4-pentenal 
with trimethylsilyl cyanide in the presence of Bi(OTf)3 in DCE or DCM at room 
temperature provided cyanohydrin 22 in 90% yield.  When carried out in a one-pot 
multicatalytic sequence, the desired tetrahydrofuran product was formed in good yield 
(70% conversion), but with poor diastereoselectivity (1.1:1.0 dr) (Figure 23).   
 





With hope of obtaining higher selectivity, we then tried an iterative sequence with 
an isopropyl-substituted ketone 23.  The hydroalkoxylation step of this sequence, 
however, failed to provide the desired nitrile product 25 (Figure 24). 
 
Figure 24.  Multicatalytic methods development to synthesize terahydrofuranyl nitriles 
from isopropyl-substituted ketone 23. 
 
 
We then turned our attention to 2-allylcyclohexanone 26 as a viable substrate that 
we hoped would provide a bicyclic tetrahydrofuran 28 with higher selectivity.  While we 
were able to isolate the desired product, we did not observe an increase in dr (1.4:1.0) 
(Figure 25). 
 
Figure 25.  Multicatalytic methods development to synthesize terahydrofuranyl nitriles 





We then tried sequential cyanation/hydroalkoxylation reactions with a gem-
diphenyl substituted 4-pentenal derivative.  A slight increase in dr to 2.1:1.0 was 
observed for the desired tetrahydrofuran product (Figure 26).  
 
Figure 26. Multicatalytic methods development to synthesize terahydrofuranyl nitrile 31 
from a gem-diphenyl substituted aldehyde 29. 
 
 
Cyclohexyl-derived aldehyde 32 and ketone 35 were also synthesized for use in 
our multicatalytic reactions with the persistent hope of improving the diastereoselectivity 
of hydroalkoxylation step.  The diastereoselectively notably increased (Figure 27), but 












Figure 27. Multicatalytic methods development to synthesize terahydrofuranyl nitriles 





In terms of mechanistic analysis for this multicatalytic process, it is believed that 
the first, nucleophilic addition step is metal-initiated and TMSOTf-catalyzed.  Bi(OTf)3 
serves as a water-stable source of TMSOTf, which is believed to be the active catalyst 
(Figure 28).  This finding is in accordance with the mechanism proposed by Carreira.96  
During this catalytic cycle, TMSOTf acts as a Lewis acid and activates the aldehyde 
towards nucleophilic attack by the silylated partner.  Following this reaction, the triflate 
counterion removes the silyl group from the newly formed carbonyl functionality, 






Figure 28.  Bi(OTf)3-catalyzed nucleophilic addidition cycle. 
 
 
Other supporting kinetics studies suggest that Mukaiyama aldol reactions have a 
similar rate when catalyzed by either TMSOTf or Bi(OTf)3.97  Independent silicon NMR 
studies by Dubac and Bosnich98 have observed transmetallation between Bi(OTf)3 and 
silyl enol ethers to produce TMSOTf.  Also, in contrast to water-stable lanthanide 
triflates, the catalytic activity of Bi(OTf)3 shuts down in the presence of water 
presumably due to the hydrolysis of TMSOTf to form triflic acid.  All of these 
observations support the notion of TMSOTf acting as the true catalyst. 
 For the hydroalkoxylation component of our multicatalytic sequence, we believe 
TfOH to be the true operative catalyst.  The reports of Spencer99 and Hartwig100 support 
this notion.  The catalytic cycle proposed in Figure 29 is believed to be operative.  It is 
believed that Bi(OTf)3 produces low levels of triflic acid.  This triflic acid then protonates 
the alkene to produce the more stable secondary carbocation.  Subsequent nucleophilic 
attack by the tethered alcohol followed by deprotonation by the triflate counterion 
regenerates the triflic acid catalyst and provides the target tetrahydrofuran product.   
  
99 
Figure 29.  Triflic acid-catalyzed hydroalkoxylation cycle. 
 
 
III.  Final Remarks 
 
We have directed multicatalytic efforts towards the synthesis of complex 
tetrahydrofurans that are readily assembled by the coupling of an aldehyde with a 
silylated nucleophilic partner under the action of 10 mol% Bi(OTf)3 at either –78 or 0 °C, 
followed by heating the reaction mixture at 80 °C with the addition of a small amount of 
MeOH to faciliate cleavage of the silyl ether intermediate.  Specifically, we found that 
Mukaiyama aldol / hydroalkoxylation sequences could be achieved with high efficiency 
to furnish 2-acetyltetrahydrofurans, a structural motif widely encountered in natural 
product architectures.  We have also found the use of TMSCN as the nucleophilic 







Chapter 1:  Experimental Data 
 
General Information.  All reactions were performed using oven-dried glassware under 
atmosphere of dry argon.  Non-aqueous reagents were transferred by syringe under argon.  
Organic solutions were concentrated using a Buchi rotary evaporator.  Acetonitrile 
(MeCN) and methylene chloride (DCM) were dried using a J.C. Meyer solvent 
purification system.  Reactions using trimethyloxonium tetrafluoroborate (Me3OBF4) 
were set up in a glove box under inert atmosphere.  Trimethyloxonium tetrafluoroborate 
and all other commercially available reagents were used as provided.  Flash column 
chromatography was performed employing 32-63 µm silica gel (Dynamic Adsorbents 
Inc).  Thin-layer chromatography (TLC) was performed on silica gel 60 F254 plates 
(EMD). 
1H and 13C NMR were recorded in CDCl3 on a Bruker DRX-300 spectrometer.  
Data for 1H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = 
singlet, brs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz), and assignment.  Data for 13C NMR are reported in 
terms of chemical shift.  Low-resolution mass spectra (LRMS) were acquired on a JEOL 
JMS-LCmate liquid chromatography mass spectrometer system using a Cl+ ionization 
technique.  IR spectra were recorded on a Nicolet Avatar 370 DTGS (Thermo) using 















   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C10 H13 B F4 N2'  
_chemical_formula_weight          248.03  
   
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'B'  'B'   0.0013   0.0007  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'F'  'F'   0.0171   0.0103  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting            Monoclinic  
_symmetry_space_group_name_H-M    P2(1)/c  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z+1/2'  
 '-x, -y, -z'  
 'x, -y-1/2, z-1/2'  
   
_cell_length_a                    12.502(9)  
_cell_length_b                    10.295(8)  
_cell_length_c                    8.754(7)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  99.691(12)  
_cell_angle_gamma                 90.00  
_cell_volume                      1110.6(14)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     150(2)  
_cell_measurement_reflns_used     1813  
_cell_measurement_theta_min       2.58  
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_cell_measurement_theta_max       21.77  
   
_exptl_crystal_description        Plate  
_exptl_crystal_colour             Colorless  
_exptl_crystal_size_max           0.30  
_exptl_crystal_size_mid           0.10  
_exptl_crystal_size_min           0.02  
_exptl_crystal_density_meas       ?  
_exptl_crystal_density_diffrn     1.483  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              512  
_exptl_absorpt_coefficient_mu     0.135  
_exptl_absorpt_correction_type    empirical  
_exptl_absorpt_correction_T_min   0.9606  
_exptl_absorpt_correction_T_max   0.9973  
_exptl_absorpt_process_details    sadabs  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       150(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'Bruker APEX-II CCD'  
_diffrn_measurement_method        '\f and \w scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_reflns_number             12951  
_diffrn_reflns_av_R_equivalents   0.1289  
_diffrn_reflns_av_sigmaI/netI     0.0897  
_diffrn_reflns_limit_h_min        -15  
_diffrn_reflns_limit_h_max        15  
_diffrn_reflns_limit_k_min        -12  
_diffrn_reflns_limit_k_max        12  
_diffrn_reflns_limit_l_min        -10  
_diffrn_reflns_limit_l_max        10  
_diffrn_reflns_theta_min          1.65  
_diffrn_reflns_theta_max          26.37  
_reflns_number_total              2271  
_reflns_number_gt                 1140  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker APEX2'  
_computing_cell_refinement        'Bruker SAINT'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 2008)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 2008)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  





 Refinement of F^2^ against ALL reflections.  The weighted R-factor 
wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are 
based  
 on F, with F set to zero for negative F^2^. The threshold 
expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. 
and is  
 not relevant to the choice of reflections for refinement.  R-
factors based  
 on F^2^ are statistically about twice as large as those based on F, 
and R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0380P)^2^+0.1484P] where 
P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_number_reflns          2271  
_refine_ls_number_parameters      159  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.1347  
_refine_ls_R_factor_gt            0.0562  
_refine_ls_wR_factor_ref          0.1194  
_refine_ls_wR_factor_gt           0.0946  
_refine_ls_goodness_of_fit_ref    1.024  
_refine_ls_restrained_S_all       1.024  
_refine_ls_shift/su_max           0.000  
_refine_ls_shift/su_mean          0.000  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
N1 N 0.83708(19) 0.5281(2) 0.1692(3) 0.0310(6) Uani 1 1 d . . .  
N2 N 0.8437(2) 0.6063(3) 0.3130(3) 0.0404(7) Uani 1 1 d . . .  
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H2A H 0.918(4) 0.570(4) 0.385(5) 0.126(18) Uiso 1 1 d . . .  
C1 C 0.9266(2) 0.4352(3) 0.1626(4) 0.0383(8) Uani 1 1 d . . .  
H1A H 0.9419 0.3867 0.2602 0.057 Uiso 1 1 calc R . .  
H1B H 0.9917 0.4828 0.1468 0.057 Uiso 1 1 calc R . .  
H1C H 0.9054 0.3745 0.0765 0.057 Uiso 1 1 calc R . .  
C2 C 0.7989(3) 0.6011(3) 0.0243(3) 0.0389(8) Uani 1 1 d . . .  
H2B H 0.7739 0.5386 -0.0601 0.047 Uiso 1 1 calc R . .  
H2C H 0.8606 0.6504 -0.0043 0.047 Uiso 1 1 calc R . .  
C3 C 0.7082(3) 0.6940(3) 0.0373(4) 0.0394(8) Uani 1 1 d . . .  
H3A H 0.6761 0.7242 -0.0678 0.047 Uiso 1 1 calc R . .  
H3B H 0.7385 0.7707 0.0977 0.047 Uiso 1 1 calc R . .  
C4 C 0.6199(3) 0.6363(3) 0.1134(3) 0.0318(8) Uani 1 1 d . . .  
C5 C 0.5123(3) 0.6737(3) 0.0760(3) 0.0372(8) Uani 1 1 d . . .  
H5A H 0.4919 0.7355 -0.0042 0.045 Uiso 1 1 calc R . .  
C6 C 0.4338(3) 0.6231(3) 0.1528(3) 0.0386(8) Uani 1 1 d . . .  
H6A H 0.3607 0.6513 0.1270 0.046 Uiso 1 1 calc R . .  
C7 C 0.4625(3) 0.5308(3) 0.2677(3) 0.0380(8) Uani 1 1 d . . .  
H7A H 0.4090 0.4954 0.3209 0.046 Uiso 1 1 calc R . .  
C8 C 0.5690(3) 0.4903(3) 0.3047(3) 0.0344(8) Uani 1 1 d . . .  
H8A H 0.5886 0.4264 0.3826 0.041 Uiso 1 1 calc R . .  
C9 C 0.6469(2) 0.5428(3) 0.2283(3) 0.0289(7) Uani 1 1 d . . .  
C10 C 0.7608(2) 0.5025(3) 0.2747(3) 0.0338(8) Uani 1 1 d . . .  
H10A H 0.7732 0.4210 0.3374 0.041 Uiso 1 1 calc R . .  
B B 0.8369(3) 0.1120(4) 0.1499(4) 0.0329(9) Uani 1 1 d . . .  
F1 F 0.79674(16) -0.01221(18) 0.1553(2) 0.0581(6) Uani 1 1 d . . .  
F2 F 0.75631(14) 0.19415(19) 0.0788(2) 0.0512(6) Uani 1 1 d . . .  
F3 F 0.87720(15) 0.15440(17) 0.29790(19) 0.0517(6) Uani 1 1 d . . .  
F4 F 0.92144(13) 0.11010(18) 0.06302(19) 0.0458(5) Uani 1 1 d . . .  
   
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
N1 0.0400(17) 0.0302(15) 0.0244(14) -0.0042(12) 0.0099(12) -
0.0019(12)  
N2 0.0469(19) 0.0421(17) 0.0334(16) -0.0110(14) 0.0096(14) -
0.0070(15)  
C1 0.042(2) 0.0327(19) 0.0417(19) -0.0034(16) 0.0123(16) 0.0021(16)  
C2 0.052(2) 0.0335(19) 0.0335(19) 0.0052(16) 0.0143(16) -0.0042(17)  
C3 0.055(2) 0.0274(17) 0.0370(19) 0.0065(15) 0.0106(16) -0.0025(17)  
C4 0.041(2) 0.0260(18) 0.0270(17) -0.0031(15) 0.0002(15) -0.0016(16)  
C5 0.053(2) 0.0289(18) 0.0286(17) 0.0017(15) 0.0028(16) 0.0079(17)  
C6 0.039(2) 0.039(2) 0.0358(19) -0.0072(17) 0.0022(16) 0.0076(17)  
C7 0.039(2) 0.041(2) 0.035(2) -0.0035(16) 0.0096(16) -0.0036(17)  
C8 0.040(2) 0.0351(19) 0.0277(18) -0.0014(14) 0.0058(16) -0.0024(17)  
C9 0.0355(19) 0.0281(17) 0.0230(16) -0.0034(14) 0.0048(14) 
0.0003(15)  
C10 0.040(2) 0.0359(19) 0.0263(17) 0.0034(14) 0.0081(15) -0.0065(17)  
B 0.039(2) 0.030(2) 0.029(2) -0.0007(18) 0.0058(18) -0.0052(19)  




F2 0.0456(13) 0.0595(13) 0.0476(12) 0.0054(10) 0.0051(9) 0.0074(11)  
F3 0.0793(15) 0.0458(12) 0.0273(10) -0.0047(9) 0.0010(9) 0.0045(10)  
F4 0.0400(12) 0.0628(13) 0.0354(11) 0.0011(10) 0.0088(9) 0.0000(10)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. 
planes)  
 are estimated using the full covariance matrix.  The cell esds are 
taken  
 into account individually in the estimation of esds in distances, 
angles  
 and torsion angles; correlations between esds in cell parameters 
are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. 
planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
N1 C10 1.459(4) . ?  
N1 C1 1.480(4) . ?  
N1 C2 1.482(4) . ?  
N1 N2 1.486(3) . ?  
N2 C10 1.487(4) . ?  
C2 C3 1.501(4) . ?  
C3 C4 1.504(4) . ?  
C4 C5 1.385(4) . ?  
C4 C9 1.392(4) . ?  
C5 C6 1.381(4) . ?  
C6 C7 1.386(4) . ?  
C7 C8 1.380(4) . ?  
C8 C9 1.381(4) . ?  
C9 C10 1.473(4) . ?  
B F1 1.378(4) . ?  
B F3 1.380(4) . ?  
B F2 1.381(4) . ?  
B F4 1.402(4) . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C10 N1 C1 119.1(2) . . ?  
C10 N1 C2 118.9(2) . . ?  
  
107 
C1 N1 C2 115.6(2) . . ?  
C10 N1 N2 60.65(18) . . ?  
C1 N1 N2 116.7(2) . . ?  
C2 N1 N2 114.4(2) . . ?  
N1 N2 C10 58.79(17) . . ?  
N1 C2 C3 113.4(2) . . ?  
C2 C3 C4 113.7(3) . . ?  
C5 C4 C9 118.1(3) . . ?  
C5 C4 C3 122.8(3) . . ?  
C9 C4 C3 119.1(3) . . ?  
C6 C5 C4 121.4(3) . . ?  
C5 C6 C7 119.6(3) . . ?  
C8 C7 C6 119.9(3) . . ?  
C7 C8 C9 120.0(3) . . ?  
C8 C9 C4 121.0(3) . . ?  
C8 C9 C10 119.0(3) . . ?  
C4 C9 C10 120.0(3) . . ?  
N1 C10 C9 118.6(3) . . ?  
N1 C10 N2 60.55(17) . . ?  
C9 C10 N2 117.6(3) . . ?  
F1 B F3 109.8(3) . . ?  
F1 B F2 110.0(3) . . ?  
F3 B F2 110.7(3) . . ?  
F1 B F4 108.5(3) . . ?  
F3 B F4 108.9(3) . . ?  
F2 B F4 108.9(3) . . ?  
   
_diffrn_measured_fraction_theta_max    1.000  
_diffrn_reflns_theta_full              26.37  
_diffrn_measured_fraction_theta_full   1.000  
_refine_diff_density_max    0.204  
_refine_diff_density_min   -0.210  














N-methyltetrahydroisoquinoline diaziridinium tetrafluoroborate (1):  A solution of 
Me3OBF4 (213 mg, 1.37 mmol) in DCM (3 mL) was cooled to 0 °C.  Then a solution of 
1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (200 mg, 1.44 mmol) in DCM 
(2 mL) was added to the solution of Meerwein’s salt at 0 °C.  The reaction was stirred at 
0 °C for 30 min.  The reaction was then concentrated under reduced pressure.  The crude 
oily yellow solid was recrystallized by dissolving in a minimal amount of a 1:1 mixture 
of hot EtOAc/DCM followed by the addition of hexanes, providing the title compound as 
colorless crystals (243 mg, 0.980 mmol, 72% yield).  1H NMR (300 MHz, CD3CN) δ 
7.68-7.65 (dd, J = 7.5 and 1.5 Hz, 1H, ArH), 7.54-7.49 (td, J = 7.5 and 1.5 Hz, 1H, ArH), 
7.46-7.40 (td, J = 7.5 and 0.9 Hz, 1H, ArH), 7.31 (d, J = 7.2 Hz, 1H, ArH), 5.30-5.23 (m, 
2H, NH and ArCH), 4.07-4.00 (ddd, J = 6.06, 6.15, and 1.2 Hz, 1H, ArCH2CH2N), 3.73 
(s, 3H, NCH3), 3.48-3.39 (td, J = 12.2 and 4.5 Hz, 1H, ArCH2CH2N), 3.31-3.12 (td, J = 
12.8 and 6.0 Hz, 1H, ArCH2CH2N), 2.91-2.84 (dd, J = 16.2 and 4.2 Hz, 1H, 
ArCH2CH2N).  13C NMR (300 MHz, CD3CN) δ 133.3, 132.0, 131.0, 129.4, 128.3, 125.8, 
63.8, 52.3, 50.7, 25.0.  IR (neat) 3625, 3238, 3052, 1635, 1453, 1296, 1064, 819, 765 cm-
1.  LRMS (APCl+) exact mass calc’d for C10H13N2+ (M+) requires m/z 161.11, found m/z 














3,4-dihydroisoquinoline (3):  Prepared according to an established method by Pelletier 
and Cava.101  N-bromosuccinimide (14.7 g, 82.7 mmol) was added portionwise to a 
solution of tetrahydroisoquinoline (10.0 g, 75.2 mmol) in DCM (200 mL) at rt.  The 
solution changed color from yellow to deep red.  The reaction was stirred for 30 min at rt, 
and then a 30% NaOH solution (50 mL) was added.  The biphasic solution was stirred 
vigorously overnight.  After dilution with water (100 mL), the mixture was extracted with 
DCM (3 xs 100 mL).  The combined organic layers were washed with brine and dried 
over Na2SO4.  Purification of the crude oil by distillation under reduced pressure (20 
Torr) provided imine 3 as a clear and colorless oil (8.5 g, 64.8 mmol, 86% yield).  1H 
NMR (300 MHz, CDCl3) δ 8.32 (t, J = 2.1 Hz, 1H, ArCH=N), 7.36-7.12 (m, 4H, ArH), 





1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (5):  Prepared according to 
an established method by Ortega et al.102  A solution of NH4OH (5.7 mL) in MeOH (13 
mL) was cooled to –20 °C, and hydroxylamine-O-sulfonic acid (4.65 g, 41.1 mmol) was 






°C, a solution of 3,4-dihydroisoquinoline (4.82 g, 36.7 mmol) in MeOH (13 mL) was 
added dropwise.  The reaction was stirred at 0 °C overnight.  Upon warming to rt, the 
reaction was filtered, and the filtrate was concentrated.  The crude yellow oil was purified 
directly by silica gel chromatography (50% EtOAc/hexanes) to yield diaziridine 5 as a 
white solid (3.10 g, 21.21 mmol, 58% yield).  1H NMR (300 MHz, CDCl3) δ 7.43-7.08 
(m, 4H, ArH), 4.06 (d, J = 6.9 Hz, 1H, CHN), 3.61-3.54 (ddd, J = 12.9, 6.0, and 1.2 Hz, 
1H, ArCH2CH2N), 3.01-2.89 (td, J = 15.6 and 6.0 Hz, 1H, ArCH2), 2.76-2.67 (td, J = 
12.8 and 4.2 Hz, 1H, ArCH2), 2.43-2.37 (dd, J = 15.3 and 3.6 Hz, 1H, ArCH2CH2N), 





(Z)-3-methyl-4,5-dihydro-3H-benzo[d][1,2]diazepine (6):103  N-
methyltetrahydroisoquinoline diaziridinium tetrafluoroborate (42 mg, 0.169 mmol) was 
dissolved in MeCN (0.50 mL), and the reaction was heated at 80 °C under Ar for 12 hr.  
After cooling to rt, the reaction was diluted with EtOAc (2 mL) and washed with 
NaHCO3 (2 mL), brine (2 mL), and dried over Na2SO4.  The solution was concentrated, 
and the crude material was purified directly by silica gel chromatography (20% 
EtOAc/hexanes) to yield benzodiazepine 6 as a yellow oil (20 mg, 0.125 mmol, 74% 
yield).  1H NMR (300 MHz, CDCl3) δ 7.31-7.16 (m, 4H, ArH), 7.11 (s, 1H, ArC(=N)H), 
3.40-3.37 (m, 2H, ArCH2CH2N), 3.25-3.22 (m, 2H, ArCH2CH2N), 3.16 (s, 3H, NCH3).  





48.3, 37.7.  IR (neat) 3060, 3017, 2955, 2905, 2854, 1586, 1563, 1494, 1444, 1422, 1400, 
1309, 1258, 1204, 1149, 1115, 1065, 1022, 946, 924, 873, 780, 757, 728, 700 cm-1.  





N–phenethylethanamide:  Prepared according to an established procedure by 
Gulamhussen et al.104  A solution of 2-phenethylamine (9.62 g, 79.39 mmol) in 
chloroform (100 mL) was cooled to 5 °C.  Then a solution of acetyl chloride (8.40 mL, 
118.09 mmol) in chloroform (150 mL) was added slowly.  After stirring 15 min, the 
solution was made basic with 1 M NaOH.  The organic layers were washed with brine 
(100 mL) and dried over Na2SO4.  The crude yellow oily solid was purified by silica gel 
chromatography (10% MeOH/DCM) to provide N-phenethylethanamide as a yellow solid 
(9.75 g, 59.74 mmol, 75% yield).  1H NMR (300 MHz, CDCl3) δ 7.35-7.19 (m, 5H, 
ArH), 5.76 (brs, 1H, NH), 3.51 (q, J  = 6.9 Hz, 2H, ArCH2CH2N), 2.83 (t, J = 6.9 Hz, 













1-methyl-3,4-dihydroisoquinoline:  Prepared according to the established procedure by 
Whaley and Hartung.105  A solution of N-phenethylethanamide (1.00 g, 6.13 mmol), P2O5 
(2.00 g, 14.09 mmol), and POCl3 (1.22 mL, 13.04 mmol) in xylenes (15 mL) was heated 
at reflux (130 °C) for 2 hr.  After cooling to rt, the reaction was quenched by pouring into 
a beaker containing ice.  The solid remaining in the flask, which contained the desired 
product, was extracted many times with 10% NaOH solution until completely dissolved.  
The combined solutions were extracted with EtOAc (3 xs 30 mL), and the combined 
organic layers were washed with brine (50 mL) and dried over Na2SO4.  The crude dark 
orange oil was purified by silica gel chromatography (10% MeOH/DCM) to provide 1-
methyl-3,4-dihydroisoquinoline as a brown oil (0.716 g, 4.93 mmol, 81% yield).  1H 
NMR (300 MHz, CDCl3) δ 7.48-7.46 (m, 1H, ArH), 7.37-7.25 (m, 2H, ArH), 7.17 (d, J = 
6.9 Hz, 1H, ArH), 3.69-3.63 (td, J = 7.2 and 1.5 Hz, 2H, ArCH2CH2N), 2.70 (t, J = 7.8 





1-methyl-1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (7):  Prepared 







MeOH (0.85 mL) was cooled to –20 °C, and hydroxylamine-O-sulfonic acid (0.290 g, 
2.57 mmol) was added portionwise to the mixture.  After stirring the suspension for about 
30 min at –20 °C, a solution of 1-methyl-3,4-dihydroisoquinoline (0.330 g, 2.27 mmol) in 
MeOH (0.85 mL) was added dropwise.  The reaction was gradually warmed to room 
temperature and stirred for 2 days.  The reaction was then filtered, and the filtrate was 
concentrated.  The crude red oil was purified directly by silica gel chromatography (50% 
EtOAc/hexanes) to yield title compound 7 as a dark yellow solid (231 mg, 1.44 mmol, 
63% yield).  1H NMR (300 MHz, CDCl3) δ 7.57-7.54 (m, 1H, ArH), 7.29-7.23 (m, 2H, 
ArH), 7.12-7.09 (m, 1H, ArH), 3.57-3.51 (ddd, J = 6.5, 6.9, and 1.5 Hz, 1H, 
ArCH2CH2N), 3.05-2.94 (td, J = 13.8 and 6.0 Hz, 1H, ArCH2CH2N), 2.85-2.75 (td, J = 
12.9 and 3.9 Hz, 1H, ArCH2CH2N), 2.47-2.41 (dd, J = 15.0 and 3.3 Hz, 1H, 
ArCH2CH2N), 1.95 (brs, 1H, NH), 1.87 (s, 3H, ArCHCH3).  13C NMR (300 MHz, 
CDCl3) δ 135.2, 134.4, 128.1, 127.6, 127.3, 126.3, 54.1, 46.2, 25.1, 24.2.  IR (neat) 3218, 
3068, 2987, 2944, 2919, 2857, 1497, 1458, 1439, 1381, 1345, 1313, 1271, 1229, 1189, 
1149, 1114, 1076, 1064, 1047, 1028, 980, 907, 785, 766, 749, 724, 634 cm-1.  LRMS 





(Z)-1,3-dimethyl-4,5-dihydro-3H-benzo[d][1,2]diazepine (8):  A solution of Me3OBF4 






methyl-substituted diaziridine 7 (30 mg, 0.187 mmol) in d3-MeCN (0.40 mL) was added 
slowly.  The reaction was stirred for 30 min at –40 °C, and then the reaction was 
quenched with NaHCO3 (1 mL).  The product was extracted with EtOAc (3 xs 2 mL), 
and the combined organic layers were washed with brine (2 mL) and dried over Na2SO4.  
The crude yellow oil (26 mg, 0.149 mmol, 82% yield) did not require further purification.  
1H NMR (300 MHz, CDCl3) δ 7.33-7.31 (m, 4H, ArH), 3.38 (t, J = 7.2 Hz, 2H, 
ArCH2CH2N), 2.71-2.67 (m, 5H, NCH3 and ArCH2CH2N), 2.36 (s, 3H, ArC(CH3)=N).  
13C NMR (300 MHz, CDCl3) δ 162.0, 139.2, 137.1, 129.2, 127.5, 126.5, 125.8, 63.8, 
47.2, 32.2, 23.2.  IR (neat) 3065, 3022, 2987, 2948, 2916, 2846, 2790, 1609, 1490, 1438, 
1370, 1295, 1279, 1220, 1202, 1107, 1055, 1041, 958, 765, 754 cm-1.  LRMS (APCl+) 




N-(4-bromophenethyl)ethanamide:107  Prepared according to an established procedure 
by Gulamhussen et al.108  A solution of 4-bromophenethylamine (3.88 mL, 24.99 mmol) 
in chloroform (30 mL) was cooled to 5 °C.  Then a solution of acetyl chloride (2.65 mL, 
37.24 mmol) in chloroform (47 mL) was added slowly.  After stirring 30 min, the 
solution was made basic with 1 M NaOH.  The organic layers were washed with brine 
(50 mL) and dried over Na2SO4.  The white solid product, N-(4-
bromophenethyl)ethanamide, (5.67 g, 23.42 mmol, 94% yield) did not require further 







8.4 Hz, 2H, ArH), 5.48 (brs, 1H, NH), 3.47 (q, J = 6.9, 6.6 Hz, 2H, ArCH2CH2N), 2.76 




8-bromo-1-methyl-3,4-dihydroisoquinoline:109  Prepared according to the established 
procedure by Whaley and Hartung.110  A solution of N-(4-bromophenethyl)ethanamide 
(3.00 g, 12.39 mmol), P2O5 (6.00 g, 42.27 mmol), and POCl3 (3.58 mL, 39.13 mmol) in 
xylenes (45 mL) was heated at reflux (130 °C) for 2 hr.  After cooling to rt, the reaction 
was quenched by pouring into a beaker containing ice.  The solid remaining in the flask 
was extracted many times with 10% NaOH solution until completely dissolved.  The 
combined solutions were extracted with EtOAc (3 xs 50 mL), and the combined organic 
layers were washed with brine (50 mL) and dried over Na2SO4.  The brown oil was 
purified by silica gel chromatography (5% MeOH/DCM) to provide 7-bromo-1-methyl-
3,4-dihydroisoquinoline as a yellow oil (1.39 g, 6.20 mmol, 50% yield).  1H NMR (300 
MHz, CDCl3) δ 7.59 (s, 1H, ArH), 7.47 (d, J = 8.1 Hz, 1H, ArH), 7.06 (d, J = 8.1 Hz, 
1H, ArH), 3.66 (td, J = 7.5, 7.4, 1.2 Hz, 2H, ArCH2CH2N), 2.64 (t, J = 7.8 Hz, 2H, 












Prepared according to an established method by Ortega et al.111  A solution of NH4OH 
(0.80 mL) in MeOH (1.80 mL) was cooled to –20 °C, and hydroxylamine-O-sulfonic 
acid (0.870 g, 7.68 mmol) was added portionwise to the mixture.  After stirring the 
suspension for about 30 min at –20 °C, a solution of 8-bromo-1-methyl-3,4-
dihydroisoquinoline (1.15 g, 5.12 mmol) in MeOH (1.80 mL) was added dropwise.  The 
reaction was gradually warmed to room temperature and stirred for 2 days.  The reaction 
was filtered, and the filtrate was concentrated.  The crude red oil was purified directly by 
silica gel chromatography (35% EtOAc/hexanes) to yield title compound 9 as a yellow 
solid (874 mg, 3.66 mmol, 71% yield).  1H NMR (300 MHz, CDCl3) δ 7.65 (s, 1H, ArH), 
7.37 (d, J = 8.1 Hz, 1H, ArH), 6.97 (d, J = 8.1 Hz, 1H, ArH), 3.55-3.49 (dd, J = 5.7, 12.5 
Hz, 1H, ArCH2CH2N), 2.95-2.84 (td, J = 5.7, 12.6 Hz, 1H, ArCH2CH2N), 2.79-2.70 (td, 
J = 3.0, 12.8 Hz, 1H, ArCH2CH2N), 2.39 (d, J = 14.4 Hz, 1H, ArCH2CH2N), 1.96 (brs, 
1H, NH), 1.83 (s, 3H, ArC(CH3)).  13C NMR (300 MHz, CDCl3) δ 136.9, 134.2, 130.5, 
130.3, 129.7, 119.7, 53.8, 46.1, 24.6, 24.0.  IR (neat) 3194, 2937, 1595, 1487, 1444, 
1423, 1381, 1330, 1226, 1187, 1118, 1046, 908, 883, 818, 790, 775, 756, 732, 711, 684 
cm-1.  LRMS (APCl+) exact mass calc’d for C10H12BrN2+ (MH+) requires m/z 240.12, 









(Z)-1,3-dimethyl-4,5-dihydro-9-bromo-3H-benzo[d][1,2]diazepine (10): A solution of 
Me3OBF4 (32 mg, 0.219 mmol) in d3-MeCN (0.60 mL) was cooled to –40 °C.  Then a 
solution of methyl-substituted diaziridine 9 (50 mg, 0.209 mmol) in d3-MeCN (0.60 mL) 
was added slowly.  The reaction was stirred for 30 min at –40 °C, and then the reaction 
was quenched with NaHCO3 (1 mL).  The product was extracted with EtOAc (3 xs 2 
mL), and the combined organic layers were washed with brine (2 mL) and dried over 
Na2SO4.  The crude dark orange oily solid was purified by silica gel chromatography (5% 
MeOH/DCM) to yield title compound 10 (49 mg, 0.194 mmol, 93% yield).  1H NMR 
(300 MHz, CDCl3) δ 7.41-7.39 (m, 2H, ArH), 7.10 (d, J = 8.4 Hz, 1H, ArH), 3.32 (t, J = 
6.9 Hz, 2H, ArCH2CH2N), 2.67 (s, 3H, NCH3), 2.62 (t, J = 6.9 Hz, 2H, ArCH2CH2N), 
2.31 (s, 3H, ArC(CH3)=N).  13C NMR (300 MHz, CDCl3) δ 159.9, 139.0, 138.2, 132.0, 
129.3, 128.8, 120.4, 63.3, 47.2, 31.8, 23.1.  IR (neat) 2949, 2848, 2793, 1585, 1561, 
1480, 1439, 1391, 1371, 1297, 1257, 1220, 1195, 1138, 1109, 1079, 1050, 1029, 880, 
824, 786, 771, 749, 718, 702, 671 cm-1.  LRMS (APCl+) exact mass calc’d for 












N–(2-phenylpropyl)-acetamide:112  Prepared according to an established procedure by 
Gulamhussen et al.113  A solution of β-methylphenethylamine (5.38 mL, 36.98 mmol) in 
chloroform (45 mL) was cooled to 5 °C.  Then a solution of acetyl chloride (3.92 mL, 
55.10 mmol) in chloroform (70 mL) was added slowly.  After stirring 30 min, the 
solution was made basic with 1 M NaOH.  The organic layers were washed with brine 
(100 mL) and dried over Na2SO4.  The solution was concentrated, and the crude yellow 
oil (5.57 g, 31.43 mmol, 85% yield) did not require further purification.  1H NMR (300 
MHz, CDCl3) δ 7.36-7.19 (m, 5H, ArH), 5.29 (brs, 1H, NH), 3.68-3.59 (m, 1H, 
ArCH(CH3)CH2N), 3.26-3.17 (m, 1H, ArCH(CH3)CH2N), 2.99-2.87 (m, 1H, 





1,4-dimethyl-3,4-dihydroisoquinoline:114  Prepared according to the established 
procedure by Whaley and Hartung.115  A solution of N–(2-phenylpropyl)-acetamide (1.00 
g, 5.64 mmol), P2O5 (2.00 g, 14.09 mmol), and POCl3 (1.19 mL, 13.04 mmol) in xylenes 
(15 mL) was heated at reflux (130 °C) for 2 hr.  After cooling to rt, the reaction was 









extracted many times with 10 % NaOH solution until completely dissolved.  The 
combined solutions were extracted with EtOAc (3 xs 50 mL), and the combined organic 
layers were washed with brine (50 mL) and dried over Na2SO4.  The brown oil was 
purified by silica gel chromatography (10% MeOH/DCM) to provide 1,4-dimethyl-3,4-
dihydroisoquinoline as a yellow oil (0.622 g, 3.91 mmol, 69% yield).  1H NMR (300 
MHz, CDCl3) δ 7.51 (d, J = 7.8 Hz, 1H, ArH), 7.44 (t, J = 1.2 Hz, 1H, ArH), 7.42-7.27 
(m, 2H, ArH), 3.80-3.72 (m, 1H, ArCH(CH3)CH2N), 3.51-3.42 (m, 1H, 
ArCH(CH3)CH2N), 2.90-2.83 (m, 1H, ArCH(CH3)CH2N), 2.42 (s, 3H, ArC(CH3)=N), 





1,4-dimethyl-1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (11):  
Prepared according to an established method by Ortega et al.116  A solution of NH4OH 
(0.60) in MeOH (1.40 mL) was cooled to –20 °C, and hydroxylamine-O-sulfonic acid 
(0.663 g, 5.86 mmol) was added portionwise to the mixture.  After stirring the suspension 
for about 30 min at –20 °C, a solution of 1,4-dimethyl-3,4-dihydroisoquinoline (0.622 g, 
3.91 mmol) in MeOH (2.0 mL) was added dropwise.  The suspension was gradually 
warmed to room temperature and stirred for 2 days.  The reaction was then filtered, and 











chromatography (35% EtOAc/hexanes) to yield diaziridine 11 as a 4:1 mixture of 
diastereomers (460 mg, 2.64 mmol, 68% yield).  1H NMR (300 MHz, CDCl3) δ 7.57 (d, J 
= 7.5 Hz, 2H, major and minor ArH), 7.37-7.17 (m, 6H, major and minor ArH), 3.51-
3.45 (dd, J = 5.7, 12.9 Hz, 1H, major ArCH(CH3)CH2N), 3.34-3.28 (dd, J = 5.6, 13.3 Hz, 
1H,  minor ArCH(CH3)CH2N), 3.11-3.03 (m, 3H, major ArCH(CH3)CH2N, minor  
ArCH(CH3)CH2N, minor ArCH(CH3)CH2N), 2.51 (t, J = 11.7 Hz, 1H, major 
ArCH(CH3)CH2N), 2.19 (brs, 1H, minor NH), 1.98 (brs, 1H, major NH), 1.88 (s, 3H, 
major ArC(CH3)(NH)N), 1.83 (s, 3H, minor ArC(CH3)(NH)N), 1.42 (d, J = 7.2 Hz, 3H, 
minor ArCH(CH3)CH2N), 1.28 (d, J = 6.9 Hz, 3H, major ArCH(CH3)CH2N).  13C NMR 
(300 MHz, CDCl3) δ 139.9, 134.0, 127.8, 127.3, 126.0, 124.5, 54.4, 26.6, 24.8, 15.1.  IR 
(neat) 3199, 3065, 3037, 2963, 2930, 2871, 1493, 1449, 1381, 1354, 1230, 1116, 1067, 
1034, 957, 920, 892, 734, 704, 664 cm-1.  LRMS (APCl+) exact mass calc’d for 





(Z)-1,3,5-trimethyl-4,5-dihydro-3H-benzo[d][1,2]diazepine (12):  A solution of 
Me3OBF4 (45 mg, 0.301 mmol) in d3-MeCN (0.60 mL) was cooled to –40 °C.  Then a 
solution of 1,4-dimethyl-substituted diaziridine 11 (50 mg, 0.287 mmol) in d3-MeCN 







°C, and then quenched with NaHCO3 (1 mL).  The product was extracted with EtOAc (3 
xs 2 mL), and the combined organic layers were washed with brine (2 mL) and dried over 
Na2SO4.  The crude oil was purified by silica gel chromatography (5% MeOH/DCM) to 
yield the title compound as a yellow oil (48 mg, 0.255 mmol, 89% yield).  1H NMR (300 
MHz, CDCl3) δ 7.37-7.26 (m, 4H, ArH), 3.30-3.25 (dd, J = 10.95, 6.9 Hz, 
ArCH(CH3)CH2), 3.05 (t, J = 10.5 Hz, 1H, ArCH(CH3)CH2), 2.93-2.85 (m, 1H, 
ArCH(CH3)CH2), 2.66 (s, 3H, NCH3), 2.34 (s, 3H, ArC(CH3)=N), 1.28 (d, J = 6.9 Hz, 
3H, ArCH(CH3)CH2).  13C NMR (300 MHz, CDCl3) δ 161.3, 142.8, 137.0, 129.1, 126.3, 
125.6, 124.2, 71.2, 47.2, 35.0, 23.2, 15.9.  IR (neat) 2954, 2844, 2790, 1610, 1487, 1436, 
1374, 1286, 1155, 1070, 1043, 980 cm-1.  LRMS (APCl+) exact mass calc’d for 




N-(2,2-diphenylethyl)ethanamide:117  Prepared according to an established procedure 
by Gulamhussen et al.118  A solution of 2,2-diphenylethylamine (5.00 g, 25.34 mmol) in 
chloroform (30 mL) was cooled to 5 °C.  Then a solution of acetyl chloride (2.69 mL, 
37.76 mmol) in chloroform (47 mL) was added to the solution slowly.  After stirring 30 
min, the solution was made basic with 1 M NaOH.  The organic layers were washed with 
brine (100 mL) and dried over Na2SO4.  The crude white solid (5.47 g, 22.86 mmol, 90% 
yield) was used without further purification.  1H NMR (300 MHz, CDCl3) δ 7.35-7.21 
(m, 10H, ArH), 5.89 (brs, 1H, NH), 4.23 (t, J = 8.1 Hz, 1H, ArCH(Ph)CH2N), 3.89 (dd, J 








1-methyl-4-phenyl-3,4-dihydroisoquinoline:  Prepared according to the established 
procedure by Whaley and Hartung.119  A solution of N-(2,2-diphenylethyl)ethanamide 
(3.00 g, 12.54 mmol), P2O5 (4.09 g, 28.83 mmol), and POCl3 (2.45 mL, 26.71 mmol) in 
xylenes (45 mL) was heated at reflux (130 °C) for 2 hr.  After cooling to rt, the reaction 
was quenched by pouring into a beaker containing ice.  The solid remaining in the flask 
was extracted many times with 10% NaOH solution until completely dissolved.  The 
combined solutions were extracted with EtOAc (3 xs 50 mL), and the combined organic 
layers were washed with brine (50 mL) and dried over Na2SO4.  The crude oil was 
purified by silica gel chromatography (10% MeOH/DCM) to provide 1-methyl-4-phenyl-
3,4-dihydroisoquinoline as a dark red oil (2.30 g, 10.39 mmol, 83% yield).  1H NMR 
(300 MHz, CDCl3) δ 7.57-7.54 (m, 1H, ArH), 7.36-7.19 (m, 7H, ArH), 6.94-6.91 (m, 1H, 
ArH), 4.07-3.98 (m, 2H, ArCH(Ph)CH2N), 3.86-3.80 (m, 1H, ArCH(Ph)CH2N), 2.44 (s, 
3H, ArC(CH3)=N).  13C NMR (300 MHz, CDCl3) δ 164.4, 141.3, 140.0, 130.8, 129.1, 
128.5, 127.2, 127.0, 126.8, 125.3, 53.9, 42.2, 23.2.  IR (neat) 3368, 3060, 3027, 2936, 
2846, 1632, 1601, 1572, 1493, 1449, 1372, 1286, 1082, 1030, 985, 934, 906, 763, 741, 
701, 679 cm-1.  LRMS (APCl+) exact mass calc’d for C16H16N+ (MH+) requires m/z 










1-methyl-4-phenyl-1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (13):  
Prepared according to an established method by Ortega et al.120  A solution of NH4OH 
(0.85) in MeOH (2.0 mL) was cooled to –20 °C, and hydroxylamine-O-sulfonic acid 
(0.928 g, 8.21 mmol) was added portionwise to the mixture.  After stirring the suspension 
for about 30 min at –20 °C, a solution of 1-methyl-4-phenyl-3,4-dihydroisoquinoline 
(1.21 g, 5.47 mmol) in MeOH (2.0 mL) was added dropwise.  The suspension was 
gradually warmed to room temperature and stirred for 3 days.  The reaction was then 
filtered, and the filtrate was concentrated.  The crude red oil was purified directly by 
silica gel chromatography (35% EtOAc/hexanes) to yield diaziridine 13 as a 2.7:1 
mixture of diastereomers (740 mg, 3.13 mmol, 65% yield).  1H NMR (300 MHz, CDCl3) 
δ 7.65 (d, J = 7.5 Hz, 2H, major and minor ArH), 7.43-7.12 (m, 14H, major and minor 
ArH), 6.94 (d, J = 7.5 Hz, 1H, minor ArH), 6.75 (d, J = 7.8 Hz, 1H, major ArH), 4.27-
4.21 (m, 2H, major ArCH(Ph)CH2N and minor ArCH(Ph)CH2N), 3.72-3.66 (dd, J = 6.0, 
13.2 Hz, 2H, major ArCH(Ph)CH2N and minor ArCH(Ph)CH2N), 3.52-3.46 (dd, J = 6.9, 
1H, 12.9 Hz, 1H, minor ArCH(Ph)CH2N), 3.04 (t, J = 12.0 Hz, 1H, major 
ArCH(Ph)CH2N), 2.26 (brs, 1H, minor NH), 2.11 (brs, 1H, major NH), 1.98 (s, 3H, 
major ArC(CH3)), 1.85 (s, 3H, minor ArC(CH3)).  13C NMR (300 MHz, CDCl3) δ 143.7, 











126.2, 77.2, 56.5, 54.7, 54.2, 53.9, 43.1, 40.0, 25.9, 24.4.  IR (neat) 3200, 3061, 3029, 
2968, 2925, 2861, 1602, 1493, 1451, 1381, 1351, 1361, 1269, 1232, 1157, 1116, 1071, 
1032, 925, 875, 794, 757, 725, 702, 682 cm-1.  LRMS (APCl+) exact mass calc’d for 





(Z)-1,3-dimethyl-5-phenyl-4,5-dihydro-3H-benzo[d][1,2]diazepine (14): A solution of 
Me3OBF4 (33 mg, 0.222 mmol) in d3-MeCN (0.60 mL) was cooled to –40 °C.  Then a 
solution of methyl-substituted diaziridine 13 (50 mg, 0.212 mmol) in d3-MeCN (0.60 
mL) was added slowly to the reaction.  The reaction was stirred for 30 min at –40 °C, and 
then quenched with NaHCO3 (1 mL).  The product was extracted with EtOAc (3 xs 2 
mL), and the combined organic layers were washed with brine (2 mL) and dried over 
Na2SO4.  The crude red oil was purified by silica gel chromatography (5% MeOH/DCM) 
to yield benzodiazepine 14 as an orange oil (46 mg, 0.184 mmol, 87% yield).  1H NMR 
(300 MHz, CDCl3) δ 7.44-7.21 (m, 8H, ArH), 6.93 (d, J = 7.8 Hz, 1H, ArH), 4.22-4.16 
(dd, J = 7.2, 10.8 Hz, 1H, ArCH(Ph)CH2N), 3.79 (t, J = 11.1 Hz, 1H, ArCH(Ph)CH2N), 
3.51-3.45 (dd, J = 7.2, 11.3 Hz, 1H, ArCH(Ph)CH2N), 2.79 (s, 3H, NCH3), 2.44 (s, 3H, 
ArC(CH3)=N).  13C NMR (300 MHz, CDCl3) δ 159.8, 141.8, 139.8, 136.2, 129.3, 128.9, 







2992, 2950, 2917, 2847, 2795, 1604, 1553, 1493, 1451, 1371, 1297, 1231, 1207, 1147, 
1114, 1063, 1042, 1020, 983, 880, 758, 701 cm-1.  LRMS (APCl+) exact mass calc’d for 




N-phenethylbenzamide:121  Prepared according to an established procedure by White.122  
A solution of 2-phenethylamine (9.62 g, 79.39 mmol) in pyridine (6.4 mL, 79.34 mmol) 
was cooled to 0 °C, and benzoyl chloride (10.13 mL, 87.27 mmol) was added.  After 
stirring 5 min at 0 °C, yellow precipitate was formed.  The mixture was then extracted 
with chloroform (3 xs 20 mL).  The combined organic layers were then washed with 
water (10 mL), 1 M HCl (10 mL), 1 M NaOH (10 mL), brine (10 mL), and then dried 
over Na2SO4.  The crude yellow solid was recrystallized by dissolving in hot ethanol and 
then leaving it in the freezer overnight to yield yellow crystals of N-phenethylbenzamide 
(7.3 g, 32.40 mmol, 41% yield).  1H NMR (300 MHz, CDCl3) δ 7.71-7.24 (m, 10H, 














1-phenyl-3,4-dihydroisoquinoline:  Prepared according to an established procedure by 
Lantos et al.123  A solution of N-phenethylbenzamide (3.00 g, 13.32 mmol), P2O5 (3.78 g, 
26.63 mmol), and POCl3 (3.92 mL, 42.09 mmol) in xylenes (53 mL) was heated at reflux 
(130 °C) for 2 hr.  After cooling to rt, the reaction was quenched by pouring into a beaker 
containing ice.  The solid remaining in the flask was extracted with 10% NaOH solution 
until the solid completely dissolved.  The combined solutions were extracted with ether 
(3 xs 50 mL), and the combined organic layers were washed with brine (100 mL) and 
dried over Na2SO4.  The crude oil was purified by silica gel chromatography (50% 
EtOAc/hexanes) to provide 1-phenyl-3,4-dihydroisoquinoline as a yellow oil (1.27 g, 
6.13 mmol, 46% yield).  1H NMR (300 MHz, CDCl3) δ 7.65-7.62 (m, 2H, ArH), 7.46-
7.38 (m, 4H, ArH), 7.30-7.28 (m, 3H, ArH), 3.91-3.86 (m, 2H, ArCH2CH2N), 2.83 (t, J = 





1-phenyl-1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (15):  Prepared 
according to an established method by Ortega et al.124  A solution of NH4OH (0.95 mL) 







6.86 mmol) was added portionwise to the mixture.  After stirring the suspension for about 
30 min at –20 °C, a solution of 1-phenyl-3,4-dihydroisoquinoline (1.27 g, 6.13 mmol) in 
MeOH (2.2 mL) was added dropwise.  The reaction was stirred at 0 °C overnight.  Upon 
warming to rt, the reaction was filtered, and the filtrate was concentrated.  The crude oil 
was purified directly by silica gel chromatography (20% EtOAc/hexanes) to yield 
diaziridine 15 (35 mg, 0.157 mmol, 3% yield, 50% yield BRSM) and starting material 
(0.80 g, 3.86 mmol).  1H NMR (300 MHz, CDCl3) δ 7.51-6.89 (m, 9H, ArH), 3.74-3.67 
(ddd, J = 6.3, 5.6, and 1.8 Hz, 1H, ArCH2CH2N), 3.22-2.94 (m, 2H, ArCH2CH2N), 2.59-
2.52 (m, 2H, ArCH2CH2N and NH).  13C NMR (300 MHz, CDCl3) δ 140.2, 135.5, 134.1, 
130.0, 128.8, 128.7, 128.4, 128.2, 128.1, 128.0, 127.7, 126.0, 60.8, 46.7, 25.1.  IR (neat) 
3240, 3061, 3028. 2938, 2862, 1654, 1602, 1587, 1538, 1488, 1448, 1424, 1337, 1224, 
1185, 1149, 1095, 1074, 1025, 963, 899, 876, 831, 772, 754, 734, 700 cm-1.  LRMS 





(Z)-3-methyl-1-phenyl-4,5-dihydro-3H-benzo[d][1,2]diazepine (16):  A solution of 
Me3OBF4 (25 mg, 0.165 mmol) in d3-MeCN (0.50 mL) was cooled to –40 °C.  Then a 
solution of phenyl-substituted diaziridine 15 (35 mg, 0.157 mmol) in d3-MeCN (0.50 mL) 
was added slowly.  The reaction was stirred for 30 min at –40 °C, and then the reaction 






mL), and the combined organic layers were washed with brine (2 mL) and dried over 
Na2SO4.  The crude yellow oil (31 mg, 0.131 mmol, 84% yield) did not require further 
purification.  1H NMR (300 MHz, CDCl3) δ 7.62-7.59 (m, 2H, ArH), 7.39-7.25 (m, 6H, 
ArH), 7.09 (d, 1H, J = 7.8 Hz, ArH), 3.54 (t, J = 6.9 Hz, 2H, ArCH2CH2N), 2.83 (s, 3H, 
NCH3), 2.79 (t, 2H, J = 7.2 Hz, ArCH2CH2N).  13C NMR (300 MHz, CDCl3) δ 161.9, 
141.2, 138.3, 135.4, 129.4, 129.2, 128.7, 128.6, 128.1, 127.3, 126.2, 65.2, 47.8, 32.2.  IR 
(neat) 3212, 3038, 2952, 2872, 1500, 1459, 1428, 1378, 1349, 1284, 1248, 1173, 1064, 
1036, 972, 921, 887, 840, 791, 756, 741, 721, 656 cm-1.  LRMS (APCl+) exact mass 




2,2,2-trifluoro-N-phenethylethanamide:  Prepared according to an established 
procedure by Barluenga et al.125  A solution of phenethylamine (10 mL, 79.39 mmol) and 
pyridine (19.3, 238.17 mmol) in DCM (200 mL) was cooled to 0 °C, and trifluoroacetic 
acid (22.1 mL, 158.78 mmol) was added slowly.  The reaction was warmed to rt and 
stirred overnight.  After quenching with water (200 mL), the organic layer was washed 
with brine (100 mL) and dried over Na2SO4.  The crude oil was purified by silica gel 
chromatography (10% EtOAc/hexanes), providing 2,2,2-trifluoro-N-
phenethylethanamide as a white solid (16.74 g, 77.08 mmol, 97% yield).  1H NMR (300 
MHz, CDCl3) δ 7.37-7.17 (m, 4H, ArH), 6.22 (brs, 1H, NH), 3.62 (q, J = 13.2 and 6.6 









1-(trifluoromethyl)-3,4-dihydroisoquinoline:126  Prepared according to an established 
procedure by Caroon et al.127  2,2,2-trifluoro-N-phenethylethanamide (4.0 g, 18.43 mmol) 
was dissolved in polyphosphoric acid (28 g) and the suspension was heated at 180 °C for 
2 days.  After cooling to rt, the reaction was quenched with 1 M NaOH (30 mL), and the 
product was extracted with ether (3 xs 50 mL).  The combined organic layers were 
washed with brine and dried over Na2SO4.  The crude brown oil was purified by silica gel 
chromatography (20% EtOAc/hexanes) to provide 1-(trifluoromethyl)-3,4-
dihydroisoquinoline as a yellow oil (1.50 g, 7.53 mmol, 41% yield).  1H NMR (300 MHz, 
CDCl3) δ 7.634 (d, J = 7.8 Hz, 1H, ArH), 7.50-7.45 (td, J = 7.5 and 1.2 Hz, 1H, ArH), 
7.32 (t, J = 6.6 Hz, 1H, ArH), 7.27 (d, J = 6.3 Hz, 1H, ArH), 3.97-3.90 (m, 2H, 





1-(trifluoromethyl)-1,2,3,7b-tetrahydro-1,1a-diazacyclopropa[α]naphthalene (17):  
Prepared according to an established method by Ortega et al.128  A solution of NH4OH 
(1.2 mL) in MeOH (5 mL) was cooled to –20 °C, and hydroxylamine-O-sulfonic acid 







suspension for about 30 min at –20 °C, a solution of 1-(trifluoromethyl)-3,4-
dihydroisoquinoline (1.50 g, 7.53 mmol) in MeOH (5 mL) was added dropwise.  The 
reaction was stirred at rt for 5 days.  The reaction was then filtered, and the filtrate was 
concentrated.  The crude oil was purified directly by silica gel chromatography (5% 
EtOAc/hexanes) to yield the title compound as a yellow oil (0.566 g, 2.64 mmol, 35% 
yield).  1H NMR (300 MHz, CDCl3) δ 7.78-7.76 (m, 1H, ArH), 7.37-7.16 (m, 3H, ArH), 
3.52 (d, J = 12.0 Hz, ArCH2CH2N), 3.03-2.84 (m, 2H, ArCH2CH2N), 2.75 (s, 1H, NH), 
2.53 (d, J = 12.6 Hz, 1H, ArCH2CH2N).  13C NMR (300 MHz, CDCl3) δ 136.0, 128.9, 
128.6, 127.8, 126.7, 126.0, 125.5, 121.8, 46.3, 24.8.  IR (neat) 3213, 2951, 2360, 1500, 
1459, 1428, 1378, 1348, 1284, 1247, 1172, 1151, 1064, 1036, 971, 920, 887, 840, 791, 
756, 740, 721, 656 cm-1.  LRMS (APCl+) exact mass calc’d for C10H10F3N2+ (MH+) 





(Z)-3-methyl-1-(trifluoromethyl)-4,5-dihydro-3H-benzo[d][1,2]diazepine (18):  A 
solution of Me3OBF4 (30 mg, 0.187 mmol) in d3-MeCN (0.40 mL) was cooled to –40 °C.  
Then a solution of trifluoromethyl-substituted diaziridine 17 (40 mg, 0.205 mmol) in d3-
MeCN (0.40 mL) was added slowly.  The reaction was stirred for 30 min at –40 °C, and 
then the reaction was quenched with NaHCO3 (1 mL).  The product was extracted with 






dried over Na2SO4.  The crude yellow oil was purified by silica gel chromatography (5% 
EtOAc/hexanes) to provide benzodiazepine 18 (10 mg, 0.044 mmol, 24% yield). 1H 
NMR (300 MHz, CDCl3) δ 7.59 (t, J = 1.8 Hz, 1H, ArH), 7.30-7.20 (m, 3H, ArH), 7.08 
(t, J = 6.3 Hz, 1H, ArH), 3.71 (t, J = 4.2 Hz, 2H, ArCH2CH2N), 3.32 (s, 3H, NCH3), 3.06 
(t, J = 4.5 Hz, 2H, ArCH2CH2N).  13C NMR (300 MHz, CDCl3) δ 141.5, 128.4, 127.7, 
127.4, 126.4, 58.3, 49.2, 35.5.  IR (neat) 2924, 1725, 1584, 1566, 1495, 1452, 1381, 
1335, 1307, 1275, 1227, 1166, 1096, 1067, 1037, 990, 974, 926, 830, 793, 764, 746, 730, 
691 cm-1.  LRMS (APCl+) exact mass calc’d for C11H12F3N2+ (MH+) requires m/z 229.09, 





(Z)-1-(1-methyl-4,5-dihydro-3H-benzo[d][1,2]diazepin-3-yl)ethanone (19):  A 
solution of diaziridine 7 (30 mg, 0.187 mmol) in MeCN (1 mL) was cooled to 0 °C.  To 
this solution was added acetyl chloride (14 µL, 0.197 mmol) dropwise via microliter 
syringe.  The clear and yellow solution gradually formed white solid precipitate after 
approximately 10 min.  After stirring at 0 °C for an additional 10 min, the reaction was 
diluted with ethyl acetate (1 mL) and washed with NaHCO3 (1 mL) and brine (1 mL).  
The organic layer was dried over Na2SO4, and concentrated to yield title compound 19 as 
a crude yellow oil (32 mg, 0.158 mmol, 84% yield) that did not require additional 








ArH), 7.20-7.17 (m, 1H, ArH), 4.19 (t, J = 5.7 Hz, 2H, ArCH2CH2N(COCH3), 2.91 (t, J 
= 5.7 Hz, 2H, ArCH2CH2N(COCH3)), 2.46 (s, 3H, ArCCH3), 2.21 (s, 3H, 
ArCH2CH2N(COCH3)).  13C NMR (300 MHz, CDCl3) δ 172.0, 156.5, 140.5, 134.4, 
129.9, 128.3, 128.1, 126.8, 50.0, 33.1, 25.5, 22.0.  IR (neat) 2925, 1670, 1491, 1389, 
1370, 1288, 1238, 1192, 1041, 1005, 981, 930, 768, 708 cm-1.  LRMS (APCl+) exact 





(Z)-1-(4,5-dihydro-3H-benzo[d][1,2]diazepin-3-yl)ethanone (20):  A solution of 
diaziridine 5 (30 mg, 0.205 mmol) in MeCN (1mL) was cooled to 0 °C.  To this solution 
was added acetyl chloride (15 µL, 0.215 mmol).  After stirring the reaction for 30 min at 
0 °C, the reaction was diluted with EtOAc (1 mL), washed with NaHCO3 (1 mL) and 
brine (1 mL), and dried over Na2SO4.  The solution was concentrated, and the crude 
product was purified on a silica gel column (50% EtOAc/Hexanes) to provide the title 
compound as a yellow solid (32 mg, 0.170 mmol, 82% yield).  1H NMR (300 MHz, 
CDCl3) δ 7.44-7.40 (m, 2H, ArH and ArCH=N), 7.32-7.20 (m, 3H, ArH), 4.19-4.16 (m, 
2H, ArCH2CH2N), 3.11 (t, J = 4.8 Hz, 2H, ArCH2CH2N), 2.40 (s, 3H, NC(=O)CH3).  13C 
NMR (300 MHz, CDCl3) δ 172.4, 141.5, 141.4, 133.8, 131.1, 129.6, 129.3, 126.7, 43.6, 







1205, 1162, 1040, 985, 955, 909, 873, 763, 734 cm-1.  LRMS (APCl+) exact mass calc’d 





(Z)-benzyl 1-methyl-4,5-dihydro-3H-benzo[d][1,2]diazepine-3-carboxylate (21): A 
solution of diaziridine 7 (30 mg, 0.187 mmol) in MeCN (1 mL) was cooled to 0 °C.  To 
this solution was added benzyl chloroformate (28 µL, 0.197 mmol) dropwise via 
microliter syringe.  The solution gradually became opaque with white solid precipitate 
after approximately 10 min.  After stirring at 0 °C for a totale of 30 min, the reaction was 
diluted with ethyl acetate (1 mL), washed with NaHCO3 (1 mL) and brine (1 mL), and 
dried over Na2SO4.  The solution was concentrated, and the crude red oil was purified by 
silica gel chromatography (35% EtOAc/hexanes) to yield benzodiazepine 21 as a white 
solid (35 mg, 0.119 mmol, 64% yield).  1H NMR (300 MHz, CDCl3) δ 7.34-7.22 (m, 9H, 
ArH), 5.15 (s, 2H, NC(=O)OCH2Ar), 4.15 (t, J = 6.6 Hz, 2H, ArCH2CH2N), 2.82 (t, J = 
6.6 Hz, 2H, ArCH2CH2N), 2.46 (s, 3H, ArC(=N)CH3).  13C NMR (300 MHz, CDCl3) δ 
168.4, 155.3, 138.3, 136.6, 135.8, 130.0, 128.3, 128.0, 127.8, 126.9, 126.8, 77.2, 67.3, 
54.4, 31.7, 24.1.  IR (neat) 2924, 2870, 1697, 1613, 1491, 1447, 1400, 1347, 1327, 1289, 
1233, 1210, 1157, 1106, 1010, 764, 698 cm-1.  LRMS (APCl+) exact mass calc’d for 








              (22) 
 
(Z)-(6-chloropyridin-3-yl)(4,5-dihydro-3H-benzo[d][1,2]diazepin-3-yl)methanone 
(22):  A solution of diaziridine 5 (30 mg, 0.187 mmol) in MeCN (1 mL) was cooled to 0 
°C.  To this solution was added 6-chloronicotinoyl chloride (35 mg, 0.196 mmol).  The 
reaction was stirred at 0 °C for 20 min, and at this time yellow precipitate was observed.  
The reaction was diluted with ethyl acetate (1 mL), washed with NaHCO3 (1 mL) and 
brine (1 mL), and then dried over Na2SO4.  The solution was concentrated, and the crude 
solid was purified by silica gel chromatography (20% EtOAc/hexanes) to yield 
benzodiazepine 22 as a white solid (49 mg, 0.171 mmol, 91% yield).  1H NMR (300 
MHz, CDCl3) δ 8.75 (s, 1H, NC(=O)C-CH=N-), 8.02-7.99 (dd, J = 2.4, 8.3 Hz, 
NC(=O)C=CH-CH-), 7.45-7.25 (m, 6H, ArH and ArCH=N), 4.37-4.34 (m, 2H, 
ArCH2CH2N), 3.28-3.25 (m, 2H, ArCH2CH2N).  13C NMR (300 MHz, CDCl3) δ 167.3, 
152.7, 150.9, 143.4, 141.3, 140.0, 134.2, 130.7, 130.3, 129.9, 129.4, 127.0, 123.2, 44.7, 
36.5.  IR (neat) 2923, 1657, 1600, 1581, 1494, 1447, 1391, 1359, 1281, 1200, 1166, 
1140, 1103, 1046, 991, 931, 891, 838, 776, 759 cm-1.  LRMS (APCl+) exact mass calc’d 















General Information.  All reactions were performed using oven-dried glassware under 
atmosphere of dry argon.  Non-aqueous reagents were transferred by syringe under argon.  
Organic solutions were concentrated using a Buchi rotary evaporator.  Acetonitrile 
(MeCN), tetrahydrofuran (THF), methylene chloride (DCM), and diethyl ether were 
dried using a J.C. Meyer solvent purification system.  Tropylium tetrafluoroborate, (–)-
sparteine, and all other commercially available reagents were used as provided.  Flash 
column chromatography was performed employing 32-63 µm silica gel (Dynamic 
Adsorbents Inc).  Thin-layer chromatography (TLC) was performed on silica gel 60 F254 
plates (EMD). 
1H and 13C NMR were recorded in CDCl3 on a Bruker DRX-300 spectrometer.  
Data for 1H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = 
singlet, brs = broad singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz), and assignment.  Data for 13C NMR are reported in 
terms of chemical shift.  Low-resolution mass spectra (LRMS) were acquired on a JEOL 
JMS-LCmate liquid chromatography mass spectrometer system using a Cl+ ionization 
technique.  IR spectra were recorded on a Nicolet Avatar 370 DTGS (Thermo) using 
NaCl salt plates.   
 
DDQ oxidation of N-(p-methoxybenzyl)-N,N-diisobutylamine. N-(p-methoxybenzyl)-
N,N-diisobutylamine (42 mg, 0.169 mmol) was added via syringe to a solution of DDQ 
(38 mg, 0.169 mmol), KCN (22 mg, 0.338 mmol), and 18-crown-6 (89 mg, 0.338 mmol) 
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in MeCN (1 mL).  The solution was then stirred for 12 hrs at rt.  The reaction was 
rotovaped, and the crude material was dissolved in ethyl acetate (2 mL) and passed 
through a pad of silica with ethyl acetate.  Purification of this crude oil by silica gel 
chromatography (5 % ethyl acetate/hexanes) provided an inseparable mixture of 
aminonitriles 9 and starting material (19 mg).  The product ratio was 1.7: 1.0 in favor of 
benzylic oxidation (15 mg, 32 % yield, 59 % yield BRSM). 
 
Reaction of KCN and 18-crown-6 with tropylium tetrafluoroborate.  Tropylium 
tetrafluoroborate (30 mg, 0.169 mmol), KCN (22 mg, 0.337 mmol), and 18-crown-6 (89 
mg, 0.337 mmol) were dissolved in d3-MeCN (1 mL).  The reaction was stirred for 5 min 
until the solution was homogenous and deep red.  The solution was then transferred to an 
NMR tube, and 100 % conversion to cycloheptatrienylnitrile was observed.   
 
Reaction of TMSCN with tropylium tetrafluoroborate.  TMSCN (42 µL, 0.337 mmol) 
was added via syringe to a solution of tropylium tetrafluoroborate (30 mg, 0.169 mmol) 
in d3-MeCN (1 mL).  After 15 min, 85% conversion to cycloheptatrienylnitrile was 
observed by NMR analysis.   
 
Attempted α-cyanation with cycloheptatrienylnitrile.  Triisobutylamine (41 µL, 0.169 
mmol) was added via syringe to a solution of cycloheptatrienylnitrile (20 mg, 0.169 
mmol) in d3-MeCN (1 mL).  The solution was heated in a sealed vial at 80 °C for 3 hr.  
After cooling to rt, the reaction was taken up into an NMR tube.  By NMR, only 
triisobutylamine and cycloheptatrienylnitrile were present.  
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α-cyanation General Procedure.  The amine (1.0 eq) was added via syringe to a stirring 
suspension of tropylium tetrafluoroborate (1.0 eq) and potassium cyanide (2.0 eq) in 
acetonitrile (0.17 M) at room temperature.  The reaction was then stirred at room 
temperature or heated for the indicated time period.  Upon completion of reaction (as 
monitored via TLC or NMR), the solvent was removed using a rotary evaporator.  The 
crude product was then purified by silica gel chromatography (unless otherwise 






(1):  A solution of triisobutylamine (31 mg, 0.169 mmol) and tropylium tetrafluoroborate 
(30 mg, 0.169 mmol) in acetonitrile (1.0 mL) was stirred at room temperature for 30 min.  
The solvent was removed to yield the colorless iminium salt 1 with 100 % conversion (45 
mg, >99% yield).  1H NMR (300 MHz, CDCl3) δ 8.31 (d, 1H, J = 9.9 Hz, 
N=CHCH(CH3)2), 3.70 (dd, 4H, J = 7.8 and 16.2 Hz, NCH2CH(CH3)2), 3.13-3.04 (m, 
1H, N=CHCH(CH3)2), 2.18-2.08 (m, 2H, NCH2CH(CH3)2), 1.29 (d, 6H, J = 6.6 Hz, 
N=CHCH(CH3)2), 1.02 (d, 6H, J = 6.6 Hz, NCH2CH(CH3)2), 0.95 (d, 6H, J = 6.6 Hz, 
NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 186.7, 67.5, 62.2, 59.2, 31.3, 27.4, 







913, 830, 743 cm-1.  LRMS (APCl+) exact mass calc’d for C12H26N+ (M+) requires m/z 





2-(diisobutylamino)-3-methylbutanenitrile (2):  Prepared according to the general α-
cyanation procedure using triisobutylamine (100 mg, 0.540 mmol), tropylium 
tetrafluoroborate (96 mg, 0.540 mmol), and KCN (70 mg, 1.08 mmol) in MeCN (5.4 
mL).  The reaction was complete after stirring at room temperature for 3 hr.  Purification 
of the crude oily solid on a short alumina plug (DCM) provided aminonitrile 2 (91 mg, 
81% yield) as a yellow oil.  1H NMR (300 MHz, CDCl3) δ 3.07 (d, 1H, J = 10.8 Hz, 
NCHCN), 2.25 (dd, 2H, J = 4.2 and 12.8 Hz, NCH2CH(CH3)2), 2.12 (dd, 2H, J = 10.5 
and 12.9 Hz, NCH2CH(CH3)2), 1.96-1.88 (m, 1H, NCH(CN)CH(CH3)2), 1.74-1.64 (m, 
2H, NCH2CH(CH3)2), 1.10 (d, 3H, J = 6.6 Hz, NCH(CN)CH(CH3)2), 1.04 (d, 3H, J = 6.6 
Hz, NCH(CN)CH(CH3)2), 0.92 (d, 6H, J = 6.3 Hz, NCH2CH(CH3)2), 0.88 (d, 6H, J = 6.3 
Hz, NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 117.6, 62.9, 60.7, 29.2, 26.2, 20.9, 
20.6, 20.3, 19.7.  IR (neat) 2957, 2869, 2812, 2363, 1467, 1386, 1367, 1328, 1277, 1186, 
1170, 1123, 1084, 1068, 980, 926, 885, 867, 811, 750, 668, 652 cm-1.  LRMS (APCl+) 












Cyanocycloheptatriene (3):129  Tropylium tetrafluoroborate (30 mg, 0.169 mmol) and 
trimethylsilylcyanide (42 µL, 0.338 mmol) were dissolved in d3-MeCN (1 mL) and 
placed in an NMR tube.  After 5 min, 69% conversion to cyanocycloheptatriene was 
observed, and after 1 hr, 96% conversion was observed. 1H NMR (300 MHz, CD3CN) δ 
6.80 (t, J = 3 Hz, 2H, CH=CH), 6.43-6.38 (m, 2H, CH=CH=CH), 5.47-5.42 (m, 2H, 





Ethyl 2-((2Z,4Z,6Z)-cyclohepta-2,4,6-trienyl)ethanoate (4): A solution of freshly-
distilled (1-ethoxyvinyloxy) trimethylsilane130 (54 mg, 0.338 mmol) was added to a 
solution of triisobutylamine (31 mg, 0.169 mmol) and tropylium tetrafluoroborate (30mg, 
0.169 mmol) in MeCN (1 mL) at rt.  After 30 min, an aliquot was taken and concentrated.  
Full conversion to title compound 4 was observed.  After purification by silica gel 
chromatography (20% EtOAc/hexanes), the title compound was obtained.  1H NMR (300 





5.20 (m, 2H, CH=CH=CH), 4.19-4.07 (m, 2H, C(=O)OCH2CH3), 2.67 (d, J = 7.5 Hz, 




(5) Table 1, Entry 1 
 
2-(dibenzylamino)-2-phenylethanenitrile (5 - Table 29, Entry 1):131  Prepared 
according to the general α-cyanation procedure using tribenzylamine (150 mg, 0.522 
mmol), tropylium tetrafluoroborate (93 mg, 0.522 mmol), and KCN (68 mg, 1.04 mmol) 
in MeCN (3.0 mL).  The reaction was heated at 120 °C.  After 12 hr, the reaction was 
quenched with sat. NaHCO3 (2 mL), washed with brine (2 mL), and dried over Na2SO4.   
Purification of the crude oil by silica gel chromatography provided a mixture of 
tribenzylamine starting material (76 mg) and aminonitrile 5 (68 mg, 85% yield based on 
recovered starting material) as a light yellow solid.  1H NMR (300 MHz, CDCl3) δ 7.59-
7.24 (m, 5H, ArH), 4.91 (s, 1H, NCH(CN)Ar), 3.88 (d, 2H, J = 13.5 Hz, NCH2Ar), 3.41 











2-methyl-1,2,3,4-tetrahydroisoquinoline:  Prepared according to an established method 
by Lemoucheux et al.132  Methyl chloroformate (0.36 mL, 4.69 mmol) was added to a 
solution of tetrahydroisoquinoline (0.47 mL, 3.75 mmol) in toluene (6 mL) at 0 °C.  Then 
a 4.1 M solution of NaOH (0.24 mL) was added to the reaction.  The biphasic solution 
was warmed to room temperature and stirred overnight.  The reaction was then diluted 
with DCM, washed with brine, and dried over Na2SO4.  The crude yellow oil was 
dissolved in THF (1 mL) and added to a solution of LAH (0.404 g, 10.65 mmol) in THF 
(5 mL).  The reaction was refluxed overnight and quenched at 0 °C with a 3.75 M 
solution of NaOH (0.30 mL).  The solution was then filtered over a pad of celite (rinsing 
with DCM) to yield the title compound as an orange oil (0.325 g, 59% yield) that was 
used without further purification.  1H NMR (300 MHz, CDCl3) δ 7.14-7.01 (m, 4H, 
ArH), 3.58 (s, 2H, N(CH3)CH2Ar), 2.93 (t, 2H, J = 6.0 Hz, N(CH3)CH2CH2Ar), 2.69 (t, 
2H, J = 6.0 Hz, N(CH3)CH2CH2Ar), 2.46 (s, 3H, NCH3).   
 
 
(6) Table 29, Entry 2 
 
2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile (6 - Table 29, Entry 2):133 






tetrahydroisoquinoline (25 mg, 0.169 mmol), tropylium tetrafluoroborate (30 mg, 0.169 
mmol), and KCN (22 mg, 0.337 mmol) in MeCN (1.0 mL).  The reaction was heated for 
2 hr at 80 °C to facilitate oxidation and then stirred at room temperature overnight to 
facilite cyanide addition.  Purification of the crude oil by silica gel chromatography (20% 
EtOAc/hexanes) provided aminonitrile 6 (18 mg, 62% yield) as a light yellow crystalline 
solid.  1H NMR (300 MHz, CDCl3) δ 7.28-7.15 (m, 4H, ArH), 4.73 (s, 1H, NCHCN), 
3.12-3.00 (m, 1H, N(CH3)CH2), 2.94-2.76 (m, 3H, N(CH3)CH2 and N(CH3)CH2CH2), 
2.61 (s, 3H, NCH3). 13C NMR (300 MHz, CDCl3) δ 226.8, 133.9, 129.6, 129.4, 128.5, 




N-benzyl-N,N-diisobutylamine:134  Prepared according to an established reductive 
amination method by Bhattacharyya.135  Titanium (IV) isopropoxide (11.16 mL, 37.69 
mmol) was added dropwise to a solution of diisobutylamine (2.44 g, 18.85 mmol) in abs. 
methanol (35 mL).  Then benzaldehyde (2.00 g, 18.85 mmol) was added to the solution.  
The reaction was stirred at rt overnight, and then NaBH4 (0.713 g, 18.85 mmol) was 
added portionwise.  The reaction was stirred for 4 hr at room temperature and quenched 
with water (2 mL).  The white precipitate was filtered off, and the filtrate was diluted 
with water (20 mL) and extracted with EtOAc (2 x 30 mL).  The combined organic layers 
were washed with brine and dried over Na2SO4.  The crude oil was purified by silica gel 
chromatography to yield the title compound as a yellow oil (1.53 g, 37% yield).  1H NMR 











(7) Table 29, Entry 3 
 
2-(benzyl(isobutyl)amino)-3-methylbutanenitrile (7 - Table 29, Entry 3):  Prepared 
according to the general α-cyanation procedure using N-benzyl-N,N-diisobutylamine (37 
mgs, 0.169 mmol), tropylium tetrafluoroborate (30 mg, 0.169 mmol), and KCN (22 mg, 
0.337 mmol) in MeCN (1.0 mL).  The reaction was stirred at room temperature for 12 hr.  
Purification of the crude oil by silica gel chromatography (5% EtOAc/hexanes) provided 
aminonitrile 7 (32 mg, 78% yield) as a light yellow crystalline solid.  1H NMR (300 
MHz, CDCl3) δ 7.56-7.24 (m, 5H, ArH), 3.96 (d, 1H, J = 13.8 Hz, NCH2Ar), 3.27 (d, 
1H, J = 13.5 Hz, NCH2Ar), 3.05 (d, 1H, J = 10.8 Hz, NCH(CN)CH(CH3)2), 2.36 (dd, 1H, 
J = 4.2 and 12.8 Hz, NCH2CH(CH3)2), 2.21 (dd, 1H, J = 10.5 and 12.9 Hz, 
NCH2CH(CH3)2), 2.09-1.94 (m, 1H, NCH(CN)CH(CH3)2), 1.89-1.72 (m, 1H, 
NCH2CH(CH3)2), 1.05 (d, 3H, J = 6.6 Hz, NCH(CN)CH(CH3)2), 0.98 (d, 3H, J = 6.6 Hz, 
NCH(CN)CH(CH3)2), 0.95 (d, 3H, J = 6.6 Hz, NCH2CH(CH3)2), 0.90 (d, 3H, J = 6.6 Hz, 
NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 138.0, 128.9, 128.4, 127.4, 117.3, 
61.4, 59.3, 56.4, 29.1, 26.0, 20.9, 20.8, 20.5, 20.3, 19.4.  IR (neat) 2959, 2871, 2816, 
1468, 1389, 1369, 1094, 1063, 913, 743, 699 cm-1.  LRMS (APCl+) exact mass calc’d for 










N-(p-nitrobenzyl)-N,N-diisobutylamine: Prepared according to an established reductive 
amination method by Bhattacharyya.136  Titanium (IV) isopropoxide (3.92 mL, 13.23 
mmol) was added dropwise to a solution of diisobutylamine (2.00 g, 15.48 mmol) in abs. 
methanol (12 mL).  Then p-nitrobenzaldehyde (1.00 g, 6.62 mmol) was added to the 
solution.  The reaction was stirred at rt overnight, and then NaBH4 (0.250 g, 6.62 mmol) 
was added portionwise.  The reaction was stirred for 4 hr at rt and then quenched with 
water (1 mL).  The white precipitate was filtered off, and the filtrate was diluted with 
water (10 mL) and extracted with ethyl acetate (2 x 30 mL).  The combined organic 
layers were washed with brine and dried over Na2SO4.  The crude oil was purified by 
silica gel chromatography (10% EtOAc/hexanes) to yield the title compound as a bright 
yellow oil (0.390 g, 22% yield).  1H NMR (300 MHz, CDCl3) δ 8.16 (d, 2H, J = 8.7 Hz, 
ArH), 7.52 (d, 2H, J = 8.7 Hz, ArH), 3.55 (s, 2H, NCH2Ar), 2.09 (d, 4H, J = 7.2 Hz, 
NCH2CH(CH3)2), 1.83-1.70 (m, 2H, NCH2CH(CH3)2), 0.87 (d, 12H, J = 6.6 Hz, 
NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 148.8, 146.9, 129.3, 123.3, 63.6, 59.5, 
26.3, 20.8.  IR (neat) 2955, 2869, 2800, 1605, 1521, 1467, 1390, 1345, 1091, 1071, 861, 
844, 740 cm-1.  LRMS (APCl+) exact mass calc’d for C15H25N2O2+ (MH+) requires m/z 










(8) Table 29, Entry 4 
 
2-(isobutyl-4-nitrobenzylamino)-3-methylbutanenitrile (8 - Table 29, Entry 4):  
Prepared according to the general α-cyanation procedure using N-(p-nitrobenzyl)-N,N-
diisobutylamine (45 mg, 0.169 mmol), tropylium tetrafluoroborate (30 mg, 0.169 mmol), 
and KCN (22 mg, 0.337 mmol) in MeCN (1.0 mL).  The reaction was heated at 120 °C 
for 12 hr.  Purification of the crude oil by silica gel chromatography (5% EtOAc/hexanes) 
provided aminonitrile 8 (38 mg, 77% yield).  1H NMR (300 MHz, CDCl3) δ 8.20 (d, 2H, 
J = 8.7 Hz, ArH), 7.52 (d, 2H, J = 8.7 Hz, ArH), 3.99 (d, 1H, J = 14.4 Hz, NCH2Ar), 
3.44 (d, 1H, J = 14.4 Hz, NCH2Ar), 3.03 (d, 1H, J = 10.8 Hz, NCH(CN)CH(CH3)2), 2.41 
(dd, 1H, J = 4.2 and 12.6 Hz, NCH2CH(CH3)3), 1.67 (dd, 1H, J = 10.8 and 12.6 Hz, 
NCH2CH(CH3)2), 2.09-1.96 (s, 1H, NCH(CN)CH(CH3)2), 1.86-1.74 (m, 1H, 
NCH2CH(CH3)2), 1.09 (d, 3H, J = 6.6 Hz, NCH(CN)CH(CH3)2), 1.03 (d, 3H, J = 6.6 Hz, 
NCH(CN)CH(CH3)2), 0.94 (d, 3H, J = 6.6 Hz, NCH2CH(CH3)2), 0.89 (d, 3H, J = 6.6 Hz, 
NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 147.4, 145.9, 129.4, 123.7, 116.8, 
61.8, 59.7, 55.8, 29.2, 25.9, 20.8, 20.5, 20.2, 19.5.  IR (neat) 2963, 2872, 2825, 1606, 
1522, 1468, 1346, 1091, 913, 849, 741 cm-1.  LRMS (APCl+) exact mass calc’d for 












N-(p-methoxybenzyl)-N,N-diisobutylamine: Prepared according to an established 
reductive amination method by Bhattacharyya.137  Titanium (IV) isopropoxide (4.35 mL, 
14.68 mmol) was added dropwise to a solution of diisobutylamine (2.85 g, 22.02 mmol) 
in abs. methanol (12 mL).  Then p-methoxybenzaldehyde (0.89 mL, 7.34 mmol) was 
added to the solution.  The reaction was stirred at rt overnight, and then NaBH4 (0.28 g, 
7.34 mmol) was added portionwise.  The reaction was stirred for 4 hr at rt and then 
quenched with water (1 mL).  The white precipitate was filtered, and the filtrate was 
diluted with water (10 mL) and extracted with ethyl acetate (2 x 30 mL).  The combined 
organic layers were washed with brine and dried over Na2SO4.  The crude yellow oil was 
purified by silica gel chromatography (5% EtOAc/hexanes) to yield the desired amine 
(1.56 g, 85% yield) as a clear and colorless oil.  1H NMR (300 MHz, CDCl3) δ 7.23 (d, 
2H, J = 8.4 Hz, ArH), 6.84 (d, 2H, J = 8.4 Hz, ArH), 3.80 (s, 3H, OCH3), 3.41 (s, 2H, 
ArCH2N), 2.06 (d, 4H, J = 7.2 Hz, NCH2CH(CH3)2), 1.83-1.69 (m, 2H, 
NCH2CH(CH3)2), 0.86 (d, 12H, J = 6.6 Hz, NCH2CH(CH3)2).  13C NMR (300 MHz, 
CDCl3) δ 158.3, 132.6, 129.9, 113.3, 63.3, 59.1, 55.2, 26.4, 20.9.  IR (neat) 2953, 2903, 
2868, 2796, 2717, 1612, 1511, 1466, 1389, 1366, 1301, 1249, 1171, 1093, 1068, 1040, 
845, 828, 807, 759 cm-1.  LRMS (APCl+) exact mass calc’d for C16H28NO+ (MH+) 











(9) Table 29, Entry 5 
 
2-(isobutyl(4-methoxybenzyl)amino)-3-methylbutanenitrile and 2-(diisobutylamino)-
2-(4-methoxyphenyl)ethanenitrile (9 – Table 29, Entry 5):  Prepared according to the 
general α-cyanation procedure using N-(p-methoxybenzyl)-N,N-diisobutylamine (42 mg, 
0.169 mmol), tropylium tetrafluoroborate (30 mg, 0.169 mmol), and KCN (22 mg, 0.337 
mmol) in MeCN (1.0 mL).  The reaction was either stirred at rt or heated at 100 °C for 12 
hr.  When the reaction is carried out at 100 °C, the reaction is subsequently stirred at rt 
for 2 hr to facilitate complete cyanide addition.  The reaction was then rotovaped to 
provide an oily solid.  Purification of the crude oil by silica gel chromatography (5% 
ethyl acetate/hexanes) provided an inseparable mixture of aminonitriles 9 and recovered 
starting material.  When conducted at rt, the product ratio is 6.1: 1.0 in favor of aliphatic 
oxidation (20 mg, 43% yield, 100% yield BRSM).  When conducted at 100 °C, the 
product ratio is 3.7:1.0 in favor of aliphatic oxidation (27 mg, 58% yield, 77% yield 
BRSM).  1H NMR (300 MHz, CDCl3) δ 7.44 (d, 2H, J = 8.7 Hz, ArH minor), 7.23 (d, 
2H, J = 8.4 Hz, ArH major), 6.90 (d, 2H, J = 8.7 Hz, ArH minor), 6.85 (d, 2H, J = 8.7 
Hz, ArH major), 4.92 (s, 1H, ArCH(CN)N), 3.89 (d, 1H, J = 13.5 Hz, ArCH2N), 3.82 (s, 
3H, CH3O minor), 3.81 (s, 3H, CH3O major), 3.19 (d, 1H, J = 13.5 Hz, ArCH2N), 3.03 
(d, 1H, J = 10.8 Hz, NCH(CN)CH(CH3)2, 2.35-2.29 (m, 3H, NCH2CH(CH3)2 major and 














NCH(CN)CH(CH3)2), 1.88-1.70 (m, 3H, NCH2CH(CH3)2 major and minor), 1.05-0.82 
(m, 24 H, NCH2CH(CH3)2 and NCH(CN)CH(CH3)2 major and minor).  13C NMR (300 
MHz, CDCl3) δ 159.7, 159.0, 130.1, 130.0, 129.2, 126.4, 117.4, 116.3, 113.8, 61.3, 59.8, 
59.2, 58.6, 55.8, 55.3, 29.0, 26.1, 20.9, 20.8, 20.5, 20.4, 20.3, 19.4.  IR (neat) 2958, 2871, 
2835, 1612, 1586, 1513, 1467, 1369, 1389, 1302, 1252, 1173, 1093, 1062, 1036, 831, 
805, 705 cm-1.  LRMS (APCl+) exact mass calc’d for C17H27N2O+ (MH+) requires m/z 
275.2123, found m/z 275.2 and 248.2 (M-CN). 
 
 
(10) Table 29, Entry 6 
 
(N-benzyl-N-methylamino)acetonitrile and 2-(N,N-dimethylamino)-2-
phenylacetonitrile (21 – Table 1, Entry 12):138,139  Prepared according to the general α-
cyanation procedure using N,N-dimethyl-N-benzylamine (50 mg, 0.37 mmol), tropylium 
tetrafluoroborate (66 mg, 0.37 mmol), and KCN (48 mg, 0.74 mmol) in MeCN (2.2 mL).  
The reaction was heated at 80 °C for 8 hr.  Purification of the crude oil by silica gel 
chromatography (20% EtOAc/hexanes) provided aminonitriles 10 as an inseparable 
mixture with a product ratio of 3.7:1.0 in favor of aliphatic oxidation (20 mg, 34% yield). 
1H NMR (300 MHz, CDCl3) δ 4.85 (s, 1H, PhCH(CN)N(CH3)2), 3.61 (s, 2H, 
PhCH2N(CH3)CH2CN), 3.45 (s, 2H, PhCH2N(CH3)CH2CN), 2.44 (s, 3H, 










N-(2,4,6-trimethylbenzyl)-N,N-dimethylamine:  Prepared according to an established 
alkylation method by Valk et al.140  A solution of α-chloroisodurene (1.0 g, 5.93 mmol) 
in dimethylamine (2 M in THF, 5.93 mL, 11.86 mmol) was stirred at room temperature 
for 48 hr.  The solution was concentrated, and the crude mixture was taken up in ethyl 
acetate (20 mL).  The solution was sequentially washed with 1 M NaOH (20 mL) and 
brine (20 mL) and then dried over Na2SO4.  The crude oil was purified by silica gel 
chromatography (5% MeOH/DCM) to yield the title compound as a light yellow oil 
(1.001 g, 94% yield).  1H NMR (300 MHz, CDCl3) δ 6.85 (s, 2H, ArH), 3.37 (s, 2H, 
NCH2Ar), 2.36 (s, 6H, N(CH3)2), 2.27 (s, 3H, p-ArCH3), 2.23 (s, 6H, o-ArCH3).  13C 
NMR (300 MHz, CDCl3) δ 137.8, 136.2, 132.6, 128.9, 57.0, 45.2, 20.9, 19.9.  IR (neat) 
2966, 2940, 2852, 2810, 2759, 1614, 1466, 1449, 1358, 1258, 1176, 1148, 1095, 1017, 
854, 842, 714 cm-1.  LRMS (APCl+) exact mass calc’d for C12H20N+ (MH+) requires m/z 













(11) Table 1, Entry 7 
 
2-(methyl-2,4,6-trimethylbenzyl)amino)ethanenitrile (11 - Table 1, Entry 7):  
Prepared according to the general α-cyanation procedure using N-(2,4,6-
trimethylbenzyl)-N,N-dimethylamine (30 mg, 0.169 mmol), tropylium tetrafluoroborate 
(30 mg, 0.169 mmol), and KCN (22 mg, 0.337 mmol) in MeCN (1.0 mL).  The reaction 
was heated at 80 °C for 12 hr.  Purification of the crude oil by silica gel chromatography 
(DCM) provided aminonitrile 11 (24 mg, 71% yield) as a bright yellow oil.  1H NMR 
(300 MHz, CDCl3) δ 6.85 (s, 2H, ArH), 3.60 (s, 2H, N(CH3)CH2CN), 3.43 (s, 2H, 
N(CH3)CH2Ar), 2.39 (s, 3H, NCH3), 2.36 (s, 6H, o-ArCH3), 2.27 (s, 3H, p-ArCH3).  13C 
NMR (300 MHz, CDCl3) δ 138.1, 137.1, 130.4, 129.2, 115.4, 53.3, 43.9, 41.4, 20.9, 19.9.  
IR (neat) 2948, 2921, 2859, 2795, 1613, 1460, 1446, 1364, 1318, 1247, 1195, 1138, 
1126, 1032, 949, 854, 834, 715 cm-1.  LRMS (APCl+) exact mass calc’d for C13H19N2+ 




1-methylcyclohexanecarboxaldehyde:141  Prepared according to an established 
alkylation method by Anderson et al.  Potassium t-butoxide (6.50 g, 57.95 mmol) was 










mL) at 0 °C.  Iodomethane (8.33 mL, 133.74 mmol) was then added to the solution.  The 
reaction was stirred for 30 min at 0 °C and then stirred at rt for an additional 1.5 hr.  The 
reaction was washed with water (2 x 50 mL), brine (50 mL), and dried over Na2SO4.  The 
solvent was removed by rotovaping under a reduced pressure (~50 Torr) due to product 
volatility.  The crude oil was purified by eluting through a silica pad with hexanes to 
provide the desired aldehyde (4.00 g, 71% yield) as a yellow oil.  1H NMR (300 MHz, 
CDCl3) δ 9.43 (s, 1H, CH(O)), 1.86-1.80 (m, 2H, C(CH3)CH2CH2CH2CH2CH2), 1.59-




N,N-dimethyl-1-(1-methylcyclohexyl)methanamine: Prepared according to an 
established reductive amination method by Abdel-Magid et al.142  Sodium 
triacetoxylborohydride (1.18 g, 5.55 mmol) was added to a solution of 1-
methylcyclohexanecarboxaldehyde (0.500 g, 3.96 mmol) and dimethylamine (2M in 
THF, 3.96 mL, 7.92 mmol).  The reaction was stirred at room temperature for 24 hrs.  
The reaction was then quenched with 1 M NaOH (4 mL), washed with brine (4 mL), and 
dried over Na2SO4.  The crude oil was then purified by silica gel chromatography (30% 
diethyl ether/hexanes) to yield 22 (150 mg, 24% yield) as a yellow oil.  1H NMR (300 
MHz, CDCl3) δ 2.29 (s, 6H, N(CH3)2), 2.08 (s, 2H, NCH2), 1.47-1.23 (m, 10H, 
C(CH3)CH2CH2CH2CH2CH2), 0.89 (s, 3H, CCH3). ). 13C NMR (300 MHz, CDCl3) δ 





1263, 1150, 1096, 1047, 847, 750 cm-1.  LRMS (APCl+) exact mass calc’d for C10H22N+ 
(MH+) requires m/z 156.17, found m/z 156.51. 
 
 
(12) Table 29, Entry 8 
 
2-(methyl(1-methylcyclohexyl)methyl)amino)ethanenitrile (12 - Table 29, Entry 8):   
Prepared according to the general α-cyanation procedure using N,N-dimethyl-1-(1-
methylcyclohexyl)methanamine (26 mg, 0.169 mmol), tropylium tetrafluoroborate (30 
mg, 0.169 mmol), and KCN (22 mg, 0.337 mmol) in MeCN (1.0 mL).  The reaction was 
stirred at room temperature for 2 hr.  Purification of the crude oil by silica gel 
chromatography (5% ether/hexanes) provided aminonitrile 12 (27 mg, 90% yield).  1H 
NMR (300 MHz, CDCl3) δ 3.49 (s, 2H, N(CH3)CH2CN), 2.44 (s, 3H, NCH3), 2.26 (s, 
2H, N(CH3)CH2CCH3), 1.48-1.41 (m, 5H, C(CH3)CH2CH2CH2CH2CH2), 1.28-1.23 (m, 
5H, C(CH3)CH2CH2CH2CH2CH2), 0.89 (s, 3H, CCH3).  13C NMR (300 MHz, CDCl3) δ 
226.8, 116.0, 67.5, 48.6, 48.6, 45.5, 35.6, 26.4, 21.9. IR (neat) 2926, 2850, 1451, 1261, 
1261, 1047, 913, 743 cm-1.  LRMS (APCl+) exact mass calc’d for C11H21N2+ (MH+) 












trans-N-methylcyclohexane-1,2-dicarboximide:  Prepared according to an established 
method by Polonski.143  Freshly-distilled acetyl chloride (2.36 mL, 38.92 mmol) was 
added dropwise to a solution of cis-1,2-cyclohexanedicarboxylic anhydride (4.00 g, 25.95 
mmol) in 33 wt % ethanolic methylamine (4.85 mL, 38.92 mmol).  After the reaction was 
refluxed for 10 min, TLC indicated complete consumption of starting material.  The 
reaction was diluted with water (40 mL) and extracted with ethyl acetate (2 x 40 mL).  
After washing with brine (30 mL), the solution was dried over Na2SO4.  The crude oil 
was purified by silica gel chromatography (50% EtOAc/hexanes) to yield the desired 
imide as a white crystalline solid (4.02 g, 93% yield).  1H NMR (300 MHz, CDCl3) δ 
2.97 (s, 3H, NCH3), 2.86-2.83 (m, 2H, C(O)CH), 1.86-1.70 (m, 4H, 




cis-dimethyl-N-methylcyclohexane-1,2-dicarboximide: Prepared according to an 
established method by Bilyard et al.144  LDA was prepared by adding BuLi (2.5 M in 
hexanes, 5.02 mL, 12.56 mmol) dropwise to a solution of diisopropylamine 1.76 mL, 













and then a solution of trans-N-methylcyclohexane-1,2-dicarboximide (1.00 g, 5.98 
mmol) in THF (6 mL) was added to the reaction.  The solution was stirred at –78 °C for 
30 min, and then MeI (1.19 mL, 19.14 mmol) was added.  The reaction was stirred for an 
additional 30 min, warmed to room temperature, and then stirred for 2 hr.  The reaction 
was quenched with 33 % aqueous acetic acid (6 mL) and diluted with water (30 mL).  
The reaction was extracted with EtOAc (2 x 30 mL), washed with brine, and dried over 
Na2SO4.  The crude yellow oil was purified by silica gel chromatography (20% 
EtOAc/hexanes) to yield the desired imide as a yellow oil (737 mg, 63% yield).  1H NMR 
(300 MHz, CDCl3) δ 2.96 (s, 3H, NCH3), 1.82-1.74 (m, 2H, C(CH3)CH2CH2CH2CH2), 




cis-octahydro-2,8,9-trimethylisoindole:  Prepared according to a general method for 
imide reduction established by Shintani et al.145  A solution of the carboximide (0.552 g, 
2.83 mmol) in THF (7 mL) was added slowly to a solution of LAH (0.322 g, 8.48 mmol) 
in THF (7 mL).  The reaction was then refluxed overnight at 100 °C, and quenched at 0 
°C with water (2 mL), 1 M NaOH (9 mL), and water (9 mL).  The product was extracted 
with DCM (2 x 20 mL), washed with brine, and dried over Na2SO4.  Crude title 
compound (0.200 g, 42% yield) appeared as a yellow oil and was used without further 
purification.  1H NMR (300 MHz, CDCl3) δ 2.80 (d, 2H, J = 9.6 Hz, N(CH3)CH2), 2.52 






C(CH3)CH2CH2CH2CH2), 1.25-1.81 (m, 2H, C(CH3)CH2CH2CH2CH2), 0.88 (s, 6H, 
CCH3).  13C NMR (300 MHz, CDCl3) δ 66.9, 44.5, 42.8, 34.23, 22.4, 22.4. IR (neat) 
3279, 2926, 2861, 2358, 1671, 1450, 1383, 1260, 1093, 1019, 980, 913, 800, 743, 704, 
676, 621 cm-1.  LRMS (APCl+) exact mass calc’d for C11H22N+ (MH+) requires m/z 
168.17, found m/z 168.17. 
 
 
(13) Table 29, Entry 9 
 
(3aR,7aS)-2,3a,7a-trimethyloctahydro-1H-isoindole-1-carbonitrile (13 – Table 29, 
Entry 9):  Prepared according to the general α-cyanation procedure using cis-octahydro-
2,8,9-trimethylisoindole (28 mg, 0.169 mmol), tropylium tetrafluoroborate (30 mg, 0.169 
mmol), and KCN (22 mg, 0.337 mmol) in MeCN (1.0 mL).  The reaction was stirred at 
80 °C for 3 hr.  After cooling to room temperature, the reaction was diluted with diethyl 
ether (3 mL) and quenched with sat. NaHCO3, washed with brine (2 mL), and dried over 
Na2SO4.  Purification of the crude oil by silica gel chromatography (10% ether/hexanes) 
provided aminonitrile 13 (27 mg, 84% yield).  1H NMR (300 MHz, CDCl3) δ 3.67 (s, 1H, 
NCHCN, major), 3.46 (s, 1H, NCHCN, minor), 3.40 (d, 1H, J = 9.9 Hz, NCH2, minor), 
2.92 (d, 1H, J = 9.3 Hz, NCH2, major), 2.61 (d, 1H, J = 9.3 Hz, NCH2, major), 2.57 (s, 
3H, NCH3, major), 2.53 (s, 3H, NCH3, minor), 2.19 (d, 2H,  J = 10.2 Hz, NCH2, minor), 
1.64-1.18 (m, 12H, NCH(CN)C(CH3)CH2CH2CH2CH2, minor and major), 1.16 (s, 6H, 







67.6, 66.0, 64.8, 63.5, 46.8, 46.1, 42.9, 42.6, 42.2, 35.1, 33.0, 32.8, 32.4, 31.5, 26.6, 22.1, 
21.9, 21.7, 21.5, 20.4, 17.6, 15.2.  IR (neat) 2934, 2861, 2785, 2236, 1458, 1378, 1245, 
1053, 913, 742 cm-1.  LRMS (APCl+) exact mass calc’d for C12H21N2+ (MH+) requires 




N-allyl-N,N-diisobutylamine:  A solution of diisobutylamine (2.70 mL, 15.48 mmol) 
and allyl bromide (2.68 mL, 30.96 mmol) in diethyl ether (10 mL) was stirred at room 
temperature overnight.  The reaction was neutralized with NaHCO3 (10 mL), washed 
with brine (10 mL), and dried over MgSO4.  The crude yellow oil was purified by silica 
gel chromatography (10% ether/hexanes) to yield the title compound (0.621 g, 24% 
yield) as a yellow oil.  1H NMR (300 MHz, CDCl3) δ 5.89-5.76 (m, 1H, NCH2CH=CH2), 
5.14-5.04 (m, 2H, NCH2CH=CH2), 2.99 (d, 2H, J = 6.3 Hz, NCH2CH=CH2), 2.08 (d, 4H, 
J = 7.5 Hz, NCH2CH(CH3)2), 1.76-1.63 (m, 2H, NCH2CH(CH3)2), 0.86 (d, 12H, J = 6.3 
Hz, NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 137.0, 116.1, 63.3, 58.2, 26.5, 
20.9.  IR (neat) 3079, 2954, 2904, 2870, 2795, 1643, 1468, 1388, 1364, 1274, 1200, 
1167, 1074, 996, 916, 850 cm-1.  LRMS (APCl+) exact mass calc’d for C11H24N+ (MH+) 











(14) Table 29, Entry 10 
 
2-(allyl(isobutyl)amino)-3-methylbutanenitrile (14 - Table 29, Entry 10):  Prepared 
according to the general α-cyanation procedure using N-allyl-N,N-diisobutylamine (29 
mg, 0.169 mmol), tropylium tetrafluoroborate (30 mg, 0.169 mmol), and KCN (22 mg, 
0.337 mmol) in MeCN (1.0 mL).  The reaction was stirred at rt for 12 hr.  Purification of 
the crude oil by silica gel chromatography (5% ether/hexanes) provided aminonitrile 14 
(24 mg, 73% yield).  1H NMR (300 MHz, CDCl3) δ 5.82-5.69 (m, 1H, NCH2CH=CH2), 
5.30-5.14 (m, 2H, NCH2CH=CH2), 3.36-3.29 (m, 1H, NCH2CH=CH2), 3.14 (d, 1H, J = 
10.8 Hz, NCH(CN)CH(CH3)2), 2.84 (dd, 1H, J = 8.7 and 14.4 Hz, NCH2CH=CH2), 2.30-
2.16 (m, 2H, NCH2CH(CH3)2), 2.01-1.89 (m, 1H, NCH(CN)CH(CH3)2), 1.79-1.67 (m, 
1H, NCH2CH(CH3)2), 1.10 (d, 3H, J = 6.6 Hz, NCH(CN)CH(CH3)2), 1.01 (d, 3H, J = 6.6 
Hz, NCH(CN)CH(CH3)2), 0.90 (dd, 6H, J = 5.1 and 6.3 Hz, NCH2CH(CH3)2).  13C NMR 
(300 MHz, CDCl3) δ 135.4, 118.2, 117.6, 61.7, 59.4, 55.0, 29.3, 26.2, 20.8, 20.5, 20.2, 
19.5.  IR (neat)  2958, 2871, 2819, 1469, 1380, 1368, 1369, 1089, 913, 743, 668 cm-1.  
LRMS (APCl+) exact mass calc’d for C12H23N2+ (MH+) requires m/z 195.19, found m/z 














Methyl 2-(diisobutylamino)ethanoate:  A solution of diisobutylamine (2.70 mL, 15.48 
mmol) and methyl bromoacetate (0.86 mL, 7.74 mmol) in diethyl ether (8 mL) was 
stirred at room temperature overnight.  The reaction was diluted with ether (10 mL), 
quenched with sat. NaHCO3 (10 mL), washed with brine (10 mL), and dried over 
MgSO4.  The crude material was purified by silica gel chromatography (10% 
ether/hexanes) to yield the title compound as a yellow oil (1.306 g, 84% yield).  1H NMR 
(300 MHz, CDCl3) δ 3.66 (s, 3H, CO2CH3), 3.30 (s, 2H, NCH2CO2CH3), 2.30 (d, 4H, J = 
7.2 Hz, NCH2CH(CH3)2), 1.70-1.61 (m, 2H, NCH2CH(CH3)2), 0.86 (d, 12 H, J = 6.6 Hz, 
NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 172.4, 63.3, 55.6, 51.0, 26.8, 20.6.  IR 
(neat) 2954, 2870, 2841, 1751, 1468, 1435, 1386, 1365, 1279, 1195, 1173, 1097, 1013, 
976, 857, 821, 713 cm-1.  LRMS (APCl+) exact mass calc’d for C11H24NO2+ (MH+) 
requires m/z 202.18, found m/z 201.99. 
 
 
(15) Table 29, Entry 11 
 
Methyl 2-((1-cyano-2-methylpropyl)(isobutyl)amino)ethanoate (15 - Table 29, Entry 
11):  Prepared according to the general α-cyanation procedure using methyl 2-
(diisobutylamino)ethanoate (136 mg, 0.676 mmol), tropylium tetrafluoroborate (120 mg, 








for 12 hr at 120 °C.  The reaction was then quenched with sat. NaHCO3 (2 mL), washed 
with brine (2 mL), and dried over Na2SO4.  Purification of the crude oil by silica gel 
chromatography (5% EtOAc/hexanes) provided aminonitrile 15 (115 mg, 75% yield).  1H 
NMR (300 MHz, CDCl3) δ 3.72 (s, 3H, CO2CH3), 3.41-3.19 (m, 3H, NCH2CO2CH3 and 
NCH(CN)CH(CH3)2), 2.43 (dd, 1H, J = 4.8 and 12.8 Hz, NCH2CH(CH3)2), 2.27 (dd, 1H, 
J = 9.6 and 12.6 Hz, NCH2CH(CH3)2), 1.97-1.89 (m, 1H, NH(CN)CH(CH3)2), 1.74-1.67 
(m, 1H, NCH2CH(CH3)2), 1.09 (t, 6H, J = 6.6 Hz, NH(CN)CH(CH3)2), 0.91 (t, 6H, J = 
6.6 Hz, NCH2CH(CH3)2).  13C NMR (300 MHz, CDCl3) δ 170.9, 117.4, 62.9, 60.6, 53.5, 
51.7, 29.9, 26.4, 20.6, 20.3, 19.9, 19.3.  IR (neat) 2959, 2873, 2360, 1754, 1469, 1436, 
1390, 1370, 1279, 1198, 1178, 1093, 1020, 913, 744, 669 cm-1.  LRMS (APCl+) exact 




(16) - Table 29, Entry 12 
 
17β-cyanosparteine (16 – Table 29, Entry 12):146  Prepared according to the general α-
cyanation procedure using (–)-sparteine (1.0 g, 4.27 mmol), tropylium tetrafluoroborate 
(0.76 g, 4.27 mmol), and KCN (0.555 g, 8.53 mmol) in MeCN (25 mL).  The reaction 
was stirred at rt for 3 hr. The reaction was then diluted with ethyl acetate (30 mL) and 
washed with sat. NaHCO3 (20 mL) and brine (20 mL).  After drying over Na2SO4, the 







with DCM to yield cyanosparteine 16 (1.00 g, 90% yield).  1H NMR (300 MHz, CDCl3) 
δ 3.38 (d, 1H, J = 2.4 Hz, NCHCN), 3.45 (m, 1H, CNCHNCH2), 2.67 (d, 1H, J = 11.4 
Hz, NCH2), 2.47 (d, 1H, J = 11.1 Hz, NCH2), 2.19-1.28 (m, 21 H, CH2 and CH).  13C 
NMR (300 MHz, CDCl3) δ 122.0, 64.8, 63.9, 61.3, 55.7, 53.9, 53.0, 40.3, 35.5, 34.7, 
29.1, 26.0, 25.8, 25.6, 24.8, 24.2.  IR (neat) 3054, 2987, 2938, 2306, 1422, 1266, 896, 
742, 706 cm-1.  LRMS (APCl+) exact mass calc’d for C16H26N3+ (MH+) requires m/z 





N-benzyl-N,N-dimethylcycloheptatrienylammonium tetraflouroborate (17):  
Dimethylbenzylamine (25 µL, 0.169 mmol) was added via syringe to a solution of 
tropylium tetrafluoroborate (30 mg, 0.169 mmol) in d3-MeCN (1mL).  The solution was 
stirred in a vial for 5 min, and then the solution was taken up in an NMR tube.  1H NMR 
(300 MHz, CD3CN) δ 7.53-7.46 (m, 5H, ArH), 6.42 (brs, 6H, C=CH), 4.36 (s, 2H, 
NCH2Ar), 2.78 (s, 6H, N(CH3)2).  13C NMR (300 MHz, (CD3)2SO) δ 132.4, 131.0, 130.1, 
128.8, 128.2, 125.1, 122.9, 74.3, 63.4, 45.4.  IR (neat) 3424, 1636, 1477, 1276, 1065, 
749, 703 cm-1.  LRMS (APCl+) exact mass calc’d for C16H20N+ (MH+) requires m/z 












2-tropyltributylamine (18):  A solution of tributylamine (31mg, 0.169 mmol) in MeCN 
(0.50 mL) was slowly added to a solution of tropylium tetrafluoroborate (30 mg, 0.169 
mmol) and KCN (55 mg, 0.845 mmol) in MeCN (0.50 mL) at rt.  The solution was 
stirred at rt overnight, and the next morning the solution was concentrated and purified by 
running through an alumina plug (DCM).  The crude NMR indicated that the β-tropylated 






aniline (19):  The unsubstituted amine (37 mg, 0.169 mmol) was added slowly to a 
solution of tropylium tetrafluoroborate (30 mg, 0.169 mmol) and potassium cyanide (22 
mg, 0.338 mmol) in MeCN (1 mL).  The reaction instantaneously turned bright purple 
and was stirred at room temperature overnight.  The reaction was concentration, and the 











para-tropyljulolidine (20):  Julolidine (29 mg, 0.169 mmol) was added to a solution of 
tropylium tetrafluoroborate (30 mg, 0.169 mmol) and KCN (22 mg, 0.338 mmol) in 
MeCN (1 mL) at room temperature.  The reaction instantaneously turned bright blue.  
After stirring the solution at room temperature for 30 min, the reaction was concentrated 
and passed through an alumina plug (DCM).  The crude NMR indicated para-





N,N-diisobutyl-1-phenylbut-3-en-1-amine (26):  A solution of benzaldehyde (0.96 mL, 
9.42 mmol) and diisobutylamine (4.94 mL, 28.26 mmol) in benzene (9.5 mL) was 
refluxed under Dean-Stark conditions for 5 hr.  Reaction was concentrated, and the crude 
iminium ion was dissolved in ether (10 mL) and cooled to –78 °C.  Then, a 1M-solution 
of allyl magnesium bromide in ether (11.30 mL, 11.30 mmol) was added.  After stirring 









reaction was then quenched with water (10 mL) and extracted with ethyl acetate (20 mL).  
The product was purified on silica gel chromatography (10% EtOAc/hexanes) to provide 
the title compound.  1H NMR (300 MHz, CDCl3) δ 7.33-7.19 (m, 5H, ArH), 5.89-5.73 
(m, 1H, CH2=CH), 5.05-4.91 (m, 2H, CH2=CH), 3.74 (t, J = 6.6 Hz, 1H, NCH(Ar)), 
2.66-2.49 (m, 2H, NCH(Ar)CH2CH=CH2), 2.14 (dd, J = 8.6, 12.7 Hz, 2H, 
NCH2CH(CH3)2), 1.94 (dd, J = 5.6, 12.7 Hz, 2H, NCH2CH(CH3)2), 1.93-1.68 (m, 2H, 






Iminium isomers (27):  A solution of N,N-diisobutyl-1-phenylbut-3-en-1-amine (44 mg, 
0.169 mmol) and tropylium tetrafluoroborate (30 mg, 0.169 mmol) in MeCN (1 mL) was 
heated at 80 °C for 3 hr.  The reaction was concentrated, and the crude NMR indicated 


















(E)-N-(4-methoxybenzylidene)-2-methylpropan-1-amine:  A solution of anisaldehyde 
(1.78 mL, 14.69 mmol) and isobutylamine (5.84 mL, 58.76 mmol) in benzene (15 mL) 
were refluxed under Dean-Stark conditions for 4 hr.  The reaction was concentrated, and 
the crude imine product (a clear and colorless oil) did not require further purification 
(2.84 g, 14.95 mmol, 100% yield).  1H NMR (300 MHz, CDCl3) δ 8.16 (s, 1H, 
ArCH=N), 7.67 (d, J = 8.8 Hz, 2H, ArH), 6.92 (d, J = 8.8 Hz, 2H, ArH), 3.84 (s, 3H, 
OCH3), 3.49 (dd, J = 1.3, 6.7 Hz, 2H, NCH2CH(CH3)2), 2.06-1.92 (m, 1H, 




N-isobutyl-1-(4-methoxyphenyl)but-3-en-1-amine:  A 1 M solution of allyl bromide in 
ether (15.68 mL, 15.68 mmol) was added to a precooled solution of (E)-N-(4-
methoxybenzylidene)-2-methylpropan-1-amine (2.00 g, 10.46 mmol) in ether (15 mL) at 
–78 °C.  The reaction was stirred at this temperature for 30 min, and the placed in a 
freezer overnight.  The next morning, the reaction was quenched with waster (10 mL), 
and extracted with ethyl acetate (20 mL).  After washing with brine, the combined 












9.21 mmol, 88% yield).  This crude oil did not require additional purification.  1H NMR 
(300 MHz, CDCl3) δ 7.23 (d, J = 8.6 Hz, 2H, ArH), 6.86 (d, J = 8.7 Hz, 2H, ArH), 5.79-
5.65 (m, 1H, NCH(Ar)CH2CH=CH2), 5.12-5.02 (td, J = 1.9, 17.1 Hz, 2H, 
NCH(Ar)CH2CH=CH2), 3.80 (s, 3H, OCH3), 3.56 (t, J = 7.2 Hz, 1H, 
NCH(Ar)CH2CH=CH2), 2.39-2.33 (m, 2H, NHCH2CH(CH3)2), 2.28-2.16 (m, 2H, 
NCH(Ar)CH2CH=CH2), 1.75-1.61 (m, 1H, NHCH2CH(CH3)2), 1.45 (brs, 1H, NH), 0.85 




N-allyl-N-isobutyl-1-(4-methoxyphenyl)but-3-en-1-amine:  A solution of N-isobutyl-1-
(4-methoxyphenyl)but-3-en-1-amine (2.15 g, 9.21 mmol), allyl bromide (3.19 mL, 36.85 
mmol), and potassium carbonate (12.73 g, 92.1 mmol) in MeCN (80 mL) was stirred 
overnight at room temperature.  The precipitate was filtered, and the filtrate was washed 
with brine and dried over MgSO4.  The crude brown oil was purified on by silica gel 
chromatography (10% EtOAc/hexanes) to yield a yellow oil (2.40 g, 8.79 mmol, 95% 
yield). 1H NMR (300 MHz, CDCl3) δ 7.15 (d, J = 8.6 Hz, 2H, ArH), 6.85 (d, J = 8.7 Hz, 
2H, ArH), 5.88-5.69 (m, 1H, NCH(Ar)CH2CH=CH2 and NCH2CH=CH2), 5.18-4.91 (m, 
4H, NCH(Ar)CH2CH=CH2 and NCH2CH=CH2), 3.81 (s, 3H, OCH3), 3.76-3.71 (dd, J = 
6.6, 8.5 Hz, 1H, NCH(Ar)CH2CH=CH2), 3.23-3.16 (m, 1H, NCH2CH=CH2), 2.84-2.75 






2.42 (m, 1H, NHCH2CH(CH3)2), 2.17 (dd, J = 8.6, 12.8 Hz, 1H, NHCH2CH(CH3)2), 
1.78-1.69 (m, 1H, NHCH2CH(CH3)2), 0.88 (d, J = 6.5 Hz, 3H, NHCH2CH(CH3)2), 0.79 






isobutyl-1-(4-methoxyphenyl)but-3-en-1-amine (46 mg, 0.169 mmol) was added to a 
solution of tropylium tetrafluoroborate (30 mg, 0.169 mmol) in MeCN (1mL) at room 
temperature.  After heating the reaction at 80 °C for 1 hr, the reaction was concentrated.  
The crude NMR indicated that there was no isobutyliminium ion present, only the 
rearranged iminium 29 was observed (with other unidentified byproducts).  See attached 




N-(diphenylmethylene)-2-methylpropan-1-amine:  A solution of benzophenone (2.00 
g, 10.98 mmol) and isobutylamine (10.9 mL, 109.76 mmol) in benzene (75 mL) was 
cooled to 0 °C.  Then, a solution of titanium(IV) tetrachloride (0.72 mL) was added 










filtered over celite, and the filtrate was concentrated.  The crude yellow oil (2.35 g, 9.90 
mmol, 90% yield) did not require further purification. 1H NMR (300 MHz, CDCl3) δ 
7.63-7.60 (m, 2H, ArH), 7.49-7.29 (m, 6H, ArH), 7.17-7.14 (m, 2H, ArH), 3.20 (d, J = 






N-isobutyl-1,1-diphenylbut-3-en-1-amine (30):  A 1 M solution of allyl magnesium 
chloride (15 mL, 15 mmol) was added to a solution of N-(diphenylmethylene)-2-
methylpropan-1-amine (2.35 g, 9.90 mmol) in ether (15 mL) at –78 °C.  The reaction was 
gradually warmed to rt, and the reaction was quenched with water (10 mL) after 45 min.  
The solution was diluted with ethyl acetate (30 mL) and washed with brine (30 mL).  The 
organic layer was dried over Na2SO4, and the crude oil was purified on a silica gel 
column (10% EtOAc/Hex) to yield the title compound as a yellow oil (1.812 g, 6.48 
mmol, 62% yield).  1H NMR (300 MHz, CDCl3) δ 7.42-7.39 (m, 4H, ArH), 7.38-7.26 (m, 
4H, ArH), 7.22-7.16 (m, 2H, ArH), 5.56-5.47 (m, 1H, NHC(Ar)2CH2CH=CH2), 5.09-
5.00 (m, 2H, NHC(Ar)2CH2CH=CH2), 3.08 (d, J = 6.9 Hz, 2H, NHC(Ar)2CH2CH=CH2), 
2.09 (t, J = 6.6 Hz, 2H, NHCH2CH(CH3)2), 1.68-1.60 (m, 1H, NHCH2CH(CH3)2), 0.91 










N-(diphenylmethylidene)-1-cyclohexylmethylamine:15  Prepared according to an 
established method by O’Donnell et al.16  The amine hydrochloride salt was prepared by 
dropwise addition of a 4 M hydrogen chloride in dioxane solution to a flask containing a 
solution of cyclohexanemethylamine in ether.  Filtration of the solid precipitate provided 
the ammonium chloride.  This ammonium salt (1.10 g, 7.35 mmol) was then dissolved in 
DCM (27 mL).  Benzophenone imine (1.23 mL, 7.35 mmol) was then added to the 
solution, and the mixture was stirred overnight at rt.  The solution was diluted with ether 
and filtered over a pad of celite.  The crude yellow oil was then purified on a silica gel 
column (5% EtOAc/hexanes) to provide the desired imine (2.0 g, 98% yield) as a yellow 
oil.  1H NMR (300 MHz, CDCl3) δ 7.82-7.79 (m, 1H, ArH), 7.62-7.57 (m, 2H, ArH), 
7.51-7.40 (m, 3H, ArH), 7.38-7.28 (m, 2H, ArH), 7.16-7.13 (m, 2H, ArH), 3.22 (d, 2H, J 






N-(cyclohexylmethyl)-1,1-diphenylbut-3-en-1-amine (31):  A solution of allyl 
magnesium bromide (6 mL of a 2.0 M solution in THF) was added to a solution of N-









–78 °C.  The solution was stirred for 30 min at –78 °C, then warmed to rt for 2 hr.  The 
reaction was quenched with water (10 mL) and extracted with ethyl acetate (2 x 20 mL).  
The ethyl acetate layer was then washed with brine (30 mL) and dried over Na2SO4.  The 
crude yellow oil was then purified on a silica gel column (2% EtOAc/hexanes) to yield 
31 (1.10 g, 46% yield) as a white solid.  1H NMR (300 MHz, CDCl3) δ 7.39-7.35 (m, 4H, 
ArH),  7.28-7.23 (m, 4H, ArH), 7.19-7.13 (m, 2H, ArH), 5.57-5.43 (m, 1H, CH2=CH), 
5.06-4.97 (m, 2H, CH2=CH), 3.06 (d, 2H, J = 7.2 Hz, NHCH2Cy), 2.11 (d, 2H, J = 6.3 
Hz, CH2=CHCH2), 1.77-1.58 (m, 6H, NHCH2CHCH2CH2CH2CH2CH2), 1.41-1.10 (m, 
4H, NHCH2CHCH2CH2CH2CH2CH2), 0.92-0.81 (m, 2H, 
NHCH2CHCH2CH2CH2CH2CH2).  13C NMR (300 MHz, CDCl3) δ 147.1, 134.2, 127.8, 
127.2, 126.1, 117.8, 63.9, 48.5, 40.8, 38.9, 31.6, 26.7, 26.2.  IR (neat) 3060, 3021, 2976, 
2921, 2850, 1639, 1598, 1493, 1446, 1275, 1259, 1182, 1131, 1032, 913, 750, 699 cm-1.  
LRMS (APCl+) exact mass calc’d for C23H30N+ (MH+) requires m/z 320.2373, found m/z 






1,1-diphenylbut-3-en-1-amine (100 mg, 0.313 mmol) and tropylium tetrafluoroborate (84 
mg, 0.47 mmol) were dissolved in MeCN (7 mL) and heated in a sealed tube at 120 °C 





combined organic layers were washed with NaHCO3 (20 mL), brine (20 mL), and dried 
over MgSO4.  The crude brown oil was purified on an alumina column (loaded with 
DCM, eluting with 1% EtOAc/hexanes) to yield imine 32 (73 mg, 73% yield) as a yellow 
oil.  1H NMR (300 MHz, CDCl3) δ 7.62-7.59 (m, 2H, ArH), 7.45-7.26 (m, 6H, ArH), 
7.16-7.13 (m, 2H, ArH), 5.79-5.65 (m, 1H, CH2=CH), 5.03-4.97 (m, 2H, CH2=CH), 
3.19-3.13 (m, 1H, NCHCy), 2.41-2.28 (m, 2H, CH2=CHCH2), 1.81-1.51 (m, 6H, 
NCHCHCH2CH2CH2CH2CH2), 1.28-0.85 (m, 5H, NCHCHCH2CH2CH2CH2CH2).  13C 
NMR (300 MHz, CDCl3) δ 166.1, 140.4, 137.6, 136.7, 129.5, 128.4, 128.2, 128.1, 127.9, 
127.8, 116.2, 66.4, 42.8, 38.3, 30.1, 29.2, 26.6, 26.5.  IR (neat) 3059, 3023, 2945, 2851, 
1624, 1577, 1489, 1446, 1313, 1282, 909, 778, 695 cm-1.  LRMS (APCl+) exact mass 

















Chapter 3:  Experimental Data 
 
General Information.  All reactions were performed using oven-dried glassware under 
an atmosphere of dry argon.  Non-aqueous reagents were transferred by syringe under 
argon.  Organic solutions were concentrated using a Buchi rotary evaporator.  Diethyl 
ether, tetrahydrofuran, hexanes, toluene, and methylene chloride (CH2Cl2) were dried 
using a J.C. Meyer solvent purification system.  1,2-Dichloroethane (DCE) and 
nitromethane (MeNO2) were freshly distilled over CaH2 under argon.  All other 
commercial reagents were used as provided.  Flash column chromatography was 
performed employing 32-63 µm silica gel (Dynamic Adsorbents Inc).  Thin-layer 
chromatography (TLC) was performed on silica gel 60 F254 plates (EMD). 
 1H and 13C NMR were recorded in CDCl3 on Bruker DRX-300, DRX-400, and 
DRX-500 spectrometers as noted.  Data for 1H NMR are reported as follows: chemical 
shift (δ ppm), multiplicity (s = singlet, brs = broad singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet), coupling constant (Hz), integration, and assignment.  Data for 13C 
NMR are reported in terms of chemical shift.  We thank Dr. John Decatur for his support 
in performing 2-D NOESY experiments.  IR spectra were recorded on a Nicolet Avatar 
370 DTGS (Thermo) using NaCl salt plates.  High-resolution mass spectra (HRMS) were 
acquired at the Columbia University Mass Spectral Core Facility on a JEOL HX110 mass 
spectrometer using the technique (FAB+ or EI+) as noted.  We are grateful to Dr. 
Yasuhiro Itagaki for acquiring the HRMS spectra.  Low-resolution mass spectra (MS) 
were acquired on a JEOL JMS-LCmate liquid chromatography mass spectrometer system 
using CI+ ionization technique.  Gas chromatography was performed on an Agilent 
  
172 
Technologies 6890N gas chromatograph equipped with a Restek 30m 5% diphenyl-95% 
dimethyl polysiloxane capillary column using the following conditions: 40 °C oven temp, 
30 °C/min gradient, 1.0 mL/min flow rate, 11.5 psi. 
 
General Multicatalytic Procedure:  A solution of the nucleophile (1.3-1.8 eq) in DCE 
(unless otherwise noted) was added dropwise via syringe to a stirring solution of the 
aldehyde and Bi(OTf)3 (10 mol %) in DCE at 0 ˚C (unless otherwise noted) under argon. 
The reaction was monitored via TLC for complete consumption of aldehyde (2-18 h). 
The solution was then warmed to room temperature, and methanol (1.5 eq) was added via 
syringe. The reaction was then warmed to 80 ˚C (unless otherwise noted) to facilitate 
hydroalkoxylation (30 min - 8 hr). The solution was then concentrated and purified by 





ethyl 3-hydroxyhept-6-enoate (1):147  LDA was prepared by adding nBuLi (17.14 mL 
of a 2.5 M solution in hexanes, 42.86 mmol) to a precooled solution of i-Pr2NH (6.00 
mL, 42.86 mmol) in THF (60 mL) at 0 °C.  The mixture was stirred at 0 °C for 1 hr and 
then cooled to –78 °C.  A solution of ethyl acetate (4.0 mL, 40.85 mmol) in THF (5.0 
mL) was added slowly and stirred at –78 °C for 30 min.  Then, 4-pentenal (1.5 g, 17.84 
mmol) was added slowly to the solution, which was stirred for an additional 30 min.  The 






The combined organic layers were washed with brine and dried over Na2SO4.  
Purification of the crude oil by silica gel chromatography (20% EtOAc/hexanes) 
provided the title compound (1.14 g, 37% yield).  1H NMR (300 MHz, CDCl3) δ 5.89-
5.76 (m, 1H, CH2=CH), 5.08-4.96 (m, 2H, CH2=CH), 4.21-4.14 (q, J = 7.11, 14.3 Hz, 
2H, C(=O)OCH2CH3), 4.06-3.98 (m, 1H, CH(OH)), 2.98 (brs, 1H, OH), 2.54-2.37 (m, 
2H, C(OH)CH2C(=O)), 2.27-2.08 (m, 2H, CH2=CHCH2CH2C(OH)), 1.69-1.46 (m, 2H, 





ethyl 2-(5-methyltetrahydrofuran-2-yl)acetate (2):148  Prepared in accordance with the  
above general, multicatalytic procedure. A solution of freshly-distilled (1-
ethoxyvinyloxy) trimethylsilane149 (50 mg, 0.31 mmol) in CH2Cl2 (0.4 mL) was added 
dropwise to a pre-cooled solution of commercially-available pent-4-enal (20 mg, 0.24 
mmol) and Bi(OTf)3 (16 mg, 0.024 mmol) in CH2Cl2 (0.8 mL) at –78 °C under Ar. The 
reaction was stirred at –78 °C until aldehyde consumption was complete (1.5 - 2 hr) as 
monitored via TLC (20% EtOAc/hexanes). The solution was then warmed to room 
temperature, and EtOH150 (21 µL, 0.36 mmol) was added via syringe. The reaction was 
then heated at 80 °C until complete as monitored by TLC (6-8 h). The solution was then 
concentrated under reduced pressure (25 ˚C/38 Torr), and the crude residue was purified 
by silica gel chromatography (5% EtOAc/hexanes) to yield the desired product as a light 





isolated as a 2.2:1.0 mixture of anti:syn diastereomers as determined by GC analysis and 
anti/syn relationship established by analogy to 2-benzyl-5-methyltetrahydrofuran (syn 
isomer: tr = 8.09 min, anti isomer: tr = 8.13 min).  1H NMR (300 MHz, CDCl3) δ 4.44-
4.36 (m, 1H, anti- OCHCH2C(O)), 4.26-4.20 (m, 1H, syn- OCHCH2C(O)), 4.14 (q, J = 
7.2 Hz, 3H, C(=O)OCH2CH3 and anti-OCHCH3),  4.03-3.94 (m, 1H, syn-OCHCH3), 
2.66-2.56 (m, 1H, OCHCH2CO2), 2.49-2.38 (m, 1H, OCHCH2CO2), 2.20-1.93 (m, 2H, 
OCHCH2), 1.70-1.43 (m, 2H, OCHCH2), 1.27-1.19 (dt, J = 10.8 and 7.2 Hz, 6H, 
OCH2CH3, C(=O)OCHCH3). 13C NMR (75 MHz, CDCl3) δ 171.3, 75.6, 75.3, 74.9, 74.8, 
60.4, 41.2, 41.0, 33.6, 32.6, 32.0, 31.2, 21.4, 21.2, 14.2. IR (neat) 3054, 2978, 1731, 




hex-5-enal:151  Prepared according to an established procedure by Taillier et al.152  A 
solution of DMSO (0.80 mL, 11.22 mmol) in CH2Cl2 (16.2 mL) was added dropwise to a 
pre-cooled solution of oxalyl chloride (1.04 mL, 12.24 mmol) in CH2Cl2 (15 mL) at –78 
°C. After stirring for 5 min, a solution of 5-hexen-1-ol (1.00 g, 10.20 mmol) in CH2Cl2 
(13.2 mL) was added dropwise.  The solution was stirred for 15 min at –78 °C, and then 
freshly-distilled triethylamine (7.11 mL, 51.0 mmol) was added. The solution was stirred 
at –78 °C for 15 min before warming to rt and stirring for an additional 20 min.  The 
reaction was diluted with CH2Cl2 (30 mL), washed sequentially with NH4Cl (30 mL) and 
brine (30 mL), and dried over Na2SO4. The solution was concentrated under reduced 




60% yield).  1H NMR (300 MHz, CDCl3) δ 9.77 (t, J = 1.7 Hz, 1H, HC(=O)), 5.84-5.70 
(m, 1H, CH=CH2), 5.07-4.97 (m, 2H, CH=CH2), 2.47-2.42 (dt, J = 1.7, 7.3 Hz, 2H, 






methyl 3-hydroxy-2-methyloct-7-enoate (3):  A solution of hex-5-enal (30 mg, 0.306 
mmol) and (E)-(1-methoxyprop-1-enyloxy)trimethylsilane (49 mg, 0.306 mmol) in DCM 
(0.60 mL) was added dropwise to a solution of Bi(OTf)3 (20 mg, 0.0306 mmol) in DCM 
(0.60 mL) at –78 °C.  After 1 hr, the reaction was concentrated and the crude material 
was purified on a silica gel column (20% EtOAc/hexanes) to provide the title compound 
(29 mg, 51% yield).  1H NMR (300 MHz, CDCl3) δ 5.85-5.72 (m, 1H, CH=CH2), 5.03-
4.92 (m, 2H, CH=CH2), 3.90-3.86 and 3.67-3.62 (m, 1H, CH(OH)), 3.70 (s, 3H, 
CH3OC(=O)), 2.58-2.49 (m, 2H, CH3OC(=O)CH(CH3) and OH), 2.10-2.03 (m, 2H, 
CH2=CHCH2CH2CH2CH(OH)), 1.68-1.36 (m, 4H, CH2=CHCH2CH2CH2CH(OH)), 1.18 













(S)-methyl 2-((2R,6R)-6-methyltetrahydro-2H-pyran-2-yl)propanoate and (S)-methyl 
2-((2R,5S)-5-ethyltetrahydrofuran-2-yl)propanoate (4): Methyl 3-hydroxy-2-
methyloct-7-enoate (43 mg, 0.231 mmol) was added to a solution of Bi(OTf)3 (15 mg, 
0.0231 mmol) in DCM (0.92 mL).  The solution was heated at 70 °C overnight in a vial 
with a Teflon-coated cap.  The crude material was purified by silica gel chromatography 
(10% EtOAc/hexanes) to yield title compound 4 as a mixture of isomers and 





S-tert-butyl 3-hydroxy-2-methylhept-6-enethioate (5):  A solution of Bi(OTf)3 (30 mg, 
0.056 mmol) in DCM (1.2 mL) was cooled to –78 °C.  To this solution was added a 
precooled solution of (E)-(1-methoxyprop-1-enyloxy)trimethylsilane153 (130 mg, 0.595 
mmol) and 4-pentenal (50 mg, 0.595 mmol) in DCM (1.20 mL) at –78 °C.  The reaction 
was stirred at –78 °C for 45 min, and the concentrated.  The crude product was purified 
by silica gel chromatography (10% EtOAc/hexanes) to provide title compound 5 (14 mg, 














2H, CH=CH2), 3.92-3.86 and 3.66-3.61 (m, 1H, CH(OH)), 2.64-2.46 (m, 2H, 
C(=O)CH(CH3) and OH), 2.31-2.04 (m, 2H, CH2=CHCH2CH2CH2CH(OH)), 1.67-1.29 






ethyl 2-methyl-2-(5-methyltetrahydrofuran-2-yl)propanoate (6):  Prepared in 
accordance with the  above general, multicatalytic procedure. A solution of freshly-
distilled (1-methoxy-2-methylprop-1-enyloxy)trimethylsilane154 (162 mg, 0.93 mmol) in 
DCE (1.8 mL) was added dropwise to a pre-cooled solution of commercially-available 
pent-4-enal (60 mg, 0.71 mmol) and Bi(OTf)3 (47 mg, 0.071 mmol) in DCE (1.8 mL) at 0 
°C under Ar. The reaction was stirred at 0 °C until aldehyde consumption was complete 
(1.5-2 h) as monitored via TLC (20% EtOAc/hexanes). The solution was then warmed to 
room temperature, and methanol (43 µL, 1.07 mmol) was added via syringe. The reaction 
was then heated at 80 °C until complete as monitored by TLC (5 hr). The solution was 
then concentrated, and the crude residue was purified by silica gel chromatography (5% 
EtOAc/hexanes) to yield the desired product as a clear and colorless oil (111 mg, 0.60 
mmol, 84% yield).  The desired tetrahydrofuran product was isolated as a 5.9:1.0 mixture 
of anti:syn diastereomers as determined by GC analysis and anti/syn relationship 
established by analogy to 2-benzyl-5-methyltetrahydrofuran (syn isomer: tr = 8.09 min, 
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anti isomer: tr = 8.13 min).  1H NMR (300 MHz, CDCl3) δ 4.18 (dd, J = 9.0, 6.6 Hz, 1H, 
OCHC(CH3)2), 4.10-3.92 (m, 1H, OCHCH3), 3.67 (s, 3H, C(O)OCH3),  2.03-1.85 (m, 
2H, OCHCH2), 1.83-1.66 (m, 1H, OCHCH2), 1.53-1.43 (m, 1H, OCHCH2), 1.21-1.18 
(m, 6H, OCHC(CH3)2), 1.13 (s, 3H, OCHCH3).  13C NMR (75 MHz, CDCl3) δ 177.2, 
83.7, 83.3, 76.1, 75.5, 51.8, 46.3, 34.1, 33.1, 27.6, 26.7, 21.4, 21.2, 21.1, 20.9, 20.7. IR 
(neat) 2976, 2871, 1731, 1470, 1388, 1271, 1193, 1144, 1084, 1012, 914, 768, 735, 647 






Methyl 3-hydroxy-2,2-dimethylhept-6-enoate (7):  A solution of 4-pentenal (60 mgs, 
0.713 mmol) in DCE (0.60 mL) was added dropwise to a solution of Bi(OTf)3 (23 mg, 
0.036 mmol) in DCE (0.61 mL) at 0 °C.  Then a solution of freshly-distilled (1-methoxy-
2-methylprop-1-enyloxy)trimethylsilane155 in DCE (0.60 mL) was added dropwise at 
0°C.  After 1 hr, the reaction was concentrated and purified by silica gel chromatography 
(5% EtOAc/hexnaes).  A 1.3:1.0 product ratio for the TMS-protected aldol product (69 
mg, 38% yield) and the desired aldol product (39 mg, 30% yield) was observed.  1H 
NMR (300 MHz, CDCl3) δ 5.86-5.75 (m, 1H, CH=CH2), 5.08-4.94 (m, 2H, CH=CH2), 







2.18-2.03 (m, 2H, CH(OH)CH2), 1.57-1.47 and 1.43-1.31 (m, 2H, 




cis-hexahydroisobenzofuran-1(3H)-one: The title compound was prepared following 
the procedure as described by Krafft156 and Fujiwara.157  To a stirring suspension of 
sodium borohydride (2.38 g, 61.6 mmol) in THF (10 mL) at 0 °C was added dropwise 
cis-1,2-cyclohexanecarboxylic acid anhydride (10.0 g, 61.6 mmol) in THF (50 mL).  The 
mixture was allowed to stir at 0 °C for 2 hr.  The reaction was quenched by the addition 
of 6 M HCl (24 mL) and diluted with H2O (120 mL).  The mixture was extracted with 
Et2O (3 x 100 mL).  The combined organics were then washed with brine (100 mL), dried 
(MgSO4), and concentrated.  The crude residue was purified by silica gel chromatography 
(20% EtOAc/hexanes) to provide the title compound as a colorless oil (8.6 g, 61.6 mmol, 
99% yield).  1H NMR (400 MHz, CDCl3) δ 4.16 (dd, J = 8.8 and 5.0 Hz, 1H, OCH2), 
3.91 (dd, J = 8.8 and 1.0 Hz, 1H, OCH2), 2.63-2.59 (m, 1H, COCH), 2.45-2.41 (m, 1H, 
OCH2CH), 2.09-2.05 (m, 1H, COCHCH2CH2CH2CH2), 1.80-1.77 (m, 1H, 
COCHCH2CH2CH2CH2), 1.62-1.53 (m, 3H, COCHCH2CH2CH2CH2), 1.25-1.14 (m, 3H, 
COCHCH2CH2CH2CH2).  13C NMR (100 MHz, CDCl3) δ 178.4, 71.6, 39.4, 35.3, 27.1, 





(3aR, 7aS) – octahydroisobenzofuran-1-ol:158  A 1.0 M solution of DIBAL in toluene 
(25.6 mL, 25.67 mmol, 1.2 eq) was added slowly via syringe to a pre-cooled solution of 
cis-7a-methylhexahydroisobenzofuran-1(3H)-one (3.0 g, 21.4 mmol) in CH2Cl2 (108 mL) 
at –78 °C.  After stirring for 1 hr, the reaction was quenched with methanol (9.4 mL) and 
Rochelle’s salt (400 mL) at –78 °C.  The solution was then warmed to rt and stirred 
overnight. The layers were separated, and the aqueous layer was washed with CH2Cl2 (2 
x 50 mL).  The combined organic layers were then washed with brine (30 mL) and dried 
over Na2SO4.  The crude yellow oil was then purified via silica gel chromatography (35% 
EtOAc/hexanes) to yield the desired lactol as a clear and colorless oil (2.98 g, 20.96 
mmol, 98% yield).  1H NMR (300 MHz, CDCl3) δ 5.17-5.16 (m, 1H, HOCH), 4.04 (t, J = 
7.8 Hz, 1H, OCH2), 3.71 (t, J = 8.1 Hz, 1H, OCH2), 3.01 (d, J = 3.6 Hz, 1H, OH), 2.60-
2.49 (m, 1H, OCH(OH)CH), 2.07-2.00 (m, 1H, OCH2CH), 1.69-1.23 (m, 8H, 
OCH2CHCH2CH2CH2CH2).  13C NMR (75 MHz, CDCl3) δ 102.6, 70.6, 44.8, 35.1, 24.3, 












cis-(2-vinylcyclohexyl)methanol:159  A solution of Ph3P=CH3 was prepared by adding 
nBuLi (6.81 mL of a 2.5 M solution in hexanes, 17.0 mmol) to Ph3PCH3Br (5.58 g, 15.6 
mmol) in THF (62 mL) at –78 °C.  After stirring for 30 min at –78 °C, the suspension 
was added dropwise via cannula to a solution of lactol (2.00 g, 14.1 mmol) and nBuLi 
(5.85 mL of a 2.5 M solution in hexanes, 14.6 mmol) in THF (62 mL) at –78 °C (which 
had been prepared by adding nBuLi to a pre-cooled solution of lactol in THF at –78 °C, 
then warming to 0 °C for 5 min, and finally cooling back down to –78 °C).  After 
addition, the reaction was warmed to rt and stirred overnight.  The reaction was diluted 
with EtOAc (75 mL), sequentially washed with NaHCO3 (2 x 30 mL) and brine (30 mL), 
and dried over Na2SO4.  The crude oil was purified using silica gel chromatography (20% 
EtOAc/hexanes) to yield the desired alcohol as a clear and colorless oil (1.65 g, 11.8 
mmol, 84% yield).  1H NMR (300 MHz, CDCl3) δ 6.12-6.00 (m, 1H, CH=CH2), 5.12-
5.02 (m, 2H, CH=CH2), 3.56-3.41 (m, 2H, HOCH2), 2.51-2.46 (m, 1H, OH), 1.80-1.23 
(m, 10H, HOCH2CHCH2CH2CH2CH2CH).  13C NMR (125 MHz, CDCl3) δ 139.1, 








cis-2-methyl-2-vinylcyclohexanecarbaldehyde:160  The title compound was prepared 
following a method established by Taillier et al.161  A solution of DMSO (84 µL, 1.2 
mmol) in CH2Cl2 (1.7 mL) was added dropwise to a pre-cooled solution of oxalyl 
chloride (0.11 mL, 1.3 mmol) in CH2Cl2 (1.6 mL) at –78 °C. After stirring for 5 min, a 
solution of cis-(2-vinylcyclohexyl)methanol (0.150 g, 1.1 mmol) in CH2Cl2 (1.4 mL) was 
added dropwise. The solution was stirred for 15 min, and then freshly-distilled 
triethylamine (0.75 mL) was added. The solution was stirred at –78 °C for 15 min before 
warming to rt and stirring for an additional 20 min.  The reaction was diluted with 
CH2Cl2 (10 mL), washed sequentially with NH4Cl (10 mL) and brine (10 mL), and dried 
over Na2SO4. The crude oil was then purified via silica gel chromatography (10% 
EtOAc/hexanes) to yield a light yellow oil (0.147 g, 1.1 mmol, 99% yield).  1H NMR 
(300 MHz, CDCl3) δ 9.69 (s, 1H, C(=O)H), 6.05-5.94 (m, 1H, CH2=CHCH), 5.12-5.05 
(m, 2H, CH2=CHCH), 2.72-2.65 (m, 1H, HC(O)CH), 2.50-2.45 (m, 1H, CH2=CHCH), 
1.89-1.79 (m, 1H, HC(=O)CHCH2), 1.72-1.53 (m, 5H, HC(=O)CHCHCH2CH2CH2), 
1.50-1.36 (m, 2H, HC(=O)CHCHCH2CH2CH2). 13C NMR (75 MHz, CDCl3) δ 205.3, 








ethyl 2-(3-methyloctahydroisobenzofuran-1-yl)acetate (8):  Prepared in accordance 
with the  above general, multicatalytic procedure. A solution of freshly-distilled (1-
ethoxyvinyloxy)trimethylsilane162 (45 mg, 0.28 mmol) in CH2Cl2 (0.55 mL) was added 
dropwise to a pre-cooled solution of aldehyde (30 mg, 0.22 mmol) and Bi(OTf)3 (14 mg, 
0.022 mmol) in CH2Cl2 (0.55 mL) at –78 °C under Ar. The reaction was stirred at –78 °C 
until aldehyde consumption was complete (1.5 hr) as monitored via TLC (20% 
EtOAc/hexanes). The solution was then warmed to room temperature, and ethanol150 (19 
µL, 0.33 mmol) was added via syringe. The reaction was then heated at 80 °C until 
complete as monitored by TLC (5-8 hr). The solution was then concentrated, and the 
crude residue was purified by silica gel chromatography (5% EtOAc/hexanes) to yield the 
desired product as a light yellow oil (37 mg, 0.16 mmol, 76% yield).  The desired 
tetrahydrofuran product was isolated as a 7.42:1.0:0.10:0.01 mixture of diastereomers as 
determined by GC analysis (major isomer: tr = 10.04 min, minor isomers: tr = 9.79, 9.91, 
10.17 min).  Stereochemical determination of major diastereomer determined by NOE 
analysis (spectra attached).  1H NMR (300 MHz, CDCl3) δ 4.34 (td, J = 4.2 and 2.7 Hz, 
1H, OCHCH2C(O)OCH2CH3), 4.14 (q,  J = 7.2 Hz, 2H, C(O)OCH2CH3), 4.06-4.00 (m, 
1H, OCHCH3), 2.60 (dd, J = 9.5 and 4.3 Hz, 1H, OCHCH2C(O)OCH2CH3), 2.45 (dd, J = 
9.3 and 4.2 Hz, 1H, OCHCH2C(O)OCH2CH3), 2.08-1.94 (m, 2H, OCHCH), 1.76 -1.73 
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(m, 1H, OCHCHCH2), 1.65-1.50 (m, 5H, OCHCHCH2CH2CH2), 1.24 (t, J = 6.5 Hz, 3H, 
C(O)OCH2CH3), 1.19 (d, J = 6.5 Hz, 3H, OCHCH3), 1.29-1.23 (m, 2H, 
OCHCHCH2CH2CH2). 13C NMR (75 MHz, CDCl3) δ 171.6, 77.3, 74.8, 60.4, 46.1, 41.8, 
35.8, 24.8, 23.9, 22.4, 21.3, 20.5, 14.2.  IR (neat) 3054, 2987, 2306, 1712, 1422, 1266, 
896, 749 cm-1. HRMS (FAB+) exact mass calc’d for C13H23O3 (MH)+ requires m/z 




cis-7a-methylhexahydroisobenzofuran-1(3H)-one:163 LDA was prepared by adding 
nBuLi (2.5 M, 8.6 mL, 21.4 mmol) dropwise over 10 min to a precooled solution of of 
diisopropylamine (3.4 mL, 24.4 mmol) in THF (30 mL) at –78 °C.  The solution was 
warmed to 0 °C and stirred for 30 min before cooling down to –78 °C.  At this temp, cis-
hexahydroisobenzofuran-1(3H)-one (2.73 g, 19.5 mmol) in THF (15 mL) was added 
dropwise over 15 min and then stirred for an additional 30 min.  Neat methyl iodide (1.5 
mL, 23.4 mmol) was added dropwise, and the reaction was warmed to rt stirred for 12 hr.  
The reaction was quenched with NH4Cl (30 mL), and the layers were separated.  The 
aqueous layer was extracted with Et2O (3 x 30 mL).  The combined organic layers were 
washed with brine (30 mL), dried (MgSO4), and concentrated.  The crude residue was 
purified by silica gel chromatography (20% EtOAc/hexanes) to provide the title lactone 
as a colorless oil (2.1 g, 13.6 mmol, 70% yield). 1H NMR (400 MHz, CDCl3) δ 4.25 (dd, 
J = 8.9, 6.4 Hz, 1H, OCH2), 3.92 (dd, J = 8.9, 5.6 Hz, 1H, OCH2), 2.14 (t, J = 6.2 Hz, 
  
185 
1H, OCH2CH), 1.83-1.70 (m, 2H, COCCH3CH2), 1.48-1.30 (m, 6H, 
COCCH3CH2CH2CH2CH2), 1.18 (s, 3H, COCCH3).  13C NMR (100 MHz, CDCl3) δ 





cis-(2-methyl-2-vinylcyclohexyl)methanol:163 The intermediate lactol was prepared 
according to method of Krafft.164  To a stirring solution of cis-7a-
methylhexahydroisobenzofuran-1(3H)-one (2.1 g, 13.6) in CH2Cl2 (70 mL) at -78 °C was 
added DIBAL (1.0 M in hexanes, 16.3 mL, 16.3 mmol) dropwise over 5 min.  The 
solution was allowed to stir at –78 °C for 3 hr before quenching the reaction by 
sequentially adding MeOH (5 mL) and Rochelle’s salt (150 mL).  This mixture was 
warmed to rt and stirred for an additional 16 hr.  The layers were separated, and the 
aqueous phase was extracted with Et2O (3 x 100 mL).  The combined organic layers were 
washed with brine (100 mL), dried (MgSO4), and concentrated.  The crude residue was 
purified by silica gel chromatography (35% EtOAc/hexanes) to provide the intermediate 
lactol as a colorless oil (2.1 g, 13.4 mmol, 99% yield). 
 The title compound was prepared following a method established by 
Kobayashi.165  To generate the ylide, methyltriphenylphosphonium bromide (6.2 g, 17.4 
mmol) was suspended in THF (30 mL) at 0 °C.  To this stirring suspension was added 
nBuLi (2.4 M in hexanes, 6.8 mL, 16.1 mmol) dropwise over 10 min.  This solution was 
stirred at 0 °C for an additional 20 min.  At the same time, the above lactol (2.1 g, 13.4 
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mmol) was dissolved in THF (30 mL) at –78 °C.  To this stirring solution was added 
nBuLi (5.9 mL, 14.1 mmol) dropwise over 5 min.  This solution was warmed to 0 °C and 
allowed to stir at 0 °C for an additional 5 min.  The solution was then cooled back down 
to –78 °C.  At this time, the brightly-colored ylide solution was added via cannula to the 
deprotonated lactol solution over 15 min.  After addition was complete, the reaction was 
warmed up to rt and stirred for 36 h.  The reaction was quenched by the addition of 
saturated NaHCO3 (50 mL).  The layers were separated, and the aqueous layer was 
extracted with EtOAc (3 x 50 mL).  The combined organic layers were washed with brine 
(50 mL), dried (MgSO4), and concentrated.  The crude residue was purified by silica gel 
chromatography (20% EtOAc/hexanes) to provide the title compound as a colorless oil 
(1.6 g, 10.4 mmol, 77 % yield).  1H NMR (400 MHz, CDCl3) δ 6.13 (dd, J = 17.6, 11.0 
Hz, 1H, CH=CH2), 5.02-4.94 (m, 2H, CH=CH2), 3.66 (dd, J = 10.8, 3.3 Hz, 1H, OCH2), 
3.34 (dd, J = 10.8, 7.0 Hz, 1H, OCH2), 1.84 (brs, 1H, OH), 1.75-1.71 (m, 2H, 
COCCH3CH2), 1.52-1.26 (m, 7H, COCCH3CH2CH2CH2CH2), 1.08 (s, 3H, COCCH3).  




cis-2-methyl-2-vinylcyclohexanecarbaldehyde:166  The title compound was prepared 
following a method established by Taillier et al.167  A solution of DMSO (67 µL, 0.948 
mmol) in CH2Cl2 (1.4 mL) was added dropwise to a pre-cooled solution of oxalyl 
chloride (87 µL, 1.0 mmol) in CH2Cl2 (1.3 mL) at –78 °C. After stirring for 5 min, a 
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solution of the lactol (0.133 g, 0.862 mmol) in CH2Cl2 (1.2 mL) was added dropwise. The 
solution was stirred for 15 min, and then freshly-distilled triethylamine (0.60 mL, 4.31 
mmol) was added. The solution was stirred at –78 °C for 15 min before warming to rt and 
stirring for an additional 20 min.  The reaction was diluted with CH2Cl2 (10 mL), washed 
sequentially with NH4Cl (10 mL) and brine (10 mL), and dried over Na2SO4. The crude 
oil was then purified via silica gel chromatography (5% EtOAc/hexanes) to yield the title 
compound (84 mg, 63% yield).  1H NMR (400 MHz, CDCl3) δ 9.68 (d, J = 2.7 Hz, 1H 
CHO), 6.11 (dd, J = 17.5, 11.0 Hz, 1H, CH=CH2), 5.05 (ddd, J = 16.6, 11.0, 1.0 Hz, 2H, 
CH=CH2), 2.06 (m, 1H, CHCHO), 1.78-1.26 (m, 9H, COCCH3CH2CH2CH2CH2CH), 
1.19 (s, 3H, COCCH3).  13C NMR (100 MHz, CDCl3) δ 205.8, 141.4, 114.0, 58.3, 39.1, 





3,3a-dimethyloctahydroisobenzofuran-1-carbonitrile (9):  Prepared in accordance 
with the above general, multicatalytic procedure. A solution of freshly-distilled 
trimethylsilyl cyanide (35 µL, 0.26 mmol) in DCE (0.5 mL) was added dropwise to a pre-
cooled solution of aldehyde (30 mg, 0.20 mmol) and Bi(OTf)3 (13 mg, 0.020 mmol) in 
DCE (0.5 mL) at 0 °C under Ar. The reaction was stirred at 0 °C until aldehyde 
consumption was complete (2 hr) as monitored via TLC (10% EtOAc/hexanes). The 
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solution was then warmed to room temperature, and methanol (16 µL, 0.39 mmol) was 
added via syringe. The reaction was then heated at 120 °C until complete as monitored by 
TLC (4 hr). The solution was then concentrated, and the crude residue was purified by 
silica gel chromatography (2.5% EtOAc/hexanes) to yield the desired product as a light 
yellow oil (24 mg, 0.13 mmol, 68% yield).  The desired tetrahydrofuran product was 
isolated as a 9.1:1.8:1.4:1.0 mixture of diastereomers as determined by 1H NMR analysis.  
Stereochemical determination of major diastereomer determined by NOE analysis 
(spectra attached).  major:  1H NMR (300 MHz, CDCl3) δ 4.83 (d, J = 3.6 Hz, 1H, 
OCHCN), 4.26 (q, J = 3.9 Hz, 1H, OCHCH3), 2.05-2.00 (m, 1H, CNCHCH), 1.93-1.83 
(m, 2H, OCH(CN)CHCH2), 1.60-1.49 (m, 4H, OCH(CN)CHCH2CH2CH2CH2), 1.40-
1.32 (m, 1H, OCH(CN)CHCH2CH2CH2CH2), 1.30-1.21 (m, 1H, 
OCH(CN)CHCH2CH2CH2CH2), 1.09 (d, J = 3.9 Hz, 3H, OCHCH3), 0.89 (s, 3H, 
OCH(CH3)CCH3).  13C NMR (75 MHz, CDCl3) δ 118.0, 78.0, 69.3, 48.0, 42.4, 31.8, 
25.9, 24.4, 23.0, 21.4, 13.8.  IR (neat) 3054, 2987, 2306, 1422, 1266, 994, 896 cm-1.  






(Z)-(cyclohex-3-enylidene(methoxy)methoxy)trimethylsilane (10):  A solution of LDA 





precooled solution of diisopropylamine (6.50 mL, 46.37 mmol) in THF (35 mL) at –78 
°C.  The solution was stirred for 30 min at –78 °C.  Then, a solution of methyl-3-
cycloxene-1-carboxylate (4.9 mL, 35.67 mmol) in THF (35 mL) that had been precooled 
to –78 °C was added via cannula.  After 30 min, TMSCl (9.05 mL, 71.34 mmol) was 
added.  After stirring for an additional 30 min, the solution was warmed to rt and 
concentrated.  After filtration through a pad of celite with hexanes, the filtrate 
concentrated and distilled (130 °C, 20 Torr) to provide the title compound as a clear and 
colorless oil.  1H NMR (300 MHz, CDCl3) δ 5.73-5.62 (m, 2H, CH=CH), 3.53 (s, 3H, 
OCH3), 2.74 and 2.66 (brs, 2H, C=CCH2CH=CH), 2.27 (t, J = 6.3 Hz, 1H, 
C=CCH2CH2CH=CH), 2.18 (t, J = 6.5 Hz, 1H, C=CCH2CH2CH=CH), 2.06 (brs, 2H, 





methyl 1-(hydroxy(phenyl)methyl)cyclohex-3-enecarboxylate (11):  A solution of 
freshly-distilled benzaldehyde (25 mg, 0.236 mmol) in DCE (0.40 mL) was added 
dropwise to a solution of Bi(OTf)3 (15 mg, 0.0236 mmol) in DCE (0.40 mL) at 0 °C.  
Then, a solution of (Z)-(cyclohex-3-enylidene(methoxy)methoxy)trimethylsilane (50 mg, 
0.236 mmol) in DCE (0.40 mL) was added dropwise.  The solution was then stirred at 0 ° 
C for 3 hr.  The reaction was concentrated, and the crude material was purified by silica 







yield).  1H NMR (300 MHz, CDCl3) δ 7.34-24 (m, 5H, ArH), 5.64 (s, 2H, CH=CH), 
4.81-4.77 (m, 1H, CH(OH)), 3.69 (s, 3H, OCH3), 3.04 (d, J = 6.0 Hz, 1H (minor 
diastereomer), OH), 2.78 (d, J = 5.1 Hz, 1H (major diastereomer), OH), 2.13-2.03 (m, 





methyl 1-(2-ethoxy-1-hydroxy-2-oxoethyl)cyclohex-3-enecarboxylate (12): A 50% 
solution of ethyl glyoxylate in toluene (29 mg, 0.283 mmol) in DCE (0.60 mL) was 
added dropwise to a solution of Bi(OTf)3 (15 mg, 0.0236 mmol) in DCE (0.60 mL) at 0 
°C.  Then, a solution of (Z)-(cyclohex-3-enylidene(methoxy)methoxy)trimethylsilane (50 
mg, 0.236 mmol) in DCE (0.60 mL) was added dropwise.  The solution was then stirred 
at 0 ° C for 3 hr.  The reaction was concentrated, and the crude material was purified by 
silica gel chromatography (5% EtOAc/hexanes) to provide the title compound (10 mg, 
18% yield).  1H NMR (300 MHz, CDCl3) δ 5.66 (brs, 2H, CH=CH), 4.32 (d, J = 6.9 Hz, 
CH(OH)), 4.25-4.18 (m, 3H, CH(OH) and C(=O)OCH2CH3), 3.70 (s, 3H, OCH3), 3.24 
(d, J = 8.5 Hz, 1H, OH), 3.14 (d, J = 6.8 Hz, 1H, OH), 2.56-1.77 (m, 4H, 












(Z)-(1-methoxy-3,3-dimethylpenta-1,4-dienyloxy)trimethylsilane (13):  A solution of 
LDA was prepared by adding nBuLi (2.5 M in hexanes, 18.28 mL, 45.71 mmol) 
dropwise to a precooled solution of diisopropylamine (6.41 mL, 45.71 mmol) in THF (35 
mL) at –78 °C.  The solution was stirred for 30 min at –78 °C.  Then, a solution of 3,3-
dimethyl-4-pentenoic acid methyl ester (5.0 g, 35.16 mmol) in THF (35 mL) that had 
been precooled to –78 °C was added via cannula.  After 30 min, TMSCl (8.92 mL, 70.32 
mmol) was added.  After stirring for an additional 30 min, the solution was warmed to rt 
and concentrated.  After filtration through a pad of celite with hexanes, the filtrate was 
distilled (81 °C, 27 Torr) to provide the title compound as a clear and colorless oil. 1H 
NMR (300 MHz, CDCl3) δ 5.98-5.89 (m, 1H, CH2=CHC(CH3)2), 4.95-4.70 (m, 2H, 
CH2=CHC(CH3)2), 3.70 (s, 1H, C(CH3)2CH=C), 3.47 (s, 3H, OCH3), 1.13 (s, 6H, 





(Z)-(1-methoxypenta-1,4-dienyloxy)trimethylsilane (14):168  A solution of LDA was 
prepared by adding nBuLi (2.5 M in hexanes, 23.70 mL, 59.26 mmol) dropwise to a 








°C.  The solution was stirred for 30 min at –78 °C.  Then, a solution of methyl pent-4-
enoate (5.2 g, 45.59 mmol) in THF (43 mL) that had been precooled to –78 °C was added 
via cannula.  After 30 min, TMSCl (11.57 mL, 91.18 mmol) was added.  After stirring for 
an additional 30 min, the solution was warmed to rt and concentrated.  After filtration 
through a pad of celite with hexanes, the filtrate was distilled (68 °C, 28 Torr) to provide 
the title compound as a clear and colorless oil.  1H NMR (300 MHz, CDCl3) δ 5.89-5.76 
(m, 1H, CH2=CH), 5.05-4.89 (m, 2H, CH2=CH), 3.70-3.65 (m, 1H, 
CH2=CHCH2CH=C(OCH3)), 3.52 (s, 3H, OCH3), 2.74-2.68 (m, 2H, 





methyl 2-ethyl-5-methyltetrahydrofuran-3-carboxylate (15): Prepared in accordance 
with the above general, multicatalytic procedure.  A solution of propionaldehyde (30 mg, 
0.517 mmol) in DCE (0.80 mL) was added dropwise to a solution of Bi(OTf)3 (34 mg, 
0.0517 mmol) in DCE (0.80 mL) at 0 °C.  Then, a solution of (Z)-(1-methoxypenta-1,4-
dienyloxy)trimethylsilane (125 mg, 0.671 mmol) in DCE (0.60 mL) was added dropwise. 
The reaction was stirred at 0 °C until aldehyde consumption was complete (45 min) as 
monitored via TLC (10% EtOAc/hexanes).  The solution was then warmed to room 
temperature, and methanol (31 µL, 0.776 mmol) was added via syringe. The reaction was 







was purified by silica gel chromatography (20% EtOAc/hexanes) to yield the title 
compound (55 mg, 51% yield) as a mixture of diastereomers (See attached 1H NMR 
spectrum).  The desired tetrahydrofuran product was isolated as a 2.8:1.7:1.0:1.3 mixture 





(furan-2-yloxy)trimethylsilane (16):169  Prepared according to a method by Boeckman 
et al.170  A solution of 2(5H) furanone (1.50 mL, 21.14 mmol) in DCE (35 mL) was 
cooled to 0 °C.  Freshly-distilled triethylamine (4.91 mL, 35.24 mmol) was added slowly 
followed by the slow addition of TMSOTf (3.19 mL, 17.62 mmol).  The reaction was 
stirred at 0 °C for 45 min, and the concentrated.  The crude oil was extracted several 
times with pentane.  Concentration of the organic layer provided the title compound as a 
light yellow oil that did not require additional purification (0.991 g, 36% yield).  1H NMR 
(300 MHz, CDCl3) δ 6.83-6.82 (m, 1H, OCH=CHCH=C(OTMS)), 6.22-6.20 
(OCH=CHCH=C(OTMS)), 5.11-5.10 (m, 1H, OCH=CHCH=C(OTMS)), 0.30 











5-(1-hydroxypent-4-enyl)furan-2(5H)-one (17):  A solution of 4-pentenal (30 mg, 
0.357 mmol) in DCE (0.60 mL) was added dropwise to a solution of Bi(OTf)3 (23 mg, 
0.0357 mmol) in DCE (0.60 mL) at 0 °C.  Then, a solution of (furan-2-
yloxy)trimethylsilane (56 mg, 0.357 mmol) in DCE (0.60 mL) was added dropwise.  The 
solution was then stirred at 0 ° C for 5 hr.  The reaction was concentrated, and the crude 
material was purified by silica gel chromatography (35% EtOAc/hexanes) to provide the 
title compound (20 mg, 34% yield) as a 2:1 mixture of diastereomers.  1H NMR (300 
MHz, CDCl3) δ 7.59-7.54 (m, 1H, minor OCHCH=CH), 7.47-7.45 (dd, J = 1.6, 5.8 Hz, 
1H, major OCHCH=CH), 6.21-6.16 (m, 1H, OCHCH=CH), 5.89-5.74 (m, 1H, 
CH2=CH), 5.09-4.90 (m, 2H, CH2=CH), 3.90-3.77 (m, 2H, major and minor CH(OH)), 






(R)-5-((2R,5S)-5-methyltetrahydrofuran-2-yl)furan-2(5H)-one (18):  5-(1-
hydroxypent-4-enyl)furan-2(5H)-one (20 mg, 0.116 mmol) was added to a solution of 








overnight in a sealed vial.  The crude material was purified by silica gel chromatography 
(20% EtOAc/hexanes) to yield title compound 18 as a 1.25:1.0 mixture of diastereomers 
(8 mg, 40% yield).  1H NMR (300 MHz, CDCl3) δ 7.44-7.40 (m, 1H, 
C(=O)CH=CHCH(O)CH(O)CH2CH2CH(O)CH3), 6.20-6.18 (dd, J = 2.0, 5.7 Hz, 1H, 
C(=O)CH=CHCH(O)CH(O)CH2CH2CH(O)CH3), 5.07-5.03 (m, 1H, 
C(=O)CH=CHCH(O)CH(O)CH2CH2CH(O)CH3), 4.33-4.27 (m, 1H, major 
C(=O)CH=CHCH(O)CH(O)CH2CH2CH(O)CH3), 4.25-4.19 (m, 1H, minor 
C(=O)CH=CHCH(O)CH(O)CH2CH2CH(O)CH3), 4.11-3.99 (m, 1H, major and minor 
C(=O)CH=CHCH(O)CH(O)CH2CH2CH(O)CH3), 2.11-1.88 and 1.67-1.39 (m, 4H, 




3-allyltetrahydro-2H-pyran-2-one:171  A solution of LDA was prepared by adding 
diisopropylamine (4.62 mL, 32.96 mmol) to a solution of nBuLi (13.18 mL, 32.96 mmol) 
in THF (75 mL) at –78 °C.  After stirring for 1 hr, a solution of δ-valerolactone (2.78 mL, 
29.96 mmol) in THF (30 mL) was added via cannula at –78 °C.  The reaction was stirred 
at this temperature for 2 hr.  A mixture of allyl bromide (2.85 mL, 32.96 mmol) in 
DMPU (4.0 mL, 32.96 mmol) was added over 1 hr via syringe pump.  The reaction was 
then warmed to rt and washed with NH4Cl.  The aqueous layer was extracted with EtOAc 
(50 mL), and the combined organic layers were washed with brine and dried over 





EtOAc/hexanes) to provide the title compound as a yellow oil (2.51 g, 60% yield).  1H 
NMR (300 MHz, CDCl3) δ 5.87-5.73 (m, 1H, CH2=CH), 5.13-5.06 (m, 2H, CH2=CH), 
4.36-4.24 (m, 2H, OCH2), 2.67-2.49 (m, 2H, C(=O)CHCH2CH=CH2), 2.35-2.25 (m, 1H, 






(5-allyl-3,4-dihydro-2H-pyran-6-yloxy)trimethylsilane (19):  A solution of LDA was 
prepared by adding nBuLi (2.5 M in hexanes, 9.33 mL, 23.33 mmol) dropwise to a 
precooled solution of diisopropylamine (3.27 mL, 23.33 mmol) in THF (17 mL) at –78 
°C.  The solution was stirred for 45 min at –78 °C.  Then, a solution of 3-allyltetrahydro-
2H-pyran-2-one (2.51g, 17.95 mmol) in THF (17 mL) that had been precooled to –78 °C 
was added via cannula.  After 30 min, TMSCl (4.56 mL, 35.90 mmol) was added.  After 
stirring for an additional 30 min, the solution was warmed to rt and concentrated.  After 
filtration through a pad of celite with hexanes, the filtrate was distilled (60 °C, 20 Torr) to 
provide the title compound as a clear and colorless oil.  1H NMR (300 MHz, CDCl3) δ 
5.78-5.69 (m, 1H, CH=CH2), 5.01-4.92 (m, 2H, CH=CH2), 3.97 (t, J = 5.1 Hz, 2H, 
OCH2CH2CH2C), 2.69 (d, J = 6.3 Hz, 2H, CH2=CHCH2), 1.93 (t, J = 6.3 Hz, 2H, 









ethyl 2-(3-allyl-2-oxotetrahydro-2H-pyran-3-yl)-2-hydroxyethanoate (20):  A 50% 
solution of ethyl glyoxylate in toluene (63 mg, 0.613 mmol) in DCE (0.30 mL) was 
added dropwise to a solution of Bi(OTf)3 (31 mg, 0.0471 mmol) in DCE (0.35 mL) at 0 
°C.  Then, a solution of (5-allyl-3,4-dihydro-2H-pyran-6-yloxy)trimethylsilane (100 mg, 
0.471 mmol) in DCE (0.30 mL) was added dropwise.  The solution was then stirred at 0 ° 
C for 7 hr.  The reaction was concentrated, and the crude material was purified by silica 
gel chromatography (35% EtOAc/hexanes) to provide the title compound (20 mg, 8% 





ethyl 3-methyl-6-oxo-2,7-dioxaspiro[4.5]decane-1-carboxylate (21): ethyl 2-(3-allyl-2-
oxotetrahydro-2H-pyran-3-yl)-2-hydroxyethanoate (20 mg, 0.0826 mmol) was added to a 
solution of Bi(OTf)3 (5 mg, 0.00826 mmol) in DCE (0.33 mL).  The solution was heated 











chromatography (50% EtOAc/hexanes) to yield title compound 21 as a 2.5:1.3:1.0 





(2R,5S)-5-methyltetrahydrofuran-2-carbonitrile (22):  Prepared in accordance with the 
above general, multicatalytic procedure. A solution of freshly-distilled trimethylsilyl 
cyanide (24 mg, 0.238 mmol) in DCE (0.6 mL) was added dropwise to a pre-cooled 
solution of 4-pentenal (20 mg, 0.238 mmol) and Bi(OTf)3 (16 mg, 0.0238 mmol) in DCE 
(0.60 mL) at 0 °C under Ar.  The reaction was stirred at 0 °C until aldehyde consumption 
was complete (3 hr) as monitored via TLC (20 % EtOAc/hexanes). The solution was then 
warmed to room temperature, and methanol (14 µL, 0.357 mmol) was added via syringe. 
The reaction was then heated at 120 °C for 12 hr.  The solution was then concentrated 
under reduced pressure (50 Torr).  Crude NMR anaylsis indicated 70% conversion to the 




2-methylhept-6-en-3-ol:172  A solution of 4-pentenal (0.400g, 4.76 mmol) in THF (37 
mL) was added slowly to a precooled solution of isopropyl magnesium bromide (1.3 M 







78 °C, the reaction was warmed to 0 °C for 2 hr.  The solution was then warmed to room 
temperature and stirred for 1.5 hr (until starting material was completely consumed).  The 
solution was cooled to 0 °C and quenched with 1M HCl and diluted with ether.  The 
organic layers were washed with brine and dried over MgSO4.  Purification of the crude 
material by silica gel chromatography (5% EtOAc/hexanes) provided the title compound 
(0.53 g, 87% yield).  1H NMR (300 MHz, CDCl3) δ 5.90-5.78 (m, 1H, CH=CH2), 5.09-
4.95 (m, 2H, CH=CH2), 3.41-3.37 (m, 1H, CH(OH)), 2.26-2.11 (m, 2H, 
CH2=CHCH2CH2CH(OH)), 1.61-1.44 (m, 4H, CH2=CHCH2CH2CH(OH)), 1.31 (d, J = 





2-methylhept-6-en-3-one (23):  A solution of DMSO (0.12mL, 1.72 mmol) in CH2Cl2 
(2.5 mL) was added dropwise to a pre-cooled solution of oxalyl chloride (0.16 mL, 1.87 
mmol) in CH2Cl2 (2.5 mL) at –78 °C. After stirring for 5 min, a solution of the 2-
methylhept-6-en-3-ol (0.200 g, 1.56 mmol) in CH2Cl2 (2.0 mL) was added dropwise.  
The solution was stirred for 15 min, and then freshly-distilled triethylamine (1.09 mL, 
7.80 mmol) was added.  The solution was stirred at –78 °C for 15 min before warming to 
rt and stirring for an additional 20 min.  The reaction was diluted with CH2Cl2 (10 mL), 
washed sequentially with NH4Cl (10 mL) and brine (10 mL), and dried over Na2SO4. The 






compound (0.115 g, 59% yield), which did not require additional purification.  1H NMR 
(300 MHz, CDCl3) δ 5.86-5.74 (m, 1H, CH=CH2), 5.06-4.96 (m, 2H, CH=CH2), 2.65-
2.52 and 2.35-2.25 (C(=O)CH(CH3)2 and C(=O)CH2CH2CH=CH2), 1.09 (d, J = 6.9 Hz, 





2-hydroxy-2-isopropylhex-5-enenitrile (24):  Freshly-distilled TMSCN (64 µL, 0.515 
mmol) was added to a solution of Bi(OTf)3 (26 mg, 0.0396 mmol) and 2-methylhept-6-
en-3-one (0.050 g, 0.396 mmol) in DCE (1.6 mL) at room temperature.  TLC (10% 
EtOAc/hexanes) indicated that the reaction was complete in approximately 5 hr.  The 
reaction was concentrated and purified by silica gel chromatography (10% 
EtOAc/hexanes) to provide the title compound (20 mg, 33% yield).  1H NMR (300 MHz, 
CDCl3) δ 5.93-5.82 (m, 1H, CH=CH2), 5.21-5.06 (m, 2H, CH=CH2), 2.44 (brs, 1H, OH), 
2.41-2.35 (m, 2H, CH2=CHCH2), 2.00-1.74 (m, 3H, CH2C(CN)(OH)CH(CH3)2), 1.09 (d, 













2-allylcyclohexanone (26):  Prepared according to an established allylation procedure by 
Shaughnessy et al.173  1H NMR (300 MHz, CDCl3) δ 5.80-5.69 (m, 1H, CH=CH2), 5.06-
4.96 (m, 2H, CH=CH2), 2.28-1.28 (m, 11H, 





2-allyl-1-hydroxycyclohexanecarbonitrile (27):174  Freshly-distilled TMSCN (35 µL, 
0.282 mmol) was added to a solution of Bi(OTf)3 (14 mg, 0.0217 mmol) and 2-
allylcyclohexanone (0.030 g, 0.217 mmol) in DCE (1.1 mL) at 0 °C.  TLC (20% 
EtOAc/hexanes) indicated that the reaction was complete in approximately 4 hr.  The 
reaction was concentrated and purified by silica gel chromatography (35% 
EtOAc/hexanes) to provide the title compound (19 mg, 53% yield).  1H NMR (300 MHz, 










(2S,7aS)-2-methyloctahydrobenzofuran-7a-carbonitrile (28):  A solution of 2-allyl-1-
hydroxycyclohexanecarbonitrile (18 mg, 0.109 mmol) and Bi(OTf)3 (7 mg, 0.0109 
mmol) in DCE (0.50 mL) was heated under Ar at 80 °C for 2 hr.  After cooling to room 
temperature, the reaction was concentrated and purified by silica gel chromatography 
(35% EtOAc/hexanes) to provide the title compound (5 mg, 28% yield).  GC analysis 
provided a 1.35:1.00 dr.  1H NMR (300 MHz, CDCl3) δ 4.47-4.35 (m, 1H, OCH(CH3)), 




2,2-diphenylpent-4-en-1-ol:175   The title compound was prepared according to the 
method of Widenhoefer.175  To a stirring solution of diisopropylamine (2.9 mL, 20.6 
mmol) in THF (15 mL) at –78 °C was added nBuLi (2.4 M in hexanes, 7.9 mL, 18.9 
mmol).  This solution was allowed to stir at –78 °C for 1 hr.  At this time, methyl 2,2-
diphenylacetate (3.9 g, 17.2 mmol) in THF (10 mL) was added dropwise over 30 min.  
After the solution stirred at –78 °C for an additional 15 min, allyl bromide (2.5 g, 20.6 
mmol) was added dropwise over 10 min.  The reaction was allowed to warm up to rt, 







extracted with Et2O (3 x 30 mL).  The combined organic layers were washed with brine 
(30 mL), dried (MgSO4), and concentrated.  The crude residue was purified by silica gel 
chromatography (15% EtOAc/hexanes) to provide the intermediate ester as a colorless oil 
(4.4 g, 16.5 mmol, 96% yield).  1H NMR (400 MHz, CDCl3) δ 7.35-7.25 (m, 10H, ArH), 
5.60-5.67 (m, 1H, CH=CH2), 4.99-4.95 (m, 2H, CH=CH2), 3.71 (s, 3H, OCH3), 3.22-
3.20 (dd, J = 1.2, 6.8 Hz, 2H, CH=CH2CH2). 13C NMR (100 MHz, CDCl3) δ 174.4, 
142.5, 134.2, 128.9, 127.8, 126.8, 118.2, 60.3, 52.3, 42.7. 
 Lithium aluminum hydride (960 mg, 25.3 mmol) was added to THF (20 mL) at 0 
°C.  At this temperature, the intermediate ester (4.4 g, 16.5 mmol) in THF (10 mL) was 
added dropwise over 10 min.  The mixture was then allowed to warm up to rt and stirred 
for an additional 2 hr.  The mixture was cooled back down to 0 °C and quenched by 
careful addition of H2O (1 mL), 15% NaOH (2 mL), and H2O (3 mL).  The reaction was 
filtered through Celite and washed with EtOAc.  The filtrate was concentrated and 
purified by silica gel chromatography (20% EtOAc/hexanes) to provide the title 
compound as a white solid (3.4 g, 14.3 mmol, 87% yield).  1H NMR (400 MHz, CDCl3) δ 
7.35-7.20 (m, 10H, ArH), 5.53-5.43 (m, 1H, CH=CH2), 5.16-5.02 (m, 2H, CH=CH2), 
4.15 (d, J = 6.8 Hz, 2H, CH2OH), 3.0 (d, J = 7.0 Hz, 2H, CH=CH2CH2), 1.35 (t, J = 6.8 










2,2-diphenylpent-4-enal (29):176  The title compound was prepared according to the 
method of Ley.177  To a flame-dried, 10-mL rbf containing activated 4Å molecular sieves 
(250 mg), was added 2,2-diphenylpent-4-en-1-ol (238 mg, 1.0 mmol), N-
methylmorpholine N-oxide (176 mg, 1.5 mmol), and CH2Cl2 (3 mL).  This mixture was 
allowed to stir at RT for 10 min before tetrapropylammonium perruthenate (18 mg, 0.05 
mmol) was added in portions.  The reaction was allowed to stir at rt for an additional 2 hr.  
At this point, the reaction was transferred directly onto a short silica gel column and 
purified (20% EtOAc/hexanes) to yield a yellow oil (190 mg, 0.80 mmol, 80% yield).  1H 
NMR (300 MHz, CDCl3) δ 8.86, (s, 1H, CHO), 7.40-7.21 (m, 10H, ArH), 5.65-5.56 (m, 
1H, CH=CH2), 5.03-4.96 (m, 2H, CH=CH2), 3.13 (d, J = 7.0 Hz, 2H, CH=CH2CH2).  13C 





2-hydroxy-3,3-diphenylhex-5-enenitrile (30):  Freshly-distilled TMSCN (14 µL, 0.114 
mmol) was added to a solution of Bi(OTf)3 (6 mg, 0.0095 mmol) and 2,2-diphenylpent-4-









stirred for 4 hr.  The solution was concentrated and purified by silica gel chromatography 
(5% EtOAc/hexanes) to provide the title compound (10 mg, 36% yield).  1H NMR (300 
MHz, CDCl3) δ 7.42-7.23 (m, 10H, ArH), 5.31-5.08 (m, 4H, CH2=CH and OH), 3.14-





(2R,5S)-5-methyl-3,3-diphenyltetrahydrofuran-2-carbonitrile (31):  A solution of 2-
hydroxy-3,3-diphenylhex-5-enenitrile (10 mg, 0.038 mmol) and Bi(OTf)3 (3 mg, 0.0038 
mmol) in DCE (0.20 mL) was heated under Ar at 80 °C for 12 hr.  After cooling to room 
temperature, the reaction was concentrated and purified by silica gel chromatography 
(5% EtOAc/hexanes) to provide a title compound 31 as an inseparable mixture of 
diastereomers (7 mg, 70% yield).  GC analysis provided a 2.1:1.0 dr.  1H NMR (300 
MHz, CDCl3) δ 7.38-7.20 (m, 10H, ArH), 5.44 (s, 1H, major CH(CN)), 5.33 (s, 1H, 
minor CH(CN)), 4.67-4.61 (m, 1H, minor CH(CH3)), 4.22-4.15 (m, 1H, major 
CH(CH3)), 3.08-3.01 (dd, J = 7.7, 12.6 Hz, 1H, minor CH(CH3)CH2), 2.75 (t, J = 10.8 
Hz, major CH(CH3)CH2), 2.61-2.55 (dd, J = 5.2, 12.3 Hz, 1H, major CH(CH3)CH2), 
2.38-2.31 (dd, J = 6.4, 12.6 Hz, 1H, minor CH(CH3)CH2), 1.45 (d, J = 6.2 Hz, 3H, major 










cis-2-methyl-2-vinylcyclohexanecarbaldehyde (32):178  The title compound was 
prepared following a method established by Taillier et al.179  A solution of DMSO (84 
µL, 1.2 mmol) in CH2Cl2 (1.7 mL) was added dropwise to a pre-cooled solution of oxalyl 
chloride (0.11 mL, 1.3 mmol) in CH2Cl2 (1.6 mL) at –78 °C. After stirring for 5 min, a 
solution of cis-(2-vinylcyclohexyl)methanol (0.150 g, 1.1 mmol) in CH2Cl2 (1.4 mL) was 
added dropwise. The solution was stirred for 15 min, and then freshly distilled 
triethylamine (0.75 mL) was added. The solution was stirred at –78 °C for 15 min before 
warming to rt and stirring for an additional 20 min.  The reaction was diluted with 
CH2Cl2 (10 mL), washed sequentially with NH4Cl (10 mL) and brine (10 mL), and dried 
over Na2SO4. The crude oil was then purified via silica gel chromatography (10% 
EtOAc/hexanes) to yield a light yellow oil (0.147 g, 1.1 mmol, 99% yield).  1H NMR 
(300 MHz, CDCl3) δ 9.69 (s, 1H, C(=O)H), 6.05-5.94 (m, 1H, CH2=CHCH), 5.12-5.05 
(m, 2H, CH2=CHCH), 2.72-2.65 (m, 1H, HC(=O)CH), 2.50-2.45 (m, 1H, CH2=CHCH), 
1.89-1.79 (m, 1H, HC(=O)CHCH2), 1.72-1.53 (m, 5H, HC(O)CHCHCH2CH2CH2), 1.50-
1.36 (m, 2H, HC(=O)CHCHCH2CH2CH2). 13C NMR (75 MHz, CDCl3) δ 205.3, 138.8, 










2-hydroxy-2-((1S,2S)-2-vinylcyclohexyl)ethanenitrile (33):  A solution of freshly-
distilled trimethylsilyl cyanide (22 µL, 0.174 mmol) was added dropwise to a pre-cooled 
solution of cis-2-methyl-2-vinylcyclohexanecarbaldehyde (20 mg, 0.145 mmol) and 
Bi(OTf)3 (10 mg, 0.0145 mmol) in DCE (0.75 mL) at rt under Ar. The reaction was 
stirred at rt until aldehyde consumption was complete (1.5 hr) as monitored via TLC 
(20% EtOAc/hexanes). The solution was then concentrated, and the crude residue was 
purified by silica gel chromatography (35% EtOAc/hexanes) to yield the title compound 
(16 mg, 67% yield) as a 1.1:1.0 mixture of diastereomers.  1H NMR (300 MHz, CDCl3) δ 
6.11-5.99 and 5.61-5.52 (m, 1H, CH2=CH), 5.27-5.02 (m, 2H, CH2=CH), 4.64 (t, J = 5.0 






(1R,3S,3aR,7aS)-3-methyloctahydroisobenzofuran-1-carbonitrile (34):  A solution of 











was heated under Ar at 80 °C for 12 hr.  After cooling to room temperature, the reaction 
was concentrated and purified by silica gel chromatography (5% EtOAc/hexanes) to 
provide a title compound 34 as an complex, inseparable mixture of diastereomers (7 mg, 




phenyl((1S,2S)-2-vinylcyclohexyl)methanol:  A solution of cis-2-methyl-2-
vinylcyclohexanecarbaldehyde (0.100g, 0.724 mmol) in THF (5.5 mL) was added slowly 
to a precooled solution of phenyl magnesium bromide in THF (4.35 mL, 3.26 mmol) at –
78 °C.  After stirring for 30 min at –78 °C, the reaction was warmed to 0 °C for 2 hr.  The 
solution was then warmed to room temperature and stirred for 1.5 hr (until starting 
material was completely consumed).  The solution was cooled to 0 °C and quenched with 
1M HCl and diluted with ether.  The organic layers were washed with brine and dried 
over MgSO4.  Purification of the crude material by silica gel chromatography (10% 
EtOAc/hexanes) provided the title compound (0.135 g, 87% yield) as a mixture of 
diastereomers.  1H NMR (300 MHz, CDCl3) δ 7.34-7.20 (m, 5H, ArH), 6.91 (t, J = 7.3 
Hz, minor OH), 6.81 (d, J = 8.6 Hz, 1H, major OH), 6.29-6.14 (m, 1H, CH2=CH), 5.26-
4.76 (m, 2H, CH2=CH), 4.43 (dd, J = 2.9, 8.0 Hz, 1H, major CH(OH)), 4.30-4.26 (dd, J 










phenyl((1S,2S)-2-vinylcyclohexyl)methanone (35):  The title compound was prepared 
following a method established by Taillier et al.180  A solution of DMSO (64 µL, 0.756 
mmol) in CH2Cl2 (1.0 mL) was added dropwise to a pre-cooled solution of oxalyl 
chloride (64 µL, 0.756 mmol) in CH2Cl2 (0.94 mL) at –78 °C. After stirring for 5 min, a 
solution of phenyl((1S,2S)-2-vinylcyclohexyl)methanol (0.135 g, 0.630 mmol) in CH2Cl2 
(0.82 mL) was added dropwise. The solution was stirred for 15 min, and then freshly 
distilled triethylamine (0.44 mL) was added. The solution was stirred at –78 °C for 15 
min before warming to rt and stirring for an additional 20 min.  The reaction was diluted 
with CH2Cl2 (10 mL), washed sequentially with NH4Cl (10 mL) and brine (10 mL), and 
dried over Na2SO4.  The crude oil was then purified via silica gel chromatography (5% 
EtOAc/hexanes) to yield the title compound (70 mg, 52% yield).  1H NMR (300 MHz, 
CDCl3) δ 7.88-7.86 (m, 2H, ArH), 7.56-7.41 (m, 3H, ArH), 6.00-5.88 (m, 1H, CH2=CH), 
4.93-4.71 (m, 2H, CH2=CH), 3.57-3.51 (m, 1H, C(=O)CH), 2.73-2.69 (m, 1H, 












2-hydroxy-2-phenyl-2-((1S,2S)-2-vinylcyclohexyl)ethanenitrile (36):  A solution of 
freshly-distilled trimethylsilyl cyanide (25 µL, 0.182 mmol) was added dropwise to a pre-
cooled solution of phenyl((1S,2S)-2-vinylcyclohexyl)methanone (30 mg, 0.140 mmol) 
and Bi(OTf)3 (9 mg, 0.014 mmol) in DCE (0.70 mL) at 0 °C under Ar.  After 
approximately 4 hr, the solution was concentrated.  The crude residue was purified by 
silica gel chromatography (10 % EtOAc/hexanes) to yield the title compound as a 5.9:1.0 





(1S,3S,3aR,7aS)-3-methyl-1-phenyloctahydroisobenzofuran-1-carbonitrile (37):  A 
solution of nitrile 36 (7 mg, 0.029 mmol) and Bi(OTf)3 (2 mg, 0.0029 mmol) in DCE 
(0.30 mL) was heated under Ar at 80 °C for 12 hr.  After cooling to room temperature, 
the reaction was concentrated and purified by silica gel chromatography (10% 
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